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Abstract 
The hip is a ball and socket joint in which the femoral head (the ball) articulates with the 
acetabulum (the socket). In a condition called femoroacetabular impingement (FAI) the hip 
has a shape abnormality and is no longer perfectly spherical. The hip shape abnormality FAI 
provokes premature impingement between the femoral head and rim of the acetabulum 
leading to pain and in the longer term osteoarthritis. Slipped capital femoral epiphysis 
(SCFE), an adolescent hip disease, is thought to be one cause of FAI. However, a cohort 
study of patients with SCFE presented in this thesis found no evidence of an association 
between worsening hip shape, function and pain. Factors other than abnormal hip shape 
may therefore have an important role in the development of hip symptoms in both SCFE and 
FAI.  
Systematic reviews presented in this thesis highlight that surgery or physical therapy can be 
used to treat FAI but the true clinical effectiveness of either treatment is not known. At least 
100 surgeons undertook 2399 surgical procedures in the year 2011/12 in the UK National 
Health Service for FAI of which 80% were done arthroscopically. A qualitative interview study 
amongst 14 of these surgeons showed that many would like to engage in a RCT measuring 
the clinical effectiveness of their surgery. To test recruitment to such a RCT a pilot RCT 
comparing hip arthroscopy versus nonoperative care for FAI was undertaken. Forty-two out 
of 60 (recruitment 70%) eligible patients were recruited. Twenty one patients were allocated 
to nonoperative care, and 81% received per protocol treatment, with no evidence of serious 
adverse events. The work in this thesis should now facilitate a RCT to be undertaken in an 
area (treatment for FAI) where no RCTs have previously been conducted. 
 
Words=289/300 
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Chapter 1 Introduction 
1.1 Declarations 
Aspects of this chapter have been published: 
Wall P, Brown J, Wyse M, Griffin D. An Introduction to Hip Arthroscopy part one: Surgical 
anatomy and technique. Orthopaedics and Trauma 2011; 25:6: 441-447 
 
Wall P, Brown J, Griffin D. An introduction to hip arthroscopy part two: indications, outcomes 
and complications. Orthopaedics and Trauma 2012; 26:1: 38-43 
1.2 Thesis aims and objectives 
The aims of this thesis are: 
1. To explore the correlation if any between abnormal hip shape and long term hip specific 
quality of life in the context of slipped capital femoral epiphysis (SCFE); which is thought 
to be one mechanism by which patients can develop cam type femorocacetabular 
impingement (FAI).  
2. Design a randomised controlled trial (RCT) to measure the clinical effectiveness of FAI 
surgery by: 
a. Establishing a suitable nonoperative treatment comparator.  
b. Exploring equipoise within the FAI surgical community in order to understand any 
barriers to a full RCT and subsequent recruitment.  
c. Estimate the size and scale of a full RCT by: 
i. Estimating the number of FAI surgeons and their individual workload within the 
National Health Service (NHS). 
ii. Estimating the recruitment rate of patients by undertaking a pilot RCT. 
1.3 Hip: structure, embryology and function 
The human hip joint is classified as an enarthrodial joint (ball and socket joint) and forms the 
connection between the pelvis and lower limb.1 A femoral head (the ball) articulates with the 
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cup shaped acetabulum (socket). Traditionally anatomists described the femoral head as 
spherical (hence the name ball and socket joint).1 More recent research suggests that the 
femoral head is not infrequently aspherical in shape. However, the use of the expression 
“ball and socket joint” continues.2,3  
 
During foetal development the hip joint forms from a single mass of scleroblastema which is 
first evident at six weeks between the cartilage structures of the femur and acetabulum.4,5 
The bony structure, cartilage, muscles and tendons are all formed from mesoderm. The joint 
space of the hip forms at 11 weeks at which point the femur and acetabulum are well formed. 
The acetabulum becomes progressively shallower during fetal life but after birth it begins to 
deepen again.6 The acetabulum is formed by the union of the pubis, ilium, and ischium, all of 
which have both primary and secondary ossification centres.7 The secondary ossification 
centres all appear during the first decade of life and have fused by 17 to 18 years of age.4  
 
The ilium, ischium and pubis make up the innominate bone. The rim of the acetabulum is 
surrounded by the labrum, which is a triangular section of fibrocartilage. The labrum is 
thought to have two important roles: 
i. It deepens the acetabulum and provides a seal to counter distraction of the femoral 
head and improve joint stability.4 
It contains and controls synovial fluid in the central compartment (see page 24) of the hip as 
the joint is loaded.4 At its inferior margin the labrum becomes the transverse ligament. The 
labrum can vary considerably in size particularly in association with diseases that alter hip 
shape. For example in developmental dysplasia of the hip (DDH), a childhood hip disease, 
the labrum often becomes hypertrophied as a result of inadequate coverage of the femoral 
head by the acetabulum and subsequent excessive weight bearing forces through the lateral 
aspect of the acetabulum and increased loading of the labrum.8 In addition damage to the 
labrum – such as tears – are strongly associated with early joint degeneration.9 The capsule 
of the hip is a tough fibrous layer that attaches to the acetabulum just peripherally to the 
labrum and transverse ligament. From this attachment the capsule extends like a sleeve 
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circumferentially and attaches to the neck of the femur. The capsule therefore provides some 
additional stability to the hip joint by virtue of its connection to both the acetabulum and 
femur. The part of the acetabulum covered with articular cartilage is called the lunate surface 
– see Figure 1.1 and Figure 1.2. 
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Figure 1.1: View of central compartment of hip joint during hip arthroscopy (Source: Wall et 
al
10
) 
 
Figure 1.2: Further view of central compartment of hip joint during hip arthroscopy (Source: 
Wall et al
10
) 
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The cartilage overlying the lunate surface forms a horseshoe-shaped configuration and 
extends from the postero-inferior aspect to the antero-inferior aspect of the acetabulum. In 
the middle of the acetabulum and therefore contained within the horseshoe of cartilage is the 
cotyloid fossa.10 The cotyloid fossa does not contain any articular cartilage but instead has 
within it a pad of fat. The cotyloid fossa is also the site of attachment for the ligamentum 
teres, which is a large strap like structure that connects the femoral head to the acetabulum. 
The attachment is in the base of the cotyloid fossa and close to the posterior attachment of 
the transverse ligament – see Figure 1.1 and Figure 1.2. The ligamentum teres is slightly 
broader and typically covered in synovial membrane at its connection to the acetabulum. The 
other attachment of the ligamentum teres is to a pit or fovea in the centre of the femoral 
head. 
The following three ligaments, which are distinct thickenings of the capsule of the hip provide 
additional stability to the joint:   
i. the iliofemoral ligament which lies anteriorly and connects the femur to the ileum; 
ii. the pubofemoral ligament which lies anteriorly and connects the femur to the pubis 
and 
iii. the ischiofemoral ligament which lies posteriorly and connects the femur to the 
ischium. 
These all form direct connections between each of the bones that constitute this part of the 
pelvis. 
 
The use of hip arthroscopy (keyhole surgery - see section 1.11) has revealed the following 
additional clinically relevant anatomical areas of the hip joint: 
i. The central compartment the space between the surface of the femoral head and the 
acetabulum, limited by the labrum. This compartment comprises the hips articular 
surfaces and labrum - see Figure 1.3 and Figure 1.4, which are Magnetic Resonance 
Arthrography (MRA) views of the hip joint. 
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ii. The peripheral compartment refers to the remainder of the hip joint within the 
intracapsular space but both lateral and peripheral to the labrum. It includes the area 
along the junction of the femoral head and neck – see Figure 1.3 and Figure 1.4. 
Figure 1.3: Coronal section of hip joint using MRA (Source: Wall et al
10
) 
 
Figure 1.4: Axial section of hip joint using MRA (Source: Wall et al
10
) 
 
The hip joint is designed to support the entire weight of the upper body whilst allowing 
movement to occur between the pelvis and lower limb during activities such as walking, 
running and climbing. The forces that cross the hip joint are large with up to three times body 
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weight transferred across the hip during normal walking and this increases to seven times 
with fast walking.11  
 
The hip joint allows movement in three anatomical planes – see Figure 1.5: 
i. Sagittal; allows flexion and extension.  
ii. Coronal; allows abduction and adduction 
iii. Transverse; allows internal and external rotation 
Figure 1.5: Anatomical planes (Source: Cook et al
12
) 
 
Ranges of movement for the hip joint can vary markedly but for the purpose of this thesis the 
following published parameters have been used:13 
i. Flexion; 0 degrees to between 100° and 135° 
ii. Extension; 0 degrees to between 15° and 30° 
iii. Abduction; 0 degrees to between 40° and 45° 
iv. Adduction; 0° to 25° 
v. Internal rotation; 0° to between 30° and 40° 
vi. External rotation; 0° to between 40° and 60° 
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1.4 Osteoarthritis of the hip 
Osteoarthritis (OA) is one of the most common types of arthritis and the hip is one of the 
joints most frequently affected.14 OA is typically defined as a clinical syndrome which affects a 
joint, with subsequent pain and loss of function.15 The pathology underlying OA involves 
structural changes within the joint. However, it is not uncommon for patients to have evidence 
of structural change without any symptoms.15 The structural changes involve loss of hyaline 
articular cartilage, subchondral changes (both sclerosis and cysts), reduction in the normal 
joint space, and evidence of new bone formation (osteophytes). Many of these structural 
features described can be evaluated with radiological imaging, which is the rationale for 
imaging being used to confirm a diagnosis of OA.16 One method described by Tonnis et al for 
assessing radiological evidence of OA, which will be used later in this thesis, is described in 
Table 1.1. 
Table 1.1: Tonnis grading system for OA of the hip
17
  
Tonnis 
Grade 
Radiographic Description  
(using anterior posterior pelvic radiograph only) 
0 No signs of osteoarthritis 
1 Slight narrowing of joint space, slight lipping at joint margin, slight sclerosis of 
femoral head or acetabulum 
2 Small cysts in femoral head or acetabulum, increasing narrowing of joint space, 
moderate loss of sphericity of femoral head 
3 Large cysts, severe narrowing or obliteration of joint space, severe deformity of 
femoral head, avascular necrosis 
 
The prevalence of structural changes consistent with hip OA found on radiological imaging is 
reported to be 27% amongst adults ≥45 years of age.14 However, of this group the prevalence 
of symptomatic hip OA (evidence of symptoms and structural change on radiological imaging) 
is much lower and has been reported as 9.2%.14  
 
The majority of hip OA is so called ‘primary / idiopathic’, for which the cause is unknown. 
Studies have shown that primary OA of the hip has a strong hereditary (genetic) component 
but the mechanism by which genetic predisposition leads to disease is not known.18,19 
Surgery for hip OA is typically reserved until other non-operative treatments no longer provide 
adequate relief of symptoms.15 In 2011, 80,314 total hip replacements were undertaken in the 
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United Kingdom, of which 93% were reported as being performed to alleviate the symptoms 
of OA.20 
1.5 Young adult hip pain 
Over recent years the management of hip pain in young adults has evolved considerably.21,22 
A small proportion of young adults with pain have established OA, inflammatory arthritis, 
avascular necrosis (AVN), fractures or preexisting childhood hip disease (such as DDH), and 
their care sometimes includes surgery.22 However, until recently the majority of patients had 
no specific diagnosis and received multidisciplinary medical care, provided by a combination 
of physiotherapists, rheumatologists, orthopaedic surgeons, sport and exercise medicine 
physicians, and general practitioners.21 Over the last ten years however, there has been 
increasing recognition of the syndrome of femoroacetabular impingement (FAI), which may 
account for a large proportion of the previously undiagnosed cases of hip pain in young 
adults and subsequent so called primary OA.21,23  
1.6 Femoroacetabular Impingement: background 
The association between an abnormal hip shape and early onset degenerative hip disease 
(OA) has been known for some time.24-26 DDH a condition, that prevents the hip joint from 
forming a normal shape in childhood and leads to a lack of acetabular coverage of the 
femoral head, is associated with and thought to be a risk factor for OA.27  
In 1966 Murray hypothesised that the majority of so called “primary” hip OA resulted from 
“minimal anatomical variations” and that these “correspond to the more gross abnormalities of 
acetabular dysplasia (DDH) and of the adult deformity resulting from epiphysiolysis (SCFE 
described later in 1.8.2)”.26 He suggested that: “their presence postulates an abnormal joint 
mechanism and the resulting incongruity of the articular surfaces makes the development of 
degenerative change more likely than in a joint having a normal anatomical structure.” He 
tested his theory by reviewing pelvis radiographs from 50 patients with no hip symptoms and 
no evidence of OA and compared these to 200 patients with primary hip OA. He assessed 
both cohorts of patients using established radiographic criteria for acetabular dysplasia which 
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included a Centre Edge (CE) angle of Wiberg and acetabular depth (see section 1.9). He also 
described a new radiographic measure - “femoral head ratio” – to determine cases of so 
called “tilt deformity” which he believed represented an abnormal relationship of the femoral 
head to the femoral neck. In 10% of the control population and 39% of patients with hip OA 
there was evidence of “tilt deformity”. Similarly in 3% of the control population and 25% of 
patients with hip OA there was evidence of subtle acetabular dysplasia. He concluded that 
“65% of so called primary hip OA is in reality secondary to a pre-existing asymptomatic 
abnormality.” He recognised that acetabular dyplasia was a “forme fruste” of DDH and that its 
association with hip OA was nothing new. However he highlighted that “tilt deformity as a 
precipitating factor in the development of OA of the hip has received astonishingly little 
comment”. Murray was referring to the dearth of publications in this field and only one other 
similar published account by Law (1952) which stated that: “I am of the opinion that quite a 
number of cases placed in the primary OA group are really the result of a slight degree of 
slipping of the upper femoral epiphysis (SCFE see section 1.8.2), which did not cause 
symptoms or signs during adolescence, and which were masked by hypertrophic changes in 
the joint later.”28 Law apparently went on to test this theory but never formally published the 
results other than in personal communications.26  
The work by Murray was closely followed by Stulberg et al in the 1960 and 1970s who noticed 
that up to 40% of patients who develop hip OA have evidence of a so called “pistol grip 
deformity” on plain radiographs prior to presentation with symptomatic OA – see Figure 1.6.24  
Figure 1.6: "Pistol grip deformity" (Source: Stulberg et al
24
) 
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It was not until 2001 when Ganz et al described a technique for safely dislocating the hip joint 
without compromising the blood supply to the femoral head (Avascular Necrosis-AVN), that 
the concept of subtle hip shape malformations and hip pain and early OA progressed further. 
Ganz et al published results for 213 procedures over a 7 year period and gave no reported 
cases of AVN. By using either this open approach or hip arthroscopy +/- Magnetic 
Resonance Arthrography (MRA – see section 1.10), Ganz and colleagues began 
investigating patients with evidence of intra-articular hip and labral pathology. They began to 
describe a population of young patients with hip pain but no evidence of overt OA.29 These 
patients had subtle hip shape abnormalities (other than known shape malformations such as 
DDH) which they collectively described as FAI (see Figure 1.8 and Figure 1.9). Associated 
with these shape abnormalities they noticed characteristic patterns of soft tissue injury (labral 
and chondral lesions - see Figure 1.10 and  Figure 1.11) within the hip joint.23 Since the early 
descriptions by Ganz et al, FAI is now generally thought of as a syndrome that results from 
subtle shape malformations of the hip combining to cause premature impingement between 
the femoral neck and anterior rim of the acetabulum during the terminal phases of hip motion 
leading to soft tissue injury. FAI is thought to occur most frequently when the hip joint is in a 
combined position of flexion, adduction and internal rotation. This is known as the FADIR 
position (Flexion, ADduction and Internal Rotation) also demonstrated by the anterior 
impingement test (see Figure 1.730,31).  
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Figure 1.7: Typical position of impingement (FADIR test) 
 
FAI seems to cause both hip pain (possibly attributable to associated soft tissue injury) and 
reduced ranges of hip movement, probably due to the mechanical block the shape 
malformation exerts on the hip joint in certain ranges of movement. Ganz et al suggested that 
these hip shape abnormalities consistent with FAI and the resultant soft tissue injury leads to 
early degenerative disease of the hip.23 The evidence is that FAI and OA are associated and 
many surgeons believe that FAI is actually a risk factor for subsequent OA.23,32-34    
Ganz et al described three types of FAI shape malformation of the hip joint:23 
a. Cam type which involves an asphericity of the femoral head and or widening of the 
femoral neck (see Figure 1.8). The “pistol grip deformity” Stulberg described back in 1975 
is similar to what Ganz et al called “cam type FAI” in 2001. 24,35 
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Figure 1.8: Axial Line drawing of hip with cam deformity 
 
b. Pincer-type which is an abnormal version of the femur or acetabulum leading to over-
coverage of the antero-superior acetabular wall or an acetabulum that is deep (coxa 
profunda or protrusio) leading to global over coverage of the femoral head (see Figure 
1.9) 
Figure 1.9: Axial line drawing of the hip with pincer deformity 
 
c. Mixed type hip impingement; a combination of cam and pincer types. 
Anyone of these three malformations can lead to excess contact forces between the proximal 
femur and the acetabular rim during the terminal motion of the hip leading to lesions of 
acetabular labrum (see Figure 1.10) and the adjacent acetabular cartilage (see Figure 
1.11).30  
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Figure 1.10: Hip arthroscopy view of a labral tear due to cam type FAI (Source: Wall et al
36
) 
 
Figure 1.11: Hip arthroscopy view of cartilage damage due to cam type FAI (Source: Wall et 
al
36
) 
 
Ganz et al thought damage to either the labrum or cartilage as a result of FAI leads to 
progressive hip joint degeneration and OA23. The association between FAI and OA may be 
expressed in the following way see Figure 1.12. 
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1.7 Femoroacetabular impingement: pathobiomechanics 
The pattern of damage caused varies depending upon the subtype of FAI involved. Beck et 
al reported on 244 hips that had undergone “Ganz  type” surgical hip dislocations for intra-
articular hip pathology.37 Preoperative pelvic radiographs (both anterior-posterior and cross 
table lateral views) were reviewed to determine which patients if any had evidence of either 
cam or pincer type FAI. During surgery the state of the labrum and acetabular cartilage and 
femoral cartilage was recorded and the location of any damage noted. Beck et al found that 
in all hips with cam type the acetabular cartilage was damaged anteriosuperiorly and that the 
cartilage had separated from the labrum, but the labrum itself was still well attached to the 
bone. In pincer type there was more circumferential damage with only a “narrow strip” of 
acetabular cartilage involved. In pincer type where the cartilage was damaged there was also 
damage to the labrum which was frequently ossified. Based upon these findings they 
suggested that there were likely to be two quite distinct pathomechanical consequences of 
cam and pincer type FAI. Beck et al and now others have proposed that in cam type an 
inclusion injury (“or outside in pattern”) occurs whereby the abnormal femoral head with 
increasing radius jams into the acetabulum during forceful hip motion (typically flexion).25,37 
The impact stretches and pushes the labrum outwards and leads to a compressive and 
Figure 1.12: Potential theory for association between FAI and OA 
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shearing force on the cartilage as it is pushed centrally particularly at the labro-chondral 
junction.4,31,37 As a result areas of cartilage delamination develop where it peels away in 
layers and from the underlying bone.31,38 In pincer-type impingement, it has been suggested 
that the femoral neck abuts the labrum (impaction type FAI) compressing it between the 
femoral neck and rim of the acetabulum.4,31,37 This force is transmitted to the acetabular 
cartilage but only to a limited degree and the labrum acts as the primary bumper. Repeated 
micro trauma to the labrum leads to intra-substance fissuring and cyst formation and can 
result in ossification of the labrum, which further deepens the socket and exacerbates the 
impingement.4,31,37 
One proposed mechanism by which patients with FAI feel pain relates to activation of the 
nerve endings which run within the non-articular portion of the labrum where it attaches to 
bone. Therefore, labral tears, degeneration and separation can all elicit pain.4,37 However, the 
mechanism by which cartilage lesions elicit pain if at all is less clear in much the same way 
as the mechanisms of pain in OA remain unclear.39   
1.8 Femoroacetabular Impingement: aetiology and epidemiology 
A description of the epidemiological characteristics of FAI is incomplete, primarily because 
the condition has only recently been formally described in published literature over the last 
decade. However, several epidemiological studies were published on FAI in 2010: 
Hack et al published a cross-sectional study of 200 asymptomatic patients (aged 21-50). 
Patients underwent an MRI of both hips. They found that 14% of patients had at least one hip 
with cam type FAI morphology. In addition 24.7% of men compared to 5.4% women had 
evidence of cam morphology.40 
Reichenbach et al published a cross-sectional study of 244 asymptomatic young (mean age 
19.9 years) male recruits to the Swiss army and found the prevalence of cam type FAI to be 
24% (95% CI 19-30%).41 
Gosvig et al published a cross-sectional study of 3620 subjects in Copenhagen, Denmark.42 
Subjects had a plain pelvis radiograph, which was used to identify evidence of hip shape 
malformations and were asked whether they had experienced frequent and recurrent deep 
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pain in the groin during the last 12 months. The results showed: 
i. Radiographic evidence of acetabular dysplasia in 4.3% men and 3.6% of women. Of 
these 22% of the men and 16% of the women had evidence of groin pain. 
ii. Radiographic deep acetabular socket (coxa profunda and/or protrusion acetabuli) in 
15.2% of men and 19.4% of women. Of these 11% of the men and 13.1% of the 
women had evidence of groin pain. 
iii. Radiographic pistol grip deformity in 19.6% of men and 5.2% of women. Of these 16.1% 
of the men and 18% of women had evidence of groin pain. 
They also found that 12.6% of the men and 15% of women with no evidence of hip shape 
abnormality had groin pain. There was no significant difference (p=0.13) in the prevalence of 
reported groin pain between the two groups (those with hip shape abnormality and those 
without hip shape abnormality). 
 
There are an increasing number of publications concerning FAI. However the concept of FAI 
is controversial. To my knowledge there are no published references that formally voice this 
controversy, but scepticism does pervade amongst the Orthopaedic and wider community. 
For example I delivered a presentation at the Annual Oswestry Research Day Meeting 2013 
(a meeting attended predominantly by Orthopaedic surgeons, Rheumatologists, laboratory 
scientists and physical therapists) on aspects of my thesis (treatments for femoroacetabular 
impingement). At the end of my presentation during questioning the meeting convenor – 
sensing a mix of opinions amongst the crowd - asked the audience to show hands if they 
believed that FAI did not truly exist as a clinical entity; a sizeable (approximately 30%) 
proportion raised their hands. This is informal anecdotal evidence but similar post 
presentation feedback was received at international and national meetings during the course 
of my research. Comments such as “this is surgeons creating work for themselves” were not 
uncommon opinions often voiced with vigour! The mixture of FAI proponents and sceptics I 
believe highlights the lack of adequate research and understanding within this subject area. 
However, in terms of evaluating treatment options for FAI it does represent a potential barrier 
whereby some clinicians (often surgeons) are strong believers (for some their livelihood relies 
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on it) reluctant to offer their patients anything other than surgery while others regard treatment 
of a “fictitious” syndrome as pointless and when surgery is involved, potentially harmful.               
1.8.1 The nine Bradford Hill principles of disease causality 
In 1965, Bradford Hill described a methodology for establishing disease causality:43 It is 
helpful to apply the nine principles described in his research to understand the possible 
relationship between FAI hip shape malformations causing hip pain and the later onset of OA. 
i. Strength of association 
 “To take a very old example, by comparing the occupations of patients with scrotal cancer 
with the occupations of patients presenting with other diseases, Percival Pott could reach a 
correct conclusion because of the enormous increase of scrotal cancer in the chimney 
sweeps”. 
Applying work published by Gosvig et al suggests the strength of association between hip 
shape abnormality and hip pain is weak; with no significant difference in prevalence of hip 
pain between those with FAI like hip shape malformations and those without.42 Unfortunately 
the authors do not present a power calculation for their research and type 2 statistical error 
remains a possibility. The research also included those with hip shape malformations 
associated with DDH in the analysis making it difficult to establish if there is any true 
association with hip pain. However, given the reported prevalence of hip shape abnormality in 
the general population (approximately 20% of men with cam type FAI) and the lower 
prevalence of hip pain (approximately 7% in the young adult population44) there are likely to 
be other extraneous factors other than hip shape malformations contributing to symptomatic 
FAI. The research presented so far suggests that abnormalities of hip shape consistent with 
FAI are so common that they should be considered as spectrums of normality and that the 
shapes described as FAI are merely an incidental finding amongst patients that have hip pain.  
However, Ochoa et al, found that the prevalence of FAI type shape abnormalities amongst 
patients with hip related complaints is as high as 87%.45 Overall the research seems to 
suggest that the strength of association between FAI shape abnormalities and hip pain is not 
strong, but in patients with hip pain in the absence of other known causes of hip pain 
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(rheumatoid arthritis, septic arthritis etc.) the prevalence of FAI type shape abnormalities is 
high.    
The association between hip shape abnormalities and OA is, however, clearer. Gosvig et al 
found that both a pistol grip deformity (cam type FAI) and a deep acetabulum (pincer type 
FAI) were associated with an increased risk of OA – risk ratio 2.2 and 2.4 respectively. 
Similarly Kim et al found an association between acetabular retroversion (pincer type FAI) 
and OA (r=0.46, p<0.01).32 
ii. Consistency 
 “Has it been repeatedly observed by different persons, in different places, 
circumstances and times?” 
The concept of FAI syndrome is consistent in the published literature. Many case series of 
patients (the majority whom have undergone surgical intervention) have been published in 
which authors describe patients with FAI as having: hip shape malformation, evidence of soft 
tissue injury (chondral or labral lesions), hip pain and evidence of early degenerative 
disease.46-48 
iii. Specificity 
When discussing amongst workers: 
“If, as here, the association is limited to specific workers” (in a nickel refinery) “and to 
particular sites and types of disease” (rates of nasal and lung cancer) “and there is no 
association between the work and other modes of dying, then clearly that is a strong 
argument in favour of causation.” 
There are already other well proven causes of both hip pain and OA. Therefore, an exclusive 
link between hip shape and hip pain or OA is unrealistic. Bradford Hill acknowledged this and 
reiterated that when specificity is present the causal link is likely to be very strong, but in most 
cases of disease particularly multifactorial disease, specificity is rarely present. 
iv. Temporality 
 “Which is the cart and which the horse? This is a question which might be particularly 
relevant with diseases of slow development.” 
There are no current published accounts of a temporal relationship between FAI hip shape 
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abnormalities and subsequent hip pain. However, Gregory et al explored the temporal 
relationship between hip shape and subsequent OA.33 The authors use an established cohort 
of patients (the Rotterdam study49) and analysed plain pelvic radiographs of patients, using a 
shape analysis model. The initial cohort had no evidence of OA. This was then divided into 
those that subsequently developed OA and those that did not. A particularly shape 
characteristic (mode 6 shape – which correlates well with cam type FAI) was found to be 
associated with subsequent OA and need for THA. 
v. Biological gradient 
 “If the association is one which can reveal a biological gradient, or dose-response curve, 
then we should look most carefully for such evidence. For instance, the fact that the death 
rate from cancer of the lung rises linearly with the number of cigarettes smoked daily, adds a 
very great deal to the simpler evidence that cigarette smokers have a higher death rate than 
non-smokers.” 
There are no well described biological gradients for FAI. For example there is no evidence 
that a more severe cam type FAI deformity increases the risk of, or severity of, hip pain and 
or OA. However, this may in part be a reflection of an inadequate quantification of shape 
abnormality. The most routine measurement of cam type FAI is the alpha angle which is 
determined from either plain hip radiographs or cross-sectional imaging, but this 
measurement provides very little detail about the volume or extent of the shape 
abnormality.50,51  
vi. Plausibility 
 “It will be helpful if the causation we suspect is biologically plausible.” 
Perhaps the most compelling aspect of FAI is the strong mechanical argument that bony hip 
shape abnormalities such as cam and pincer type FAI can lead to soft tissue injury in and 
around the hip joint, particularly to the labrum and articular cartilage. A better understanding 
of the structure and function of the labrum has helped support the plausibility of FAI. The 
labrum is innervated with nerve fibres around its attachment to the non-articular zone of the 
acetabulum and therefore injury to it is typically painful.4 In addition the labrum is thought to 
act as a high pressure seal for synovial fluid around the hip and therefore it is entirely 
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plausible that damage to this seal by bony impingement might lead to early hip joint failure 
and subsequent OA.4 
vii. Coherence 
 “The cause-and-effect interpretation of our data should not seriously conflict with the 
generally known facts of the natural history and biology of the disease.” 
The concept of FAI is coherent with the current understanding of hip pain and OA. For 
example it is well established that gross shape abnormality of the hip such as that seen after 
malunited hip fractures or Legg-Calve-Perthes disease leads to hip pain and stiffness and 
subsequent OA.27 The FAI model really describes a spectrum of hip shape abnormality that is 
less severe than this but the implications of which are a risk of hip pain and subsequent OA. 
viii. Experiment 
 “Occasionally it is possible to appeal to experimental, or semi-experimental, evidence. For 
example, because of an observed association some preventive action is taken. Does it in fact 
prevent?” 
There are numerous case-series and now systematic reviews of these case series detailing 
the favourable outcome of surgery for FAI in terms of reduced hip pain and improved hip 
function.48 See Chapter 3 for a review of the available RCT level evidence examining 
treatments for FAI. 
ix. Analogy 
 “In some circumstances it would be fair to judge by analogy. With the effects of thalidomide 
and rubella before us we would surely be ready to accept slighter but similar evidence with 
another drug or another viral disease in pregnancy.” 
DDH is a condition that leads to a hip shape abnormality (see section 1.3 and 1.5). DDH hip 
shape is different to FAI-like shape malformations but nevertheless DDH is associated with 
hip pain and a risk of subsequent OA. 
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1.8.2 Slipped Capital Femoral Epiphysis and cam type FAI 
Leunig et al identified a possible link between Slipped Capital Femoral Epiphysis (SCFE) and 
the cam type FAI deformity (described in section 1.6).25 Many researchers now believe that 
SCFE is one mechanism by which patients could develop cam type FAI.52 SCFE is a rare hip 
disorder (prevalence approximately 0.71 to 10.8 per 100,000 children) that presents in 
adolescence.53 The adolescent femoral head and neck which is still growing is made up of an 
epiphysis (the rounded end or femoral head), a physis (the growth plate) and a metaphysis 
(the widening of the femoral neck which connects to the diaphysis or shaft of the femur) – 
see Figure 1.13. 
Figure 1.13: Cross-section of proximal femur showing the physis (Source: 
www.orthopediatrics.com)  
 
 
The underlying pathology of SCFE is disruption through the proximal femoral physis allowing 
the metaphysis to displace superiorly and anteriorly, while the epiphysis remains in the 
acetabulum (see Figure 1.14).54  
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Figure 1.14: Pelvis radiograph of pelvis showing SCFE of right hip  
 
Southwick reported a method for quantifying the severity of SCFE by referring to amount of 
angulation that results at the hip following a SCFE. Southwick describing an angle subtended 
between the epiphysis and femoral shaft taken from a frog lateral radiograph.55 These angles 
can be categorised into mild – less than 30°, moderate – 30° to 50° and severe – greater 
than 50°.55,56 
 
Historically a substantial proportion of patients with SCFE undergo in-situ fixation for the full 
spectrum of SCFE severity.56 However, more recently there is some controversy about the 
best treatment even amongst patient with mild SCFE.52,54 The main reason for this 
controversy relates to the variation in reported long term clinical outcome in terms of pain 
and function following surgery for SCFE and the realisation that if SCFE is a cause of cam 
type FAI, accepting any degree of hip shape abnormality may be detrimental in the longer 
term.56-59  If SCFE is a cause of cam type FAI, then it may be expected that an increase in 
severity of SCFE would be associated with a deterioration in long term functional outcome.  
The relationship between abnormalities of hip shape associated with SCFE/FAI and the 
effects on hip specific quality of life are explored further in Chapter 2.    
Epiphysis: held in acetabulum 
Physis: area of slip 
Metaphysis: displaced 
and prominent 
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1.9 Femoracetabular impingement: radiographic measures of hip 
shape 
There are a number of ways of quantifying hip shape for both the femoral and acetabular 
side in relation to FAI, these include: 
Femoral side 
i. Alpha (α) angle50 
The alpha angle is the angle subtended between two lines projecting from the centre of the 
femoral head: one along the line of the femoral neck and the other to a point where the 
femoral head is no longer spherical – see Figure 1.15 
Figure 1.15: Diagramatic representation of the α angle (Source: Notzli et al 2002
50
) 
 
ii. Beta (β) angle60 
The beta angle is the angle subtended between two lines projecting from the centre of the 
femoral head; one to the edge of the acetabulum, other to a point where the femoral head is 
no longer spherical (see Figure 1.16). 
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Figure 1.16: Diagramatic representation of the β angle (Source: Brunner et al 2010
60
) 
 
iii. Anterior offset61 
The anterior offset is the perpendicular distance from the femoral neck to the outer cortex of 
the femoral head (see Figure 1.17).  
Figure 1.17: Diagramatic representation of the anterior offset / ratio (Source: Pollard et al 
2010
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) 
 
iv. Triangular offset63 
The distance r (radius of the femoral head) is measured – see Figure 1.18. H is then 
measured which is the distance to the anterior cortex measured at a point ½ r along a line 
from the centre of the femoral head through the centre of the femoral neck (line B). Distance 
R, which is √(H2 + (1/2r)2) is then calculated. If R is >r then it is regarded as pathological. 
45 | P a g e  
Figure 1.18: Diagramatic representation of the triangular index (Source: Gosvig et al 2007
63
) 
 
Acetabular side 
i. Lateral centre edge angle (Centre edge angle of Wiberg) 
The angle is formed between two lines emerging from the centre of the femoral head (see 
Figure 1.19): one vertical line perpendicular to the transverse axis of the pelvis and one line 
to the lateral edge of the dense subchondral plate of the acetabulum.  
Figure 1.19: Diagramatic representation of the lateral centre edge angle 
 
ii. Tonnis angle 
The Tönnis angle is the angle formed between lines 2 and 3 (see Figure 1.20). Line 1 is a 
line connecting the base of the teardrops of each acetabulum. Line 2 is a horizontal line 
parallel to line 1 so that it intersects the inferior point of line 3. Line 3 runs from the inferior 
point of the sclerotic acetabular sourcil and the lateral margin of the acetabular sourcil.  
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Figure 1.20: Diagramatic representation of the Tonnis angle (Source: Clohisy et al)
64
 
 
1.10  Femoroacetabular Impingement: cross-sectional imaging 
The radiographic measures described in section 1.9 can be taken from plain radiographs of 
the pelvis and hip or more accurately from cross-sectional imaging such a Computed 
Topography (CT) or Magnetic Resonance (MR) imaging. The advantage of cross-sectional 
imaging is that measures such as the alpha angle can be obtained in multiple anatomical 
planes, thus allowing a more three dimensional perspective of FAI like shape abnormality to 
be appreciated. Rakhra et al described a process of using the multi planar reformation (MPR) 
feature of MR to generate images perpendicular to the long axis of the femoral neck using 
the centre of the femoral neck as the axis of rotation, with images generated at 15 degree 
intervals (see Figure 1.21).65 The result is radial MPR images oriented orthogonal to the 
femoral head neck junction see Figure 1.21 - image C. 
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Figure 1.21: Radial reformatting of MR images along femoral neck (Source: Rakhra et al)
65
  
 
The same MPR process with radial reformatting along the axis of the femoral neck can also 
be achieved with CT imaging. 
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1.10.1 CT imaging 
Additional features of FAI that may be identified from CT include ossification of the labrum 
along the acetabulum in the zone of impingement and sclerosis and subchondral cyst 
formation which may be features of both FAI and early onset joint degeneration.66 
1.10.2 MR Imaging  
MR provides high resolution imaging of the labrum, cartilage and joint space as well as 
depicting the regional soft tissues.67 Several MR techniques have been described including:  
i. conventional MR Imaging; 
ii. direct MR Arthrography (D-MRA) which involves an intra-articular injection of contrast 
medium; 
iii. indirect MR arthrography (I-MRA) where the contrast medium is administered by 
peripheral intravenous injection.68  
D-MRA is currently the preferred imaging technique for detecting intra-articular hip pathology 
associated with FAI such as labochondral separation and labral tears.68-70  
1.11  Femoroacetabular Impingement: management options 
1.11.1 Surgical options 
The “Ganz” approach by dislocating the hip joint without damaging the blood supply to the 
femoral head allowed the development of open surgical techniques to correct the shape 
abnormalities of FAI. The aim of surgical treatment is to reshape those parts of the hip joint 
which appear to be responsible for premature femoral abutment against the rim of the 
acetabulum. This is achieved by re-profiling the rim of the acetabulum (in pincer-type FAI) 
and/or reshaping the femoral head/neck (in cam-type FAI).71 Good clinical results were 
initially reported for the “Ganz” open surgical approach.48,72 Beck et al reported a mean 
improvement in the Merle d’Aubigne Score of 2.4 points with 68% patients reporting a 
clinically good or excellent outcome in their case series of 19 patients with a mean follow-up 
of 4.7 years.46  
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The “Ganz” approach is a major operation and involves a trochanteric osteotomy in order to 
dislocate and expose the hip joint. The post-operative rehabilitation, is, long and patients 
typically have to use crutches while the osteotomy heals. In order to try and minimise the 
invasiveness of open surgery some surgeons have adopted a “mini-open” approach.73 This 
involves surgical intervention on the anterior aspect of the hip joint, and the risk of damaging 
the blood supply to the femoral head is low. However, while theoretically less invasive and 
without the need for a trochanteric osteotomy the technique only provides limited access to 
the anterior aspect of the hip joint. It is therefore inappropriate for correcting anything other 
than localised anterior shape abnormalities.   
 
It must be questionable whether the outcomes of such relatively extensive open surgery are 
sufficiently positive to justify the risks. As a result hip arthroscopy is rapidly becoming a 
favoured alternative technique in the management of FAI. It was not until the 1990’s that hip 
arthroscopy became well established with the advances in imaging and arthroscopic 
equipment.10 The technique remains a challenge due to the bony and soft-tissue anatomy of 
the joint and the surgery typically requires a general anaesthetic and muscle relaxant. This 
allows the hip joint to be distracted when traction is applied to the leg and provides space in 
the hip joint for the arthroscopic instruments. Small portals are then inserted under image 
intensifier guidance into the hip joint. An arthroscope can then be passed through these 
portals into the hip joint allowing visualisation of the joint and the FAI shape abnormalities. 
Surgical instruments are then passed through other portals allowing the surgeon to 
undertake FAI surgery.10  
  
Studies suggest that the results for arthroscopic FAI surgery are favourable.36 Byrd and 
Jones reported a median improvement of 21.5 points in mean Harris Hip Score at 2-year 
follow-up, in a consecutive group of 100 patients who had shape corrective surgery for FAI.74 
This group included 63 cam-type, 18 pincer-type and 23 mixed-type FAI. Philippon et al 
reported a mean 26-point improvement at a minimum follow-up of 2 years, although ten 
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patients had a THR at a mean of 16 months.75 Almost all patients had associated labral and 
chondral injuries. Arthroscopic management of FAI in athletes produced excellent results, 
with 95% of professional athletes able to return to their previous level of competition.74 
Arthroscopic FAI surgery has also shown some success in a series of 40 patients above the 
age of sixty.76 The overall results of these studies are promising but most have relatively 
limited follow-up.  
 
The current evidence suggests that the outcomes from hip arthroscopy for FAI are 
comparable to open surgical techniques, but the risk of complications for open surgery is 
greater than those undergoing arthroscopic surgery.77  
1.11.2 Nonoperative care 
There is a strong and compelling argument that FAI is a mechanical disorder secondary to a 
hip shape abnormality and it follows therefore that symptoms should not improve unless the 
shape abnormality is corrected.23 For this reason many authors and surgeons dismiss 
nonoperative treatment.78 However, given the risks of surgery, insufficient detail about the 
natural history of FAI and lack of good quality evidence for surgery this may be inappropriate. 
There is in fact some mechanical explanations by which nonoperative care could influence 
FAI. For example if a patient’s adopted pelvic inclination could be reduced then this may 
reduce the effective anterior coverage of the hip and may reduce anterior impingement.79 
There is already some evidence that this can be achieved by physical therapy and has been 
used in the treatment of lower back pathology.80  
Kennedy et al observed the gait patterns of patients with FAI and a control group.81 The FAI 
group had a significantly lower peak hip abduction (p=0.009) and an attenuated pelvic frontal 
ROM (pelvic roll p=0.004). The authors suggest that limited pelvic roll may be secondary to 
limited mobility at the lumbo-sacral joint. Physical therapy based treatment strategies could 
attempt to address these issues and may help patients’ symptoms.  
Interestingly in 1993 prior to FAI being formally recognised and reported in the literature, 
Cibulka et al undertook a randomised study of two different physiotherapy regimes for 
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treating hip pain in runners (20 patients) without evidence of arthritic changes.80 One group 
received mobilisation to the involved hip while the other group had a manipulative technique 
known to affect sacroiliac joint dysfunction. Patients were evaluated with a pain questionnaire 
which showed significantly (p=0.016) less pain at follow up in those patients treated with 
sacroiliac manipulation. It is reasonable to hypothesise that a proportion of these patients 
would have had FAI if not a substantial proportion given the demographics of the patients 
(i.e. age 15-35, athletic population, no established cases of OA). The study result would give 
further strength to an argument that forceful mobilisation (ROM exercises) of a hip with FAI 
may be counterproductive but other physical therapy techniques that improve mobility at the 
joints in the region of the hip (i.e. sacroiliac and lumbosacral) could be beneficial. 
 
There is evidence to suggest that nonoperative treatments in the form of physical therapy, 
activity modification and simple analgesia can alleviate symptoms and potentially postpone 
or even negate the requirement for FAI surgery.82 There is however a need to clarify the 
quantity and quality of evidence including determining the most appropriate methods of 
nonoperative care (see Chapter 4).  
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Chapter 2 Hip shape and long term hip specific quality 
of life: an analysis of Slipped Capital Femoral Epiphysis 
(SCFE)  
2.1 Declarations 
This work has been presented at an international conference: 
April 2012: European Paediatric Orthopaedic Society Annual Meeting (EPOS) Helsinki.  
Long-term hip function after surgery for slipped capital femoral epiphysis surgery 
 
This work has been presented as a poster at a national conference: 
May 2012: Oswestry Research Day. Long-term hip function after surgery for slipped capital 
femoral epiphysis surgery 
 
This work has been published: 
Wall PDH, Brown JS, Freshney S, Parsons H, Griffin DR. Hip shape and long term hip 
function: A study of patients with in-situ fixation for slipped capital femoral epiphysis. Hip 
international: the journal of clinical and experimental research on hip pathology and therapy. 
DOI: 10.5301/hipint.5000075. 
 
This work was co-sponsored by University Hospital Coventry and Warwickshire and the 
University of Warwick. 
 
This work was granted research ethics approval 11/WM/0228 from the regional ethics board. 
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2.2 Introduction 
It has been suggested that a substantial number of cases of SCFE are reflected in 
subsequent diagnoses of cam type FAI.25,52,54 The impingement in such instances occurs 
between the more prominent femoral head neck junction (cam type deformity) and the 
anterior rim of the acetabulum in the extremes of functional hip movement, particularly in 
flexion adduction and internal rotation.25,83,84  
In order to evaluate how alterations in hip shape as a result of SCFE in adolescence may 
influence long term function, a cohort study was undertaken of patients who had previously 
undergone in-situ fixation for SCFE. The aim was to establish if the radiological hip shape 
associated with both SCFE and cam type FAI had any effect on long term hip specific quality 
of life. In a secondary analysis, the effect of time since surgery on long term hip specific 
quality of life was explored. Obtaining a better understanding of the possible relationship 
between FAI like hip shape and hip specific quality of life would also help to clarify the role, if 
any, of interventions for FAI that address factors other than hip shape (such as the role of 
physical therapy).    
2.3 Objectives 
Establish if there is a strong correlation between long term hip specific quality of life and the 
radiological hip shape associated with SCFE and cam type FAI.   
2.4 Methods 
The purpose of the study was to explore the correlation between hip specific quality of life 
and hip shape measured using Southwick angle (as described by Southwick55,56 see Chapter 
1) and alpha angle (as described by Notzli et al50 see Chapter 1).  
2.4.1 Sample size 
A sample size calculation for the study was done using R (http://www.r-project.org). The 
sample required to detect a negative or positive correlation coefficient ≥0.5 (medium to 
strong correlation) with 80% power, and significance at the 0.05 level was 23 patients. 
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Hip specific quality of life was assessed using the IHOT-33 patient reported outcome tool. 
IHOT-33 is a validated patient reported outcome tool to measure health-related quality of life 
in young, active patients with hip disorders.85 The tool uses a visual analog scale from 0-100. 
A total score of 0 is the worst possible outcome and 100 is the best possible outcome. All 
patients aged 18-50 who had undergone SCFE surgery in our own institution from 1970 
onwards were identified by screening operative logs. The following inclusion criteria were 
applied: 
i. Patients who had in-situ fixation for SCFE 
ii. Patients with pre and post-operative radiographic imaging 
iii. Patients able to understand written English 
iv. Patients with up to date contact details available 
A number of potential confounding variables were identified prior to the study that may 
independently affect the long term hip specific quality of life. These included subsequent hip 
shape changing surgery (e.g. femoral osteotomy); total hip arthroplasty (THA) and 
complications (e.g. penetration of the fixation into the hip joint, osteonecrosis and 
chondrolysis). Therefore the following additional exclusion criteria were applied: 
i. Patients undergoing further hip surgery except removal of metalwork (e.g. femoral 
osteotomy and THA) 
ii. Patients with evidence of screw penetration on post-operative imaging 
iii. Patients with documented evidence of chondrolysis or osteonecrosis 
All recruited patients provided informed written consent. All patients were sent a postal 
questionnaire which included the IHOT-33. Patients who did not respond to the first 
questionnaire were sent one reminder. In cases of bilateral SCFE where both hips met the 
eligibility criteria patients were asked to complete a questionnaire for each hip independently.  
Hip shape measures were taken from the immediate post-operative radiographs (within 5 
days of surgery) these included: 
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i. Southwick angle on both hips using frog lateral projection. In order to take account of 
normal variance the unaffected hip Southwick angle was measured and subtracted 
from the effected hip. In cases of bilateral SCFE an angle of 12° was subtracted.55 
ii. Alpha angle on index hip using frog lateral projection. 
iii. Tonnis grading for radiological evidence of OA.17 
When follow-up imaging was available the most recent frog lateral projection was used to 
obtain a further lateral alpha angle on the index hip. All measures were taken by two 
researchers (PW and SF). The average of the two results was taken as the final radiographic 
result for each of the variables.  
Patients with complete data for the primary analysis were then matched 1:1 by age and sex 
to a cohort of control patients with no history of childhood SCFE. Control patients were 
derived sequentially from an upper limb fracture clinic within the host institution and invited to 
complete the IHOT-33 questionnaire.  
2.4.2 Statistics 
IBM SPSS version 21 for Windows was used for the statistical analysis.86 In patients with 
bilateral SCFE (i.e. those who completed a questionnaire for each hip), one hip was selected 
at random for analysis per patient thereby ensuring independence of the variables between 
each unit of analysis. Correlation analysis between independent variables (Southwick angle, 
lateral alpha angle, time since surgery and IHOT-33 score) was done using Pearson’s 
correlation coefficient. Differences in outcome between cases and controls was analysed 
using a Student’s T-test. The level of statistical significance (p-value) was set at 0.05. 
Multiple linear regression was used to model the IHOT-33 score, when controlling the 
variables of side of SCFE, gender, days since first surgery, Southwick angle and lateral 
alpha angle. 
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2.5 Results 
A total of 47 patients (60 hips comprising 13 bilateral and 34 unilateral cases) with a history 
of SCFE surgery were identified on first screening of records from our institution. Six patients 
(11 hips) were excluded for the following reasons: 
i. One hip underwent revision in-situ fixation. 
ii. Eight hips had a proximal femoral osteotomy at some stage (in 5 cases osteotomy was 
the initial treatment). 
iii. Two hips underwent THA. 
iv. Three of the excluded patients also lacked of up to date patients contact details or 
adequate radiological imaging and would have been excluded on those grounds alone.  
There were no reported cases of subsequent chondrolysis or avascular necrosis. There were 
38 patients (46 hips) who met the eligibility criteria. We obtained follow–up data for 32 
patients (38 hips), 83% follow-up. Ten patients (20 hips) had bilateral SCFE, but only 12 of 
these hips were eligible for inclusion. Two patients refused to take part and 4 did not return 
questionnaires. All included cases were chronic (symptoms >3weeks).87 The mean follow up 
was 13.5 years (SD 6.7), with a minimum of 6.6 and maximum of 25.6 years follow up.  
The inter observer reliability of the radiographic measures taken between the two observers 
is shown in Table 2.1. 
Table 2.1: Inter-observer reliability of radiographic measures taken 
 Intra-class correlation single measures 
(two-way mixed effects model) 
Southwick angle 0.961 
Lateral alpha angle 0.960 
 
A comparison of characteristics and hip specific quality of life between the cases and 
controls is shown in Table 2.2. 
Table 2.2: Characteristics of SCFE cases and control data 
Category Number of 
patients 
Mean age at 
follow up (SD) 
Sex Mean IHOT-33 at 
follow up (95% CI) 
Between IHOT-33 
category p-value 
Case 32 25.9 (6.7) 16 F, 
16 M 
71.8 (63.1-80.6) 
p<0.01 
Control 32 26.7 (5.7) 16 F, 
16 M 
96.1 (94.6-97.6) 
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The correlation analysis between the measures of hip shape (Southwick angle and lateral 
alpha angle), time since surgery and IHOT-33 outcome are shown in Table 2.3.  
Table 2.3: Correlations between Southwick angle, lateral alpha angle, time since surgery and 
IHOT-33. *significant result at p<0.05, **significant result at P<0.01 
 Southwick 
angle 
Mean lateral 
alpha 
Time since first 
surgery 
IHOT-33 
Score 
Southwick angle 1 .438
**
 .126 -.179 
Mean lateral alpha .438
**
 1 .166 .030 
Time since first 
surgery 
.126 .166 1 .202 
IHOT-33 Score -.179 .030 .202 1 
 
Multiple linear regression was used to model the IHOT-33 score, when controlling the 
variables of Southwick angle and years since surgery (see Table 2.4). For these continuous 
variables the coefficient is the change made by one unit increase.  
Table 2.4: multiple linear regression analysis modelling IHOT-33 scores 
Variable Coefficient p-value 
Years since first surgery 0.248 0.176 
Southwick angle -0.210 0.249 
 
All 32 patients included in our study had a Tonnis grade of 0 on the initial imaging of the hip 
under investigation. Follow up frog lateral imaging was available for 23 patients. The mean 
time to the follow-up imaging was 2.6 years (SD 1.9). The mean change between initial alpha 
angle and follow-up alpha angle was -2.3 degrees (95% CI -8.8-4.2). For all 23 patients with 
follow-up imaging the Tonnis grade was ≤1 for the index hip under investigation. 
2.6 Discussion 
2.6.1 Summary of findings 
Long term hip specific quality of life using IHOT-33 scores is significantly worse in patients 
who have undergone in-situ fixation for SCFE when compared to age and sex matched 
members of the general population with no history of SCFE (mean IHOT-33 scores of 71.8 
and 95.8 respectively). There was, however, no significant (P>0.05) correlation between long 
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term hip specific quality of life (IHOT-33 scores) and Southwick angle or lateral alpha angle 
(correlation coefficient -0.179 and 0.030 respectively) amongst patients who had undergone 
in-situ fixation. These findings suggest that patients with a SCFE are more likely to suffer 
impaired long term hip specific quality of life when compared to those who have never had a 
SCFE. It is apparent that the initial hip shape (in terms of both severity of SCFE and FAI like 
cam deformity) has no strong influence on subsequent long term hip specific quality of life.  
2.6.2 Methodology 
The study excluded 8 patients who had undergone an osteotomy at any stage. These 
exclusions were necessary because of the inevitable effect such surgery has on hip shape.  
 
To ensure the validity of the research it was necessary to check that the severest forms of 
SCFE were not inadvertently excluded by virtue of having had early osteotomy surgery. It 
was established that 5 of the 8 excluded patients had an osteotomy as the initial treatment 
for SCFE; a clinical decision which is likely to be based on the initial severity SCFE (shape 
abnormality) rather than any long standing symptoms. This left only 1 patient with severe 
SCFE in the study. However, there is an established view that severe SCFE leads to an 
“impaction” type impingement as the femoral neck abuts the acetabular rim causing an extra-
articular impingement with little or no damage to the intra-articular cartilage.52 For the above 
reasons this study concentrates principally on patients with in-situ fixation with either mild or 
moderate SCFE. There remains considerable debate about outcome and optimal 
management in patients with mild and moderate SCFE. These types of SCFE (mild and 
moderate) are thought to lead to an “inclusion” type impingement with the prominent shape 
abnormality entering the central compartment of the hip and thus causing intra-articular 
cartilage damage.52.52,54,58,84  
 
The two measures used to assess hip shape abnormality (Southwick angle and lateral alpha 
angle) did correlate (0.438) significantly (p<0.05), suggesting that both provide similar 
evidence of hip shape abnormality. This is helpful as the alpha angle is regarded as a 
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standard methodological technique for assessing evidence of cam type FAI, but the 
Southwick angle is not. The Southwick angle was introduced to quantify SCFE severity many 
years before FAI was formally described in the medical literature.  
 
The plain radiographs used to assess hip shape abnormality are not the most advanced 
techniques available.66 Cross-sectional hip imaging using Computed Topography (CT) and or 
Magnetic Resonance (MR) imaging is now used routinely used to aid the diagnosis of a hip 
shape abnormality such as FAI. The majority of the patients in this study had surgery before 
routine use of CT and/or MR in such cases. More importantly surgery took place at a time 
before FAI had been formally recognised in the medical literature. However, evidence 
suggests that plain radiographic measures of alpha angle as used in this study correlate well 
with cross-sectional imaging and are adequate for diagnosing FAI.88 The frog lateral 
radiograph as used in this study is the preferred radiographic projection to assess evidence 
of FAI.89 It is unlikely that the results are affected by using plain radiography alone and the 
intra-class reliability of the two independent measures of Southwick angle and lateral alpha 
angle (0.961 and 0.960 respectively) is reassuring. This suggests that the findings are 
reproducible and is consistent with previous studies of inter-observer reliability on frog lateral 
radiographs.89 
 
The current measures of FAI hip shape abnormality including the measures used in this 
study may not accurately quantify the extent/volume of such abnormalities. For example, a 
small alpha angle evident in multiple anatomical planes may represent a greater volume of 
hip shape abnormality than a large alpha angle in fewer anatomical planes (i.e. less 
extensive). It has to be acknowledged that the nomenclature/methodology currently used to 
measure the extent of hip shape abnormality is inadequate. Until more sophisticated 
techniques become available to establish precise measures and location of hip shape 
abnormality the relationship between hip shape and hip specific quality of life may remain 
difficult to determine.  
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Many of the typical complications of SCFE and SCFE surgery such as chondrolysis, 
avascular necrosis and screw penetration were excluded in this study. However, because 
many patients with SCFE who have in-situ fixation undergo surgical removal of metalwork it 
was not feasible to exclude them from this study. It seems unlikely that surgical removal of 
metalwork has any additional influence on long term hip specific quality of life. 
2.6.3 Incidental findings 
A surprising secondary finding was the lack of correlation between the time since in-situ 
fixation and subsequent long term hip specific quality of life as reported by patients 
(correlation coefficient 0.202, p>0.05). There is some suggestion in the literature that a 
degree of hip remodelling occurs after in-situ fixation.59 It is therefore possible that, given 
time, hip shape abnormality associated with SCFE resolves spontaneously and hip 
symptoms then plateau or even improve. If this does occur then it may explain the finding 
that initial radiological hip shape appears not to influence long term hip specific quality of life 
following surgery (see section 2.6.1). Interestingly, however, follow-up imaging of 23 patients 
(mean follow-up at 2.6 years) found no evidence of a significant change in hip shape as 
measured using the lateral alpha angle. This admittedly small sample contradicts the 
supposition that spontaneous hip remodelling occurs but is worthy of further research using 
larger sample.    
2.6.4 Conclusions 
Evidence suggest that those undergoing SCFE in-situ fixation experience worse long term 
hip specific quality of life than an age and sex matched control group. However, the evidence 
does not indicate that the initial severity of the shape abnormality necessarily indicates the 
severity or otherwise of long term hip specific quality of life e.g. a moderate SCFE or larger 
cam type morphology does not always result in a poorer long term functional outcome. This 
has important implications for measures (such as in-situ fixation combined with arthroscopic 
femoral osteoplasty) to correct shape abnormality in SCFE.52 This study suggests that other 
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extraneous factors not related to hip shape may have an equally important role to play in 
determining long term outcomes for SCFE. This study sought to establish whether there is a 
medium to strong correlation between SCFE/cam type FAI and long term hip specific quality 
of life90 but to detect a smaller correlation a much larger sample size would be required.  
 
SCFE has been suggested as a cause of cam type FAI in some patients, but this remains 
unproven. It follows that basing this study on an assumption that SCFE and FAI are linked 
could be flawed but never the less it was important to explore this putative relationship. 
 
A more robust although technically more difficult modification of the study would be to follow 
patients with an established diagnosis of FAI to determine both the severity of the hip shape 
abnormality and long term hip specific quality of life. This would remove potential 
uncertainties and variables such as: 
i. Surgery effecting long term hip specific quality of life. 
ii. SCFE as a cause of cam type FAI. 
iii. Changes in adolescent hip shape due to remodelling.     
Such a study presents difficulties because established practice is to favour surgery for 
FAI.23,48 Once diagnosed many patients with FAI are told that surgery is the preferred 
solution. These factors are discussed and addressed in the remainder of this thesis.
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Chapter 3 Surgery for treating femoroacetabular 
impingement: a systematic review of the literature 
3.1 Declarations 
The analysis plan was completed with input from Dr N Parsons at the University of Warwick 
and Professor R Buchbinder at Monash University, Australia. 
 
This protocol for this work is published: 
Wall PDH, Brown JS, Parsons N, Buchbinder R, Costa ML, Griffin DR. Surgery for treating 
femoroacetabular impingement: Study protocol. Cochrane Database of Systematic Reviews. 
DOI: 10.1002/14651858.CD010796. 
3.2 Introduction 
FAI surgery has evolved rapidly and at a pace far quicker than our understanding of the 
natural history and epidemiological characteristics of the condition.42,64,91-93 Although some 
evidence exists to suggest abnormal hip shape morphology, pain and OA are associated, a 
true causal effect relationship has yet to be proven. It is, therefore, far from clear that 
surgically correcting shape will have any beneficial effect on symptoms such as pain or 
reduce the risk of OA. Establishing the true effect of surgery in terms of benefit and harm will 
help guide both clinicians and patients when considering treatment. Multi-centre RCTs are 
acknowledged to be the best design for evaluating the effectiveness of health care 
interventions as they provide robust evidence of effect.94-97 It is clear that such RCTs 
comparing surgery for FAI versus nonoperative care would assist in evaluating the relative 
merits of the two options.48 A systematic review was undertaken to determine if any RCT 
level evidence currently exists to support FAI surgery as a preferred option. 
3.3 Objectives 
To determine the benefit and safety of surgery for FAI. 
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3.4 Methods 
Only studies where participants were either randomised or quasi-randomised into 
intervention groups were included in the review. There are no established diagnostic criteria 
for FAI with a diagnosis generally made on the basis of symptoms of hip or groin pain or 
both, restricted range of motion and a positive anterior impingement test, or both, and the 
presence of abnormal hip shape morphology and abnormalities of the adjacent labrum and 
cartilage, or both on imaging. The hip shape imaging should include cross-sectional studies, 
these may be: CT or MRI or MRA.23,66 Trials with participants with FAI that conformed to the 
above criteria were included. Studies with patients with established OA were excluded.  
Studies of all types of FAI surgery were included. Surgery could be performed using open, 
mini-open, arthroscopic assisted mini open or arthroscopic approaches and the interventions 
could consist of: 
i. Reshaping of the hip joint by removing bone, cartilage or both (osteoplasty, 
osteochondroplasty) from either the femoral head neck junction or rim of the 
acetabulum. 
ii. Reorientating the hip joint by cutting the bones around the hip joint (osteotomy) and 
refixing the bones in a new orientation. The new orientation of the hip should reduce 
the risk of future FAI. The bony reorientation can be done for the femur, acetabulum 
or both. 
Accepted comparators included: 
i. Placebo (sham surgery) 
ii. No treatment 
iii. Non-operative treatment (for example physical therapy, analgesia, glucocorticoid 
injection, activity modification) 
No studies were excluded on the basis of outcome measures. However a hierarchy was 
used based upon recent work and evidence supporting the use of a set of core outcomes for 
painful musculoskeletal conditions.98,99 
Primary outcomes were: 
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i. Efficacy: proportion with reported pain relief of 30% or greater 
ii. Number and type of serious adverse events (SAEs), defined as adverse events that 
are fatal, life-threatening, or require hospitalisation. Possible SAEs include: death; 
pulmonary embolism; fluid extravasation, fracture and avascular necrosis. 
Secondary outcomes were: 
i. Pain reported as: 
Proportion with pain relief of 50% or greater 
Proportion below 30/100mm on the Visual Analogue Scale (VAS) 
Change in pain score on a VAS or numerical rating scale 
ii. Adverse events (AEs) 
iii. Hip specific function and quality of life measured using multi-domain outcome 
measures such as the Non-arthritic Hip Score and IHOT-33 
iv. Generic quality of life, as measured by instruments such as: Short Form-36 (SF-36), 
Short Form-12 (SF-12), EuroQol-5D (EQ-5D) 
v. Participant global assessment of treatment success 
3.4.1 Search methods for identification of studies   
The following electronic databases, unrestricted by date or language were searched: 
Cochrane Central Register of Controlled Trials (CENTRAL, via The Cochrane Library); 
MEDLINE (Ovid); and EMBASE (via) MEDLINE (Ovid; 1946 to present), EMBASE (1980 to 
present) and Cochrane Central Register of Controlled Trials (CENTRAL, via The Cochrane 
Library). In OVID MEDLINE, a subject-speciﬁc search was combined with the Cochrane 
Highly Sensitive Search Strategy for identifying randomised trials: sensitivity-maximising 
version.100 The strategy was designed in OVID MEDLINE and adapted to the other 
databases (see appendix A). The search terms used are shown in Table 3.1. 
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Table 3.1: Search terms used 
Population Intervention Design 
Femoracetabular Impingement Surgical Procedures randomized controlled trial 
 
cam  cheilectomy Randomly 
Pincer trochanteric flip Placebo 
femoro-acetabular hueter Controlled clinical trial 
 arthroscopy  
 ganz  
 arthroscopic assisted  
 mini-open  
 Osteochondroplasty  
 Osteoplasty  
 Osteotomy  
 Operative  
 
Reference lists of relevant articles were also searched and trial registries (WHO International 
Clinical Trials Registry Platform - http://apps.who.int/trialsearch/, ClinicalTrials register - 
http://www.clinicaltrials.gov/, Current controlled trials register - http://www.controlled-
trials.com/) were also searched to identify trials that were currently underway. 
3.4.2 Selection of studies   
Two researchers (PW and JB) independently selected the studies for inclusion in the review. 
Titles and abstracts obtained from the searchers were reviewed to determine potential 
eligibility and short listed if appropriate. The full text of each study in the shortlist was then 
reviewed to determine which studies are eligible for inclusion in the review. Any 
disagreement between the two authors was resolved by consensus or discussion with a third 
reviewer DG. Studies were translated into English where necessary. 
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3.4.3 Data extraction and management   
Two review authors (PW and JB) independently extracted the following data from any 
included trials and entered it into RevMan 5: 
i. Trial characteristics including size and location of the trial, and source of funding; 
ii. Characteristics of the study population including age, and characteristics of FAI 
including: diagnosis criteria, type and duration of symptoms; 
iii. Characteristics of the surgery and comparator treatment including: surgical approach 
used, type of FAI being addressed (cam/pincer/mixed), type of intervention used to 
correct the FAI (osteochondroplasty/osteotomy). 
iv. Risk of bias domains as outlined in 'Assessment of risk of bias in included studies', 
below; 
v. Outcome measures - mean and standard deviation for continuous outcomes (pain - 
when reported as a change in pain score, hip function or quality of life), and number 
of events for dichotomous outcomes (efficacy, pain - when reported as a proportion, 
SAEs, AEs and participant global assessment of treatment success). 
If additional data was required, the trial authors were contacted to obtain this. Where data 
was imputed or calculated this was to be reported in the characteristics of included studies 
table.  
3.4.4 Assessment of risk of bias in included studies   
The plan was that studies included in the review would each be assessed for risk of bias 
using the recommended Cochrane Collaboration ’Risk of bias’ tool.101 This tool incorporates 
assessment of randomisation (sequence generation and allocation concealment), blinding 
(participants, personnel and outcome assessors), completeness of outcome data, selection 
of outcomes reported and other sources of bias. To determine the risk of bias of a study, it 
was planned to assess each criterion for the presence of sufficient information and the 
likelihood of potential bias. Each criterion was to be rated as ‘Low risk’ of bias, ‘High risk’ of 
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bias or ‘Unclear risk’ of bias (uncertain of the potential for bias, or insufficient information 
reported to make an assessment).  
3.4.5 Measures of treatment effect   
Risk ratios with 95% confidence intervals (CIs) were to be used to express the intervention 
effect for the following dichotomous outcomes: 
i. pain, when reported as a proportion of participants within defined limits (i.e. reduction 
in pain of 30% or greater, 30/100 mm or less on VAS); 
ii. AEs; 
iii. SAEs; 
iv. participant global assessment of treatment success. 
Where dichotomous data from cross-over trials were combined with data from parallel-group 
trials, the odds ratio (OR) with 95% CI were to be calculated, rather than relative risk (RR). It 
was planned to calculate mean difference (MD) or, where studies used different 
measurement tools, standardised mean difference (SMD), both with 95% CIs, for the 
following continuous outcomes: 
i. pain, when reported as either mean change in pain scores or mean absolute pain 
scores; 
ii. hip function; 
iii. quality of life. 
3.4.6 Unit of analysis issues   
It was expected that most studies would report outcomes at a number of follow-up times; for 
example, at 3, 6 and 12 months. It was therefore planned to extract at three time points: 
≤3months; >3 and <12months; ≥12months. If there were multiple time points within each 
category, we planned to extract data at 3, 6 and 12 months.  
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3.4.7 Dealing with missing data   
It was planned to seek additional information from authors of any included studies where the 
published information or data was incomplete. In cases where individuals were missing from 
the reported results, we planned to assume that the missing value had a poor outcome. For 
dichotomous outcomes that measured SAEs and AEs (for example number of SAEs), the 
number of patients that received treatment were to be used as the denominator (worst case 
analysis). For dichotomous outcomes that measure benefits, the worst case analysis was to 
be calculated using the number of randomised participants as the denominator. For 
continuous outcomes (for example pain) we planned to calculate the mean difference (MD) 
or standardised mean difference (SMD) based on the number of patients at the time point. If 
the numbers of patients was not presented for each time point, the numbers of randomised 
patients in each group at baseline were to be used. Sensitivity analysis was to be conducted 
to test the effect of these assumptions. Where possible, missing standard deviations were to 
be computed from other statistics such as standard errors, confidence intervals (CI) or p-
values according to the methods recommended in the Cochrane Handbook for Systematic 
Reviews of Interventions.101 If small amounts of outcome data are missing (for example 
standard deviations), the plan had been to consider imputing them (with appropriate 
sensitivity analyses) from other studies.101 
3.4.8 Assessment of heterogeneity   
For any studies judged as clinically homogenous, the degree of statistical heterogeneity 
between studies was to ﬁrst be assessed graphically using a forest plot and more formally 
using the I² statistic, the following as a rough guide for interpretation: 0-40% might not be 
important, 30-60% may represent moderate heterogeneity, 50-90% may represent 
substantial heterogeneity, and 75-100% considerable heterogeneity.102 In cases of 
considerable heterogeneity (defined as I2 ≥75%), it was planned to explore the data further, 
including subgroup analyses, in an attempt to explain the heterogeneity. 
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3.4.9 Assessment of reporting biases   
In order to determine whether reporting bias was present, it was important to establish 
whether the protocol of the RCT was published before recruitment of patients of the study 
was started. For studies published after July 1st 2005, the Clinical Trial Register at the 
International Clinical Trials Registry Platform of the World Health Organisation was screened. 
The plan was then to evaluate whether selective reporting of outcomes was present 
(outcome reporting bias). 
It was decided to compare the fixed-effect estimate against the random-effects model to 
assess the possible presence of small sample bias in the published literature (i.e. in which 
the intervention effect is more beneficial in smaller studies). In the presence of small sample 
bias, the random-effects estimate of the intervention is more appropriate than the fixed-effect 
estimate.103 The potential for reporting bias was to be explored by funnel plots if ≥10 studies 
were available. 
3.4.10 Data synthesis   
If studies were found to be sufficiently homogeneous that it was clinically meaningful for them 
to be pooled, meta-analysis was to be performed using a random-effects model, regardless 
of the I2 results. Analysis was to be performed using Review Manager 5 and forest plots 
produced for all analyses. Risk ratios with 95% CIs were to be used to express the 
intervention effect for dichotomous outcomes. For continuous data, such as patient reported 
quality of life measures, it was planned to calculate MD or, where studies may have used 
different measurement tools, SMD; both with 95% CIs. Where dichotomous data from cross-
over trials were combined with data from parallel-group trials, the odds ratio (OR) with 95% 
confidence interval were to be calculated, rather than relative risk (RR). 
3.4.11 Subgroup analysis and investigation of heterogeneity   
The inclusion of intervention effects at a number of time points (e.g. three, six months and 
twelve months) should provide some sensitivity to the selection of an appropriate follow-up 
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time for assessment of the treatment effect. Where sufficient data was available, the 
following sub-group analyses were planned: 
Cam versus pincer type FAI. These two shape abnormalities arise from different aspects of 
the hip joint and therefore the results of surgery may differ between these two types. 
Subgroup analysis will measure the result of surgery using pain as the outcome. 
The subgroup analysis will informally compare the magnitudes of effect to assess possible 
differences in response to treatment by considering the overlap of the CIs of the summary 
estimates in the two subgroups - non-overlap of the CIs indicates statistical significance. 
3.4.12 Sensitivity analysis   
If it was necessary to exclude any studies because they appeared to differ markedly (i.e. if 
the outcome is different - effect goes in opposite direction) from the majority of studies then 
all main analyses were to be reported with and without these studies. Where sufficient 
studies existed, sensitivity analyses were planned to assess the impact of any bias 
attributable to inadequate or unclear treatment allocation (including studies with quasi-
randomised designs). 
3.4.13 Summary of findings tables 
The main results of the review were to be presented in a summary of findings (SoF) table 
which would provide key information concerning the quality of evidence, the magnitude of 
effect of the interventions examined, and the sum of available data on the outcomes 
(efficacy; SAEs; pain; AEs; hip function; participant global assessment; quality of life), as 
recommended by the Cochrane Collaboration.104 The SoF table included an overall grading 
of the evidence related to each of the main outcomes, using the Grading of 
Recommendations Assessment, Development and Evaluations (GRADE) approach.105 
In addition to the absolute and relative magnitude of effect provided in the summary of 
findings table, for dichotomous outcomes, the number needed to treat to benefit (NNTB) or 
the number needed to treat to harm (NNTH) were to be calculated from the control group 
event rate. 
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3.5 Results 
A breakdown of the search results and subsequent analysis is shown in Table 3.2. 
Table 3.2: Search results 
Database, and coverage Search date Number of 
references 
retrieved 
Number 
after de-
duplication 
Ovid MEDLINE(R) In-Process & 
Other Non-Indexed Citations 
and Ovid MEDLINE(R) <1946 to 
July 30, 2013 
July 30, 2013 105 92 
Ovid Embase Classic+Embase 
<1947 to 2013 July 30> 
 
July 30, 2013 75 52 
Wiley Cochrane Library – 
CENTRAL 
July 30, 2013 185 176 
 
Clinical Trials. Gov 
July 30, 2013 11 11 
Totals  376 331 
 
None of the 331 titles/abstracts reviewed met the inclusion criteria when reviewed 
independently by PW and JB.  
3.6 Discussion 
In order to participate in RCTs, surgeons need to acknowledge collective uncertainty or 
equipoise between treatments. For patients, the idea that there is uncertainty about the 
comparative effectiveness of treatments can be very difficult to accept. Lack of surgeon and 
patient equipoise could both be major barriers to recruitment in a RCT of surgery versus 
control for FAI. All of these factors may help explain why no RCTS or quasi randomised 
controlled trials examining the effectiveness of FAI were found. The results are in keeping 
with a systematic review of surgical treatment for FAI conducted by Clohisy et al in 201048 in 
which observational studies only are reported. The systematic review protocol presented in 
this chapter has helped outline the potential structure for a full RCT and the remainder of this 
thesis explores and addresses some of the major barriers to the feasibility of a RCT to 
measure the clinical effectiveness of FAI surgery against nonoperative care. 
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Chapter 4 Nonoperative treatment for FAI: a systematic 
review of the literature 
4.1 Declarations 
This work has been presented at a national and international conference: 
 
September 2011: International Society of Orthopaedic Surgery and Traumatology (SICOT) 
Prague September 2011. Does an effective nonoperative treatment exist for 
femoroacetabular impingement: A systematic review of the literature? 
 
May 2011: Oswestry Research Day. Does an effective nonoperative treatment exist for 
Femoroacetabular Impingement? 
 
This work has also been published: 
 
Wall PDH, Fernandez M, Griffin DR, Foster NE. Nonoperative Treatment 
for Femoroacetabular Impingement: A Systematic Review of the Literature. PM&R, 2013; 
5:5: 418-426. 
 
This project was facilitated by the NIHR Health Technology Assessment programme (project 
number 10/41/02).  
4.2 Introduction 
Nonoperative treatment for FAI is often dismissed on the grounds that surgery is the only 
effective mechanism by which the shape abnormalities of FAI can be corrected to improve 
patient’s symptoms. There is, however, evidence that nonoperative care is being used in 
routine National Health Service (NHS) clinical practice for patients with FAI.106 Although 
 73 | P a g e  
changes in hip shape without surgery are not possible there are number of other 
mechanisms by which nonoperative care could theoretically help patients with FAI including: 
i. Avoidance of positions that cause impingement such as flexion, adduction and internal 
rotation of the hip. 
ii. Addressing associated soft tissue dysfunction such as muscle weakness and poor 
muscle control. There is evidence that FAI is associated with hip muscle weakness, while 
this may be primary or secondary to FAI, strengthening these muscles may improve 
functional outcome.107,108 
iii. Pain relief for symptoms. Simple analgesia is already a well proven mechanism for 
relieving the symptoms of other chronic musculoskeletal conditions. 
iv. A relative increase in the arc of anterior impingement free movement. If a patient  can 
maintain their pelvis in a position of relative posterior tilt then it would reduce the anterior 
acetabular coverage of the femur and allow the femur more flexion before impingement 
occurs.109 There is some evidence that pelvic inclination can be altered with exercise and 
this has been employed in the treatment of lower back pathology.110 
In order to determine the quantity and quality of evidence supporting nonoperative care for 
FAI a systematic review of the literature was undertaken. The results were then used to help 
determine a suitable nonoperative treatment comparator to surgery in a RCT.  
4.3 Objectives 
To establish whether any nonoperative treatment options for FAI have been reported and the 
evidence for them.  
4.4 Data Sources and Searches 
A search of the published literature was performed up until June 2012 in accordance with a 
prospectively registered review protocol (registration no. CRD42012002456, 
www.crd.york.ac.uk/PROSPERO).111 The following databases were searched: Pubmed, Ovid 
Medline, Excerpta Medica Database (EMBASE), Cumulative Index to Nursing and Allied 
Health (CINAHL), Allied and Complementary Medicine Database (AMED) and Cochrane 
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Library databases. The search terms used were: Femoroacetabular Impingement, Femoro-
Acetabular Impingement and Hip Impingement. Medline example of our search strategy = 
("femoroacetabular impingement" OR "femoro-acetabular impingement" OR "hip 
impingement").af (Limit to: English Language). In addition we searched the International 
Standard Randomised Controlled Trial Number Register (ISRCTN) and metaRegister of 
Controlled Trials (mRCT) for reports of on-going and unpublished trials. The references 
generated were then transferred to EndNote® to determine any duplicates.  
4.5 Study Selection 
Article titles and abstracts were independently screened by two researchers PW and MF, to 
look for relevant publications which satisfied the following inclusion/exclusion criteria: any 
systematic review, discussion paper, clinical trial or case series which discussed or 
evaluated a non-operative treatment for FAI. Single series case reports and abstract only 
publications were excluded, as were studies in which all patients were treated with FAI 
surgery. Where abstracts were not available or did not provide sufficient detail, the full text 
publication was retrieved. Adjudication from a third researcher (DG) was sought where 
disagreement about inclusion occurred. The full texts were then further analysed and the 
inclusion/exclusion criteria applied.   
4.6 Data Extraction and Quality Assessment 
Final full texts for inclusion then underwent data extraction by PW. This was validated for all 
papers by MF. Where there was disagreement a third researcher (DG) was consulted. The 
following data was extracted: type of study, baseline patient details and diagnosis, details of 
non-operative treatments and comparators, reported outcomes, and follow up period. Papers 
were divided into those that provided primary experimental evidence about the effectiveness 
of non-operative treatment of FAI and review or discussion papers (i.e. expert opinion – level 
5 evidence112 and below) about FAI. For primary experimental evidence papers we used the 
GRADE tool to judge the quality of the experimental evidence as high, moderate, low or very 
low.113 A scientific quality assessment tool specifically designed for case series was also 
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applied to all the experimental evidence articles.114 If the studies were sufficiently 
homogeneous that it was clinically meaningful for them to be pooled, a meta-analysis was to 
be performed using a random-effects model, regardless of the I2 results. For 
reviews/discussion papers data was put into prearranged SoF tables detailing all non-
operative treatment strategies mentioned. 
4.7 Synthesis 
The search returned 1030 abstracts (after removal of duplicates). There were a total of 53 
papers that met our eligibility criteria. There were a total of 5 papers providing primary 
experimental evidence about the effectiveness of non-operative treatment of FAI and 48 
review or discussion papers about FAI. A flow diagram in Figure 4.1 describes the review 
process which is compliant with PRISMA (Preferred Reporting Items for Systematic reviews 
and Meta-Analyses) guidelines.115 
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Figure 4.1: PRISMA flow diagram of search results (Source: Moher et al
115
) 
 
A detailed analysis of the 5 papers describing primary evidence and a synthesis of 48 
review/discussion papers in order to identify non-operative treatment themes for FAI is 
presented.  
4.7.1 Primary Experimental Evidence 
Five papers were included which described primary studies involving the non-operative 
treatment of FAI – these included four case-series (three prospective and one retrospective) 
and one descriptive epidemiological study - outlined in Table 4.1 and Table 4.2. No 
randomised trials were identified.
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Table 4.1: Details of papers that provide experimental evidence on non-operative treatment for 
FAI 
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Table 4.2: Sources of bias and quality assessment 
Author 
Level of 
Evidence 
Sources of Bias 
GRADE quality 
of evidence113 
Evaluation of 
scientific quality 
score114 
Reynolds 
et al 
1999
116
 
4 
No outcomes defined 
No evidence of sample size 
calculation 
No evidence of group 
homogeneity testing 
Very low 
 
3 of 13 
Jager et al 
2004
117
 
4 
Primary outcome measure not 
defined 
No evidence of sample size 
calculation 
No clear eligibility criteria 
Selective outcome reporting with 
different outcome measures used 
for treatment groups 
Treatment groups had significant 
differences prior to treatment 
No evidence of group 
homogeneity testing 
No evidence of blinding for 
outcome assessment 
Marked differences in duration of 
follow up 
Very low 
 
 
 
 
 
 
5 of 13 
Feeley et 
al 2008
118
 
4 
Primary outcome measure not 
defined 
No evidence of sample size 
calculation 
No clear eligibility criteria 
Descriptive differences between 
treatment groups 
No homogeneity testing 
Very low 
 
 
6 of 13 
Emara et 
al 2011
82
 
4 
Primary outcome measure not 
defined 
No evidence of sample size 
calculation 
Selective outcome reporting  - 
"failure" not defined  
Low 
 
11 of 13 
Hunt et al 
2012
119
 
4 
Outcomes reported for 
heterogeneous groups with mixed 
pathology (numbers too low to 
perform subgroup analysis) 
Primary outcome measure not 
defined 
Low 
 
 
11 of 13 
 
The mean patient age amongst these five papers ranged from 28–34 years with a follow up 
between 3 – 28 months.82,116-119 The pathology and pre-treatment patient characteristics 
varied considerably. Three studies report outcomes for cam-type FAI which has been 
diagnosed using plain radiographs/MR measure of either alpha-angle or other similar 
measures with differing ‘cut-off’ values.82,117,118 One study reports outcomes from patients 
with FAI as a result of acetabular retroversion diagnosed by CT.116 One study reports 
outcomes from patients with all mild types of FAI.119 Patients were reported to have a positive 
anterior impingement test (flexion, adduction and internal rotation) in three of the five studies, 
of which one study assessed only professional athletes.82,118,119 Non-operative treatments 
were: NSAIDS and physical therapy-led treatments in three of the five studies,82,117,119 
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physical therapy-led care alone in one study,118 and no defined treatment in one study.116 
Where non-operative care was employed, two studies gave a detailed description of the 
regime used - see Table 4.182,119  
Analysis of the  quality of evidence reviewed was very low for three of the studies and low for 
two studies according to the GRADE recommendations - see Table 4.2.113 Outcomes were 
poorly defined and heterogeneous amongst the studies. Patient reported outcome measures 
were used in two studies where a mean improvement following non-operative treatment was 
shown.82,119 The other studies either did not report an outcome or reported a return to normal 
sporting activity or continued pain. No study explicitly defined a primary outcome measure. 
There was no evidence of homogeneity testing in any study and there were substantial 
differences in the patient characteristics and the type/definition of FAI used across the five 
studies making a cross comparison of the results difficult. An assessment tool specifically 
designed for case series was used to assess the scientific quality of the studies reviewed.114 
The average score was 7.2 out of a maximum of 13. The low score was mainly attributed to 
the irreproducibility of the treatments employed due to a lack of detailed treatment protocols 
and a lack of clearly defined outcomes. 
4.7.1.1 Assessment of homogeneity 
There was no evidence that any of the five papers described were clinically homogenous or 
had any comparable measure of clinical outcome. It was therefore neither possible nor 
clinically meaningful to attempt a meta-analysis. 
4.7.2 Review/Discussion Papers 
Forty-eight (48) papers were either: full clinical reviews about FAI, clinical commentary about 
FAI and its treatment or primary experiments for another aspect of FAI with some discussion 
about non-operative care. No review / discussion papers focused solely on non-operative 
care. Similar non-operative treatment strategies emerged in all the review papers and they 
have been summarised in Table 4.3.  
 80 | P a g e  
Table 4.3: Details of treatment themes and frequency of promotion amongst review / 
discussion papers 
Theme Number of papers promoting the theme 
with references (% out of total 48 papers)  
A trial of conservative treatment 31 (65)30,31,120-148 
Activity modification 39 (81)30,31,109,120-123,125-133,135-140,142,144-159 
Avoid excessive hip movement and or rest 17 (35)30,120,122,126,127,130,132,138-
140,142,144,146,148,151,155,160 
Physical therapy 23 (48)30,121-123,125-127,129,138,139,143,145,148-
151,156,158,160-164 
Osteopathy and Chiropractic 1 (2)163 
Non-steroidal anti-inflammatory medications 36 (75)30,31,120-122,125-128,130-133,135-138,140,142-148,150-
154,156,157,159,165  
Intra-articular corticosteroid injections 5 (10)127,151,153,156,159 
 
The only treatment strategy reported with further detail was physical therapy, these details 
are summarised in Table 4.4. It is important to note that when details were provided for 
physical therapy amongst the review / discussion papers none provided references to 
sources of experimental evidence supporting the regimes proposed. 
Table 4.4: Details of physical therapy when provided in review / discussion papers 
Paper Further details of physical therapy where 
available 
Lavigne et al 200430 Physical therapy may be beneficial but 
passive ROM and stretching is 
counterproductive. 
Nicholls et al 2004149 Protected weight bearing, taping the thigh 
into 
abduction and external rotation, orthotics, 
and motor control strategies may be 
considered. 
Bathala 2007150 Strengthening abdominal and gluteal 
muscles. Stretching paravertebral 
musculature to change posture or pelvic 
inclination. 
Leunig et al 2007145 Improve core and hip flexor strength. 
Attempts to improve passive ROM may be 
counterproductive. 
Maheshwari et al 2007138 Emphasis on muscle strengthening 
and avoidance of extremes of ROM. 
Pierannunzii et al 2007139 Postural rehabilitation to reduce pelvic 
inclination. Achieved through strengthening 
abdominal muscles and gluteus maximus 
and stretching iliopsoas and the 
paravertebral muscles. 
Kassarjian et al 2008121 3-6 months of rehabilitation / physical 
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therapy. If no response then offer surgery 
Keogh 2008122 Specific technique modification and muscle 
balance work for some athletes. 
Sink et al 2008123 Pelvic muscle and core strengthening. 
Pilates, with abdomen and pelvic muscle 
strengthening. 
Hart et al 2009126 Hip flexor stretches to deal with iliopsoas 
tightness and core stability strengthening 
Kuhlmann 2009161 Improve hip muscle flexibility and strength, 
posture and other muscle or joint deficits. 
Emary 2010127 Address hip flexor tightness. Stretching and 
manipulation of the FAI hip to improve 
passive. ROM may exacerbate the condition. 
Kaplan et al 2010156 Muscle strengthening and education to avoid 
extremes of motion can alleviate symptoms. 
Avoid passive ROM or stretching which may 
exacerbate the symptoms. 
Smith et al 2010162 Improve hip muscle flexibility and strength 
and posture. Sport technique modification 
Pollard 2011160 Core muscle strengthening 
Samora et al 2011148 Physical therapy can identify movements that 
exacerbate the pain and optimise the 
alignment and mobility of the joint. However, 
physical therapists should avoid passive 
ROM or stretch because these can 
exacerbate symptoms. Core strengthening is 
also recommended, which includes 
coordinative and proprioceptive training. 
Jacoby et al 2011164 Physical therapy to improve hip muscle 
flexibility and strength may help with the 
painful symptoms of impingement. 
Chakraverty et al 2012163 Attempt to identify the tissues causing the 
pain, and to attempt to offload these tissues 
by altering biomechanics through passive 
mobilization, joint distraction and stretching 
techniques, as well as active muscle 
strengthening approaches. Strong flexing 
mobilization (‘articulatory’) manoeuvres to the 
hip joint may only serve to exacerbate labral 
injury and are to be avoided. 
Hackney 2012158 Core stability exercises and stretching. 
4.8 Discussion 
4.8.1 Available evidence 
The experimental evidence examining non-operative treatment for FAI is limited to five 
papers. This may be because of an overwhelming focus on surgery for FAI. However, 
despite this amongst the two papers with a higher GRADE quality of evidence (Emara et al 
and Hunt et al) the suggestion is that physical therapy and activity modification for FAI can 
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benefit patients.82,119 The physical therapy regimes that were tested in both these papers 
were based on a staged approach. Fundamental to both regimes was an exercise based 
programme focussing on the core hip musculature. These programmes were all augmented 
by education and advice to help reduce the frequency of impingement. In addition early use 
of simple analgesia and NSAID was promoted.  
 
Three studies (Feeley et al118, Jager et al117 and Reynolds et al116) had a GRADE evidence of 
very low. This was based on the study design alone (i.e. case series and descriptive 
epidemiological study). We upgraded two studies (Emara at al82 and Hunt et al119) for the 
following reasons; (1) both clearly define the methodology and interventions employed (i.e. 
details of the physical therapy regime), (2) both studies use quantitative outcome measures 
(e.g. NAHS, HHS) which provide a consistent and precise measure of the magnitude of the 
intervention. This increases our confidence in the results from these studies and is also 
reflected by their scientific quality scores in Table 4.2..  
4.8.2 Emara et al82 
The results from Emara et al82 (a prospective case-series) suggest that a staged based 
regime of physical therapy and other treatment modalities including activity modification and 
NSAIDS can help patients’ symptoms and function up to 28 months after treatment. The 
regime of non-operative care is clearly defined in this paper. However, the chosen population 
of patients with cam type FAI (“mild FAI”) is questionable and includes only patients with a 
radiographic alpha angle of <60 degrees. Typically in order to establish a diagnosis of cam 
type FAI an alpha angle of at least 50 degrees or more is used.75,166 The authors suggest that 
the outcome of their non-operative care regime is comparable to surgery, however as 
highlighted the criteria for study eligibility (i.e. the definition of FAI that is being used) is 
probably very different to the typical criteria used in studies measuring the outcome for 
surgery. The authors report that the mean alpha angle of the unaffected hip is 47 degrees 
versus 57 degrees for the affected hip (p<0.01) but do not provide the spread for this data. In 
part the authors acknowledge this by referring to the patients as “mild FAI”. However, it is 
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possible that, given the eligibility criteria, some patients did not even have FAI. The authors 
refer to patients who “underwent surgical treatment after conservative management failed” 
(N=4). No indication is given for when this decision was made and the criteria used for failure 
of conservative management. In addition the authors do not comment on the compliance with 
the nonoperative care protocol. 
4.8.3 Hunt et al119 
The results from Hunt et al119 (a prospective case-series) suggest that their regime of 
nonoperative care offers some therapeutic benefit to patients with “pre-arthritic” hip disease, 
of which FAI is one included subtype. However, the authors acknowledge that subgroup 
analysis would be inappropriate due to the small numbers involved. It is difficult to determine 
whether FAI patients alone benefit from their regime of non-operative care. The study used a 
cohort of patients who are defined as having “mild osseous” abnormalities. The criteria used 
(an alpha angle of 50-54 degrees for a diagnosis) seem more reasonable and in keeping with 
the published literature than those used by Emara et al for defining patients with “mild FAI”. 
The regime of nonoperative care is clearly defined which includes patient education, activity 
modification and a directed physical therapy protocol (including NSAIDS and narcotics as 
necessary), but the authors acknowledge the difficulty in standardising the delivery of this 
care. Importantly the authors report marked variability in the attendance at the physical 
therapy sessions which form part of the non-operative care protocol (range of therapy visits 
was 1 to 19, with an average of 6.4 visits), but they do not define what constituted a 
satisfactory delivery of care per protocol.       
4.8.4 Conclusions 
As a result of the substantial variability (heterogeneity) in the five experimental studies 
presented a meta-analysis was neither feasible nor clinically meaningful. This a further 
reflection of the lack of high quality research in this area. 
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Many of publications to date on the non-operative management of FAI are in the form of 
review/discussion papers. The consensus (>50%) of opinion amongst these papers 
promoted the following nonoperative treatment themes for FAI: a trial of conservative 
therapy, activity modification and NSAIDs. No further details about any of these themes were 
provided by the reviews’ authors.  
 
Forty eight percent of the review/discussion papers promote physical therapy led care for 
FAI. Interestingly all the experimental evidence, albeit limited, supporting nonoperative 
treatment of FAI uses physical therapy led care. However, the literature on nonoperative 
treatment does not appear to be supported by any randomised trials testing nonoperative 
care for FAI.  
 
Theoretical arguments have been advanced that early FAI surgery may prevent the 
development of future OA, despite no formal evidence for this. An equally strong argument 
could be made that a well-constructed regime of activity modification and appropriate 
physical therapy led care for patients is likely to reduce the incidence of symptomatic 
impingement. This may prevent progression, allow established lesions to heal and prevent 
future recurrence of symptoms.  
 
The strengths of the review include a registered review protocol, a reproducible search 
strategy, application of the PRISMA statement115, and the use of quality assessment 
tools114,167 to grade the quality of the evidence reviewed. The review is limited by the level of 
evidence available for analysis and as such the possible introduction of bias. An attempt to 
address this has been made by identifying potential sources of bias and applying the GRADE 
recommendations to assess the quality of evidence. The reason the review used such broad 
eligibility criteria was to capture all available literature. Preliminary searches revealed very 
few articles regarding the non-operative care for FAI and therefore wide eligibility criteria 
were used in our protocol to ensure all available data were included.  
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Presenting both the review based and experimental based literature in this systematic review 
has helped highlight that the published literature is saturated with messages promoting the 
use of nonoperative care for FAI despite the weak supporting clinical evidence. It seems 
likely that a considerable number of the review/discussion papers were expressing opinion 
rather than actual evidence based advice and should be viewed with some caution.  
 
More high quality research, preferably RCTs to evaluate nonoperative treatment against 
surgery is required. The available evidence based literature seems to suggest that physical 
therapy led care and activity modification for FAI is a potential treatment strategy but its true 
clinical effectiveness is not yet known. Two publications provide some basic structure about 
how such care could be delivered.
 86 | P a g e  
Chapter 5 Nonoperative treatment for FAI: Design of a 
package of care 
5.1 Declarations 
This work has been presented at a national and international conference: 
May 2012: Femoroacetabular Research Symposium, Chicago, USA. FASHIoN Study: 
Designing a non-operative comparator.   
May 2013: Oswestry Research Day. Designing and testing a package of non-operative care 
for Femoroacetabular Impingement. 
 
The parts in this chapter enititled “naming of the protocol” is research that was undertaken by 
Ms A. Realpe and Dr A Adams, qualitative researchers working at Warwick Medical School. 
The section has been included for completeness and to justify the name “Personalised Hip 
Therapy” being used.  
 
This work was part of a larger project (UK FASHIoN study) funded by the NIHR Health 
Technology Assessment programme (project number 10/41/02) and the draft final report for 
the whole project has been submitted to HTA September 2013: 
 
Griffin DR, Wall PDH, Realpe A, Adams A, Parsons N, Hobson R, Achten J, Fry J, Costa M, 
Petrou S, Foster NE, Donovan J. UK FASHIoN: Feasibility study of a randomised controlled 
trial of arthroscopic surgery for hip impingement compared with best conservative care. 
 
5.2 Introduction 
Many RCTs measuring the effectiveness of drug therapies use the so called “placebo 
controlled” design. Undertaking similar RCTs in surgery with a placebo controlled study 
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design is less straightforward and in some cases simply not feasible.168 The typical logical 
placebo for surgical RCTs is a “sham” operation, and understandably many patients feel 
uncomfortable with this. Although many healthcare professional understand the rationale 
behind “placebo controlled” design, they remain strongly opposed to taking part on the 
grounds that it is unethical to subject their patients to such risks.168 For this reason very few 
placebo controlled RCTs are ever conducted in surgery. A more acceptable, though still 
challenging, approach is to use a genuine nonoperative intervention for comparison. 
Examples of this include: knee arthroscopy versus physical therapy for patients with OA and 
carpal tunnel decompression versus hand therapy for carpal tunnel syndrome.169,170 These 
types of operative versus nonoperative study designs tend to lead to more viable RCTs with 
acceptable levels of recruitment and adherence (see Chapter 8). Consequently if a RCT is to 
measure the effectiveness of FAI surgery a suitable nonoperative comparator will be 
required.  
 
The systematic review reported in Chapter 4 suggested that nonoperative care is being used 
as a treatment for FAI. There is published primary research evidence that nonoperative care 
can improve patients’ symptoms.171 Such nonoperative care is typically physical therapy led,  
with an exercise based regime, activity modification and appropriate analgesia.171 Although 
there is literature supporting this type of physical therapy the only experimental evidence 
specific to FAI providing guidance on how such physical therapy led care should be delivered 
is work by Emara et al.82 Unfortunately the nonoperative care outlined by Emara et al in 
Chapter 4 lacks sufficient detail to be implemented directly into a RCT.  
 
As well as a substantial proportion of the published review literature promoting physical 
therapy led nonoperative care, a number of healthcare policy makers endorse it too. In 2011 
the Cornwall and Isles of Scilly NHS Primary Care Trust in the UK published a policy 
statement that only patients who have failed to respond to all available conservative 
treatment options including activity modification, pharmacological intervention and specialist 
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physiotherapy should be considered for FAI surgery.106 Similarly, the National Institute for 
Health and Clinical Excellence (NICE) published guidance on arthroscopic FAI surgery which 
suggested the management of FAI can include conservative measures, such as modification 
of activity and NSAID medication.172 The inclusion of physical therapy led nonoperative care 
for FAI in NHS healthcare policy has important implications. It suggests that there are likely 
to be a number of physical therapists within the NHS who have experience in managing 
patients with FAI as part of normal healthcare. 
5.2.1 Consensus gathering approaches 
Where there is a lack of evidence to guide care it is not unreasonable to use a consensus 
gathering approach in order to develop and rationalise best practice.173 Physical therapists 
are clearly an appropriate group with whom to develop a consensus for nonoperative care of 
FAI given that they are the professionals most frequently cited in literature and policy as 
providing this type of treatment.  
 
Murphy et al173 summarised three formal consensus gathering techniques which have been 
used to guide healthcare in other subject areas: 
i. Delphi method involves participants completing private questionnaires. The 
questionnaires invite participants to respond to “cues” i.e. statements that provoke 
decision making. Results are aggregated and reviewed for agreement. Successive 
rounds of questionnaires are undertaken until a set level of agreement is reached. 
The perceived advantage of this approach is that decisions are made in private, 
which some researchers regard as important to avoid contamination or influence 
decision making from others. In addition the technique can be applied over a large 
population and geographical area which might improve generalizability and 
applicability of findings.173-175 
ii. Nominal Group Technique (NGT) involves a group process of generating ideas 
which are then either accepted or rejected by members.  The process is structured 
with an aggregation of numbers of individual agreement. The process can continue 
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until a group judgment is reached. A modification of this technique is used most 
frequently for clinical guideline development.173,176 
iii. Consensus Development Conference (CDC) requires a group of individuals to 
attend a conference in which evidence is presented to them by experts. The 
individuals then hold subgroup meetings in which they seek to establish group 
consensus based upon the information and evidence that has been presented to 
them.173 
Figure 5.1 sourced from Murphy et al provides a summary comparison of these and other 
consensus gathering techniques. 
Figure 5.1: Characteristics of consensus development as outlined by Murphy et al (Source: 
Murphy et al
173
) 
 
There is considerable overlap between these techniques and no one method can be 
regarded as superior to another. As a result researchers frequently modify/combine several 
techniques depending upon the particular problem with which they are faced.173   
5.2.2 Developing complex interventions 
The Medical Research Council (MRC) has published guidance for the development of 
complex interventions.177 A complex intervention is defined as one which contains several 
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interacting components. In addition it is acknowledged that there are several dimensions to 
complexity such as the: 
i. number of and interactions between components within the intervention; 
ii. number and difficulty of behaviours required by those delivering or receiving the 
intervention; 
iii. number of groups or organisational levels targeted by the intervention; 
iv. number and variability of outcomes and the 
v. degree of flexibility or tailoring of the intervention permitted 
Physical therapy led care of any description would be regarded as a complex intervention 
based on these definitions and dimensions. Thus, if a physical therapy led nonoperative care 
protocol were to be developed it would be reasonable to use the MRC principles as 
guidance. The MRC suggest that in developing a complex intervention the following should 
be considered: 
i. Identify the evidence preferably by carrying out a systematic review 
ii. Identifying and develop relevant theory in order to improve the chances of an 
effective intervention being developed. The theory behind a complex intervention and 
how it might invoke change may not be clear at the start.  It is therefore essential to 
develop a theoretical understanding of the likely process by which the intervention 
might invoke change; this can be achieved by using existing evidence and theory, 
supported if necessary by new primary research. 
iii. Modelling process and outcomes. Before undertaking a full evaluation modelling the 
process and outcome may provide useful information to inform the design of the 
intervention.   
5.3 Objectives   
i. To develop a suitable nonoperative protocol of care for FAI that is feasible within the 
constraints of the NHS. 
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5.4 Methods 
i. Identifying best methods of conservative care 
A high quality, best conservative care treatment protocol for FAI was derived using an initial 
Delphi consensus technique supported by NGT methodology. Throughout, protocol 
development was guided  by the available evidence and guidance from the MRC for 
developing a complex intervention.177 A core study group was formed to oversee the 
development, evaluate information gathered and provide the layer of NGT consensus which 
supported the initial Delphi technique. The core study group comprised two senior 
musculoskeletal physical therapists with an interest in managing patients with FAI (DR and 
IH), an academic research physical therapist (NF) and PW.  
 
The systematic review reported in Chapter 4 showed that only the work by Emara et al 
201182 provided both an experimental evaluation and an explicit description of how treatment 
for FAI should be delivered. This programme was used as the starting point for a best 
conservative care treatment protocol for FAI (see Table 5.1). It was circulated to physical 
therapists involved in the management of patients with FAI in order to begin a process of 
Delphi consensus gathering.  
Unfortunately at the time of this study, there was no way of knowing which therapists are 
directly involved in the management of patients with FAI, in order to construct a target 
sample. For this reason it was not possible to conduct simple random samples of the 
physical therapy profession in the UK. We therefore took a targeted approach to sampling, 
using networks of physical therapists most likely to be involved in the management of this 
patient group.  
Adverts were posted nationally on the electronic network operated by Chartered Society of 
Physiotherapy (CSP) and in the CSP’s “Frontline” magazine distributed to approximately 
50,000 CSP members in the UK. UK physical therapists were invited to help develop a 
consensus for a best conservative care treatment protocol for FAI. Electronic invitations were 
also sent to physical therapists in the United States and Australia known to members of the 
core study group through previous collaborative work on FAI. To encourage a process of 
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“snowball sampling” within the international community, these therapists were encouraged to 
invite colleagues with experience and interest in managing FAI to join in the consensus 
development process.  
 
Each physical therapist was sent an electronic copy of the first protocol in a questionnaire 
format (appendix B). The physical therapists were asked whether they agreed or disagreed 
with the proposed programme for the conservative treatment of FAI patients and where 
appropriate to provide comments and suggestions for improvement. Results were tabulated 
by the core study group and additional comments and treatment strategies suggested by the 
respondents were grouped into themes. An agreement level of ≥50% for this Delphi 
consensus technique was used. If no consensus was evident from the survey the core study 
group refined the protocol in light of the available feedback using a NGT type approach. The 
refined protocol was then recirculated to the physical therapists taking part in the Delphi 
consensus process and the cycle repeated until a consensus of ≥50% was achieved.  
 
After a consensus was reached, the agreed best conservative care treatment protocol was 
implemented within a multicentre pilot RCT (see Chapters 8 and 9).  
 
All physical therapists selected to provide best conservative care in the RCT were asked to 
detail exercises that would allow them to deliver the protocol. The exercises were then 
ranked and the most popular were included as a database resource (exercise template) to be 
used alongside the best conservative care protocol. 
 
In the early phases of recruitment to the pilot RCT (Chapter 8) physical therapists involved in 
the pilot RCT and delivering the care were invited to a workshop (CDC technique) to share 
their experiences of delivering the protocol and make any suggestions for further 
amendments. All physical therapists delivering the best conservative care protocol were 
asked to complete case report forms for each patient, which included details about the 
number, nature and duration of the patient contact. In addition details of the exercises 
prescribed to each patient were recorded. 
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ii. Naming best conservative care 
Prior to commencing recruitment to the RCT, a qualitative research study was undertaken to 
name the best conservative care treatment protocol for FAI. Previous qualitative research 
has highlighted the importance of naming treatments in order to improve uptake and 
compliance in particular when being used in RCTs.178 Patients with FAI treated by one of the 
authors (DG) within the last 2 years and who also had up to date contact details were invited 
to take part in the qualitative study to help develop a name for the conservative treatment 
package. Patients who had been treated both operatively and conservatively were invited to 
take part. A maximum variation sample of about 16 of these patients who would have been 
eligible for the RCT (selected to include a range of age, sex, disease severity, activity and 
socioeconomic status) were to be included in the study group. Semi-structured qualitative 
interviews were undertaken with all the patients in order to derive a suitable name for the 
protocol. 
5.5 Results 
i. Identifying best conservative care 
 
The initial conservative care treatment protocol proposed by Emara et al which was 
circulated to physical therapists for consensus development is shown in Table 5.1.   
Table 5.1: Conservative care protocol proposed by Emara et al
82
 
Initial assessment 
and treatment 
Stage 1 
Avoidance of excessive physical activity and anti-
inflammatory drugs for 2 to 4 weeks 
Stage 2 
Physical therapy for 2 to 3 weeks in the form of 
stretching exercises to improve hip external rotation and 
abduction in extension and flexion 
Further assessment 
and treatment 
Stage 3 
Assessment of the normal range of hip internal rotation 
and flexion after the acute pain has subsided 
Stage 4 
Modification of activities of daily living predisposing to 
FAI (e.g. hip internal rotation associated with flexion and 
adduction) 
 
In total, 36 physical therapists responded and agreed to take part in the consensus process; 
24 from the UK, 10 from the US and 2 from Australia. All 36 were senior musculoskeletal 
physical therapists who had previously managed patients with FAI. Details of the initial round 
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of consensus development received from 36 physical therapists are summarised in Table 5.2 
and the further comments they provided are shown in Table 5.3. 
Table 5.2: Level of agreement with the Emara protocol (initial protocol) 
 Agreement 
 
Stage 1 and 2 of the Emara et al 
protocol (initial assessment and 
treatment) 
Level of agreement n (%) 
Stage 2 and 3 of the Emara et al 
protocol (further assessment and 
treatment) 
Level of agreement n (%) 
Yes 16 (44) 9 (25) 
No  7 (19)  6 (17) 
Unsure 13 (36)  21 (58) 
Total 36 36 
 
Table 5.3: Summary of additional comments made with respect to the Emara et al protocol 
(initial protocol) 
 
 Additional themed comments made 
Number of PTs 
suggesting theme 
Origin of 
comments 
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Core stability exercise and movement control  
21 UK x17, Australia x2, 
USA x2 
Muscle strengthening important 7 UK x6 USA x1 
See patients more frequently / over a longer period 5 UK x4 Australia x1 
Stretching exercise depending on what is limited.  4 UK x2 USAx2 
Soft tissue mobilisation to facilitate range of movement 3 UK x2 USA x1 
Address flexion contractures 2 UK x2 
Massage to relieve tightness in hip muscles 2 UK x1 Australia x1 
Avoid flexion stretching exercises during initial stages 1 UK x1 
Internal rotation stretching when pain free  1 USA x1 
Gentle exercise to mobilise the joint in all directions 1 UK x1 
Reduce overactive hamstrings muscles 1 UK x1 
Work on active abduction and external rotation 1 UK x1 
Avoid excessive hip flexion 1 UK x1 
See patients less frequently  1 UK x1 
Prolonged follow-up often needed 1 UK x1 
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) Advice that cycling is acceptable with activity 
modification
7 
UK x 6 Australia x1 
Continue strengthening 6 UK x6 
Zigzag running no better than straight running 4 UK x3 Australia x1 
Reassessment important 2 UK x2 
Using orthotics may help 2 UK x2 
Encourage hip capsule stretches 2 UK x2 
Stretches can be harmful 2 UK x1 Australia x1 
Identify dysfunctional movement patterns to achieve 
long term change 
2 
UK x1 Australia x1 
More than twice monthly supervision required 2 UK x1 Australia x1 
Advice about lifestyle modification 
2 
UK x1 USA x1 
Advice about alternative forms of exercise 2 UK x1 Australia x1 
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Advise to avoid deep squatting 1 UK x1 
Advice on return to sport specific training 
1 
Australia x1 
Strengthening of internal and external rotators of hip 1 UK x1 
Activity restriction on an individual basis 1 UK x1 
Modification of running on an individual basis 1 UK x1 
Ensure activities can be undertaken with minimal 
adduction/Internal rotation 
1 
UK x1 
 
The level of agreement with the Emara et al protocol (initial protocol) amongst the 36 
physical therapists was below the 50% threshold that had been set for the Delphi consensus 
method.  However, using the additional comments made by the physical therapists, available 
evidence and established theory; two further protocols were developed independently by NF 
and PW (see appendix C and D) and presented at a core study group meeting. Using the two 
independent protocols presented, the core study group derived a second protocol based on a 
majority within the group (NGT type methodology). The second protocol which the core study 
group formulated had 4 core components and 4 optional components, which are described 
below along with a justification provided by the core study group for including each 
component: 
 
Core component 1: Patient assessment 
i. Both independently-developed protocols featured this component 
ii. Although not formally a treatment and as such not specifically mentioned in the 
questionnaire feedback received, the core study felt that this component should be 
explicitly included in the protocol as it would underpin the remainder of the best 
conservative care treatment protocol. 
 
Core component 2: Patient education and advice 
i. Both independently-developed protocols featured this component 
ii. 13 additional comments from questionnaire respondents suggested that physical 
therapists should provide patient specific education and advice about FAI with an 
indication that this should focus on lifestyle modification, advice on how to undertake 
different forms of exercise and how to undertake common activities such as walking, 
cycling, etc. 
 96 | P a g e  
iii. Advice particularly with respect to activity modification was a feature of the published 
literature, including the Emara et al protocol.82,119  
iv. In addition to points i, ii and iii, the core study group felt that education and advice 
would be regarded as a core component of best practice amongst physical therapists 
managing any painful musculoskeletal condition. 
v. Both lifestyle and activity modification draws on relevant theory i.e. behavioural 
modifications that might lead to reduced functional impingement should result in 
reduced symptoms.34  
 
Core component 3: Help with pain relief 
i. Both independently-developed protocols featured this component 
ii. This was a feature of the published literature, including the Emara et al protocol 
(stage 1), to which 44% of the physical therapists agreed.82,119 
iii. Analgesia is an established treatment for musculoskeletal pain.179,180 Controlling 
musculoskeletal pain associated with FAI with analgesia therefore follows MRC 
guidance that treatment draws on relevant theory.   
 
Core component 4: Exercise based hip programme 
i. Both independently-developed protocols featured this component 
ii. 37 additional comments from questionnaire respondents endorsed both hip specific 
and more general exercises for managing patients with FAI. Of these, core or stability 
exercises were the most common (n=21 additional comments). The feedback 
suggested that the exercise programme should be individualised to the patient and 
progressed over time from core stability exercise and stretching to strengthening 
exercises. 
iii. Exercise was a predominant feature of the Emara et al protocol and the other 
published literature for managing FAI nonoperatively.82,118,119  
iv. Exercise is an effective treatment for many other musculoskeletal pain problems181,182 
and exercise-based programmes can produce similar improvements in symptoms to 
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surgery.183 Therefore including an exercise based hip regime to help manage the 
symptoms of FAI follows MRC guidance that treatment draws on relevant theory.   
 
Additional optional components 
The core study group decided to include the following optional components which could be 
undertaken in addition to the core components in order to individualise treatment, at the 
discretion of the physical therapist delivering care: 
 
Option 1: Additional symptoms that patients with FAI may present with can also be treated. 
Option 2: Orthotics can be used to aid the treatment of biomechanical abnormalities 
Option 3: Corticosteroid hip joint injection may be used for patients who cannot engage with 
‘core’ treatment due to acute pain symptoms. 
Option 4: Manual Therapy: hip joint mobilisations may be added if felt appropriate e.g. 
distraction and trigger point work. 
 
The Emara et al protocol suggested that physical therapy should be offered over a period of 
between 2 to 3 weeks. The initial round of physical therapist responses suggested patients 
should be seen over a longer period and more frequently in order to provide best care. 
Currently within the NHS the average number of treatment sessions given by physical 
therapists to musculoskeletal pain patients is between 3 to 4 face to face contacts. There is 
evidence to suggest that better outcomes are achieved from exercise based regimes when 
they are supervised and the contact between the supervisor and patient is increased.184,185 In 
order to allow more contact between therapists and their patients without increasing the 
burden of having to travel to clinic appointments non face to face contacts (e.g. telephone 
and email) were also allowed in order to progress the exercise programme and to support 
patients to adhere to the recommended exercise. The core study group decided that the 
agreed protocol could be delivered over a 12 week period. A minimum of 6 treatment 
sessions should be provided (of which at least 3 should be face to face). The duration of care 
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was both in keeping with established theory that suggests physiological changes in muscle 
occur after a 12 week programme of exercise.186  
 
The core study group agreed on the following protocol exclusions:  
i. Painful hard end stretches. Although only mentioned by two physical therapists in the 
initial questionnaire responses, there is some evidence in the literature to suggest 
that painful hard end stretches and forceful manual techniques in a restricted range of 
movement may be harmful. Therefore although stretching was permitted these hard 
end stretches were excluded.30  
ii. Group based treatment. In order to ensure care was individualised. 
iii. Care delivered by a technical or student instructor. In order to ensure the highest 
standard of care was delivered. 
The second protocol is outlined in Figure 5.2. 
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Figure 5.2: Second protocol 
 
At the second Delphi round 30 out of the original 36 participating (83%) physical therapists 
responded and agreed with the second protocol and provided no additional suggestions for 
change. One physical therapist did not respond and 5 disagreed with the second protocol 
and made suggestions for change. These points were discussed amongst the core study 
group and the following changes were made: 
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i. Two optional booster sessions that could be delivered between 12 weeks and 6 
months were added to a revised protocol. This was in response to concerns that the 
initial 12 week programme could prove to be insufficient to correct what is likely to be 
a chronic biomechanical dysfunction. Booster sessions would also help with 
adherence to the programme. 
ii. Taping techniques: to help with postural modification / reminding was added to the 
protocol. Although only mentioned by one physical therapist, it was noted that taping 
was a feature of the published literature and had been noted though not included in 
the NF protocol.171 
 
Given the level of agreement (83%) achieved with the second protocol the core study group 
decided to use the second protocol with the modifications discussed above for 
implementation in the RCT. 
 
Twelve physical therapists were initially part of the pilot RCT (Chapter 8) and delivering the 
best conservative care protocol. Examples of some of the most popular exercises that 
formed an exercise template to accompany the protocol are shown in appendix E. Eight 
physical therapists (out of 12 physical therapists participating in the RCT) from 8 recruiting 
centres attended the workshop to review the content and delivery of the protocol. Collectively 
the physical therapists were treating 18 patients within the pilot RCT. The therapists all felt 
that the protocol worked well but collectively they wanted to change the number of treatment 
sessions and the overall duration of the protocol, in order to ensure they were able to deliver 
best care. As a result one change was made to the protocol which allowed a minimum of 6 
and a maximum of 10 contacts over a 6 month period. The physical therapists agreed that no 
further amendments would be needed to the protocol. 
 
ii. Naming best conservative care 
Sixteen patients with FAI took part in qualitative study to derive a name for the best 
conservative care protocol. They were asked to choose between 4 potential names which 
had been suggested by the core study group, with the option to suggest a different name if 
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they wished to do so.  Eight patients opted for the name ‘Personalised Hip Therapy (PHT)’, 4 
patients voted for ‘Personalised Hip Programme’, one patient preferred the name ‘Focused 
Hip Therapy’ and 3 offered their own suggestions (i.e. ‘Conservative Hip Rehabilitation 
Programme’ and the inclusion of the word ‘Non-Invasive’). ‘Conservative’ or ‘Non-invasive’ 
were disregarded because they appeared to have a value attached to them; for example the 
term conservative could be confused with terms used in politics. The word ‘personalised’ was 
preferred for most people, as exemplified in the quote below:   
“I said the last two [personalised hip treatment and personalised hip therapy] because it 
makes it a personal issue for that person ....going down a non-operative route would require 
different treatment for every different patient” (Patient 3) 
A patient explained the preference for the word ‘therapy’ as indicative that there was an effort 
to ‘solve’ or ‘cure’ the condition as opposed to ‘programme’:   
“Therapy from a psychological point of view, people understand therapy (...) with regards to 
clinical treatment rather than a programme which can relate to anything in life” (Patient 13) 
The results of this consultation showed that the ‘Personalised Hip Therapy’ appealed to and 
conveyed a positive message to patients. The purpose of the research to name the protocol 
was to convey a message that the treatment was active and different to more general 
regimes of physical therapy that patients may have previously tried. 
5.6 Discussion 
The design of a structured protocol of physical therapy led nonoperative care for FAI has 
been outlined, including the approaches that were used to develop this protocol. The protocol 
has been designed with the support of available published evidence, expert consensus from 
physical therapists treating FAI patients including those that might be expected to provide the 
protocol of care as part of a pilot RCT. The systematic review of nonoperative care for FAI 
revealed a lack of both detail and quality of evidence but did suggest that nonoperative care 
might be effective. It is probably for this reason that the initial round of Delphi consensus 
gathering revealed low levels of agreement amongst physical therapists.  
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The Charted Society of Physiotherapy has approximately 50,000 members.187 Only 36 
physical therapists engaged with our research; the reasons for this are not clear but may 
reflect that a limited proportion will undertake regular musculoskeletal work and of these few 
may be sufficiently aware of FAI as a potential cause for young adult hip pain. As a result 
many may feel they were not appropriately qualified/experienced to make expert 
commentary about nonoperative care for patients with FAI. The approach used to gather 
experts for a Delphi method consensus does suffer from responder bias. As a result the 
subsequent protocol may not truly reflect the range of views and opinions of all physical 
therapists that routinely manage FAI. However, if the number of physical therapists that 
engaged in the initial survey had been much larger establishing a Delphi consensus with 
>50% agreement is likely to have been substantially more difficult even with subsequent 
iterations of the protocol.  
 
A further criticism of the approach used to develop the protocol may be that it does not 
represent one true consensus gathering methodology in its purest form. However, previous 
literature suggests that consensus development in healthcare which purports to use an 
established methodology rarely does and in fact modifications are often more appropriate 
and entirely reasonable.173    
 
It is already known that there is enthusiasm to undertake a RCT of surgery versus 
nonoperative care for FAI in the USA.188 By including a small proportion of international 
physical therapists (USA and Australia) the PHT protocol should be more applicable to care 
outside the UK and may be an appropriate nonoperative comparator in its current format for 
such an RCT. If not, it would provide a starting point for a further level of Delphi method 
consensus in the local physical therapy population e.g. USA and Australia.   
   
Where possible the protocol followed MRC guidance that an intervention is based upon 
some theory either proven or not. Research has already shown that exercise is an effective 
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treatment for many types of musculoskeletal pain181,182, and has identified that exercise-
based programmes can produce similar improvements in symptoms to surgery.183 
Personalised regimens of nonoperative care have been effective and sometimes superior to 
surgery in managing musculoskeletal problems, with the advantage of much less risk than 
that associated with surgery. 
Some examples include: 
i. Knee arthroscopy used to be a routine treatment for patients with knee osteoarthritis. We 
now recognise after performing similar large scale randomised controlled trials that 
regimes of pain medication and physiotherapy-led exercise are more effective at 
managing a patients symptoms without the risks of surgery.189,190 
ii. Similar findings have been shown for the treatment of knee meniscal tears where 
exercise based physical therapy is equally effective as surgery without the same level of 
risk.191 
iii. A large randomised trial of lumbar spine fusion versus intensive rehabilitation supervised 
by physical therapists found no difference in outcome between groups but considerably 
less risk in the non-surgical treatment group.192 
Therefore it is not unreasonable to propose that PHT may have some treatment effect above 
and beyond placebo only effects. The PHT protocol has two goals: 
i. Control and reduce symptoms 
ii. Prevent recurrence of symptoms 
It is proposed that the PHT programme will achieve these goals by teaching patients new 
techniques and ways of moving during everyday tasks and leisure activities to both reduce 
and avoid FAI. PHT will focus on improving the stability and fine control of movement around 
the hip, as well as improving the strength and flexibility of the joints and muscles close to the 
hip. Through this PHT, patients should be better equipped with the right knowledge and skills 
to modify and maintain ways of moving to reduce the effects of FAI. It is anticipated that 
these improved movement patterns will need to be consciously learnt to begin with but will 
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become routine with practice over time. The PHT programme aims to provide patients with a 
better understanding of FAI.  
 
The PHT protocol provides some guidance to other clinicians and researchers in an area 
where evidence and guidance are very limited. The protocol is not truly a new treatment for 
FAI and it merely represents a collection of expert opinions about nonoperative treatment 
that is already being undertaken in the real world for patients with FAI. The PHT protocol will 
be tested for safety, compliance and deliverability in a pilot RCT – see Chapter 9. By road 
testing in a pilot RCT it is anticipated that the protocol may be further refined and evolve, 
which is line with MRC guidance that complex interventions should always undergo a 
process of modelling prior to a full evaluation.177   
 
FAI affects a considerable proportion of young adults. It is important that FAI patients have 
access to and can decide between both operative and nonoperative care, until better 
evidence emerges in support of either treatment, particularly given the risks of surgery.
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Chapter 6 Femoroacetabular Impingement: surgical 
workload 
6.1 Declarations 
This work has been presented at a national conference: 
April 2013: Oswestry Research Day. Surgery undertaken for femoroacetabular impingement 
in the UK. 
 
This work was part of a larger project (UK FASHIoN study) funded by the NIHR Health 
Technology Assessment programme (project number 10/41/02) and the draft final report for 
the whole project has been submitted to HTA September 2013: 
 
Griffin DR, Wall PDH, Realpe A, Adams A, Parsons N, Hobson R, Achten J, Fry J, Costa M, 
Petrou S, Foster NE, Donovan J. UK FASHIoN: Feasibility study of a randomised controlled 
trial of arthroscopic surgery for hip impingement compared with best conservative care. 
6.2 Introduction 
The prevalence in the general population of symptomatic FAI is not known, nor is the 
proportion of these patients who subsequently undergo surgery. In order to plan and design 
a RCT to determine the effectiveness of surgery it is necessary to determine the quantity of 
FAI surgery (number of likely eligible patients) being undertaken. This information can be 
then used to predict the number of recruiting centres required for a RCT based on the 
required sample size. The National Institute for Health Research (NIHR) has suggested that 
a RCT comparing surgery and nonoperative care for FAI would be funded if such a study 
was deemed feasible within the NHS. In this context the workload of FAI surgery within the 
NHS was determined.193 Unfortunately it is unlikely that any routinely collected procedural 
data such as Hospital Episode Statistics (HES) within the NHS will be homogenous or 
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accurate enough. FAI and its treatments are a comparatively new phenomenon within the 
NHS and no diagnostic or procedural codes have been agreed. Therefore a survey based 
approach was required in order to determine the workload of FAI surgery.   
6.3 Objectives 
To obtain an estimate for the quantity of surgery being undertaken for FAI within the NHS. 
6.4 Methods 
A list of all NHS Hospital Health Boards and Trusts within England, Northern Ireland, 
Scotland and Wales was compiled using the NHS online resource. All Hospital Trusts and 
Health Boards were then contacted by telephone to determine if they had an Orthopaedic 
service. Subsequently, each orthopaedic service was contacted to determine the number of 
Orthopaedic departments which made up the service and the identities of the Clinical 
Directors. A list of all Orthopaedic Clinical Directors in the UK was then compiled. Each 
orthopaedic Clinical Director was then contacted by letter requesting the names, and contact 
details of all surgeons in their unit performing surgery for FAI. A letter was then sent to each 
identified FAI surgeon requesting the following statistics for the financial year 2011/2012:  
i. Number of NHS funded hip arthroscopies performed.  
ii. Number of NHS funded hip arthroscopies performed for FAI. 
iii. Number of NHS funded open surgical procedures performed for FAI.  
Consultants who did not consider themselves as FAI speciality surgeons were removed from 
the database. Consultants who considered themselves to be FAI specialty surgeons but 
were not currently performing surgery were kept on the database. The reasons given were 
recorded e.g. no current primary care trust funding for the procedure. Those FAI surgeons 
who did not want to participate in the study were removed from the database. Data collection 
was undertaken over a 6 month period between May and October 2012. Where consultants 
gave results for a period of less than a year, the results were not re-scaled. Instead, 
conservative estimates were obtained by keeping case numbers the same, no matter the 
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period. Where consultants provided an estimation using a range, this was recorded and final 
calculations were made based on the lowest figure in that range. 
 
In order to try and validate this workload data, NHS HES data was obtained for procedures 
undertaken in 2011/2012 using Office of Population Censuses and Surveys Classification of 
Interventions and Procedures (OPCS-4) codes within England. OPCS is a procedural 
classification for the coding of operations, procedures and interventions performed during in-
patient stays, day case surgery and some out-patient attendances in the NHS. OPCS-4 is an 
alphanumeric nomenclature, with a 4 character code system. The first character is always a 
letter. The code system can also be combined to provide further detail. Combinations of 
codes are separated by a “.”. Specific procedure codes for FAI surgery have not yet been 
established. 
 
In the absence of any established OPCS-4 codes for FAI surgery the codes currently agreed 
and applied to FAI surgery within University Hospital Coventry and Warwickshire (UHCW) 
were used. These were: 
i. Z843 which represents surgery on the hip joint was combined with the following 
categories 
ii. w844 = endoscopic decompression of joint 
iii. w802 = open debridement of joint 
Validation of the HES data was undertaken using an independently locally collected 
database for FAI surgery at UHCW.  
6.4.1 Statistics 
IBM SPSS version 21 for Windows statistical software package was used for the statistical 
analysis.86 Summary statistics including; mean (with standard deviations - SD) and median 
(with inter-quartile ranges) values were reported for the data.   
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6.5 Results 
There were a total of 193 NHS Hospital Health Boards and Trusts in the UK. Of these 27 did 
not have an orthopaedic surgical service. The workload data for FAI surgeons that 
responded to our survey is shown in Table 6.1. 
Table 6.1: Breakdown FAI surgeons and workload within the NHS 
  
No. of Hospital 
Health Boards and 
NHS Trusts with an 
FAI Surgeon 
No. of FAI 
Surgeons 
No. of 
Hospital 
Health Board 
and NHS 
Trusts with 
no funding 
for FAI 
surgery 
No. of 
open FAI 
surgery 
cases 
2011/12 
No. of 
arthroscopic 
FAI cases 
2011/12 
England  69  110  6 (8 surgeons)  444 1791 
Scotland  2  2  0  38  62 
Wales  2  6  0  9  55 
N. Ireland  2  2  2  0  0 
Total  75  120  8  491  1908 
 
Of the 120 FAI surgeons identified only 100 provided workload data. Four consultants gave 
results for a practise spanning less than a year. Of the 100 surgeons returning workload data 
25 did not perform any arthroscopic surgery over the 2011/2012 financial year and 55 did not 
perform any open surgery over the same period. The mean and median workload of FAI 
surgeons for arthroscopy, open surgery and total FAI surgery is shown in Table 6.2. 
Table 6.2: Workload for FAI surgeons 
 Arthroscopic FAI 
workload per 
surgeon 
Open FAI per 
surgeon  
Total FAI surgery 
workload per 
surgeon 
Mean (SD) 19 (23) 5 (12) 24 (34) 
Median (IQR) 12 (0-30) 0 (0-4) 12 (0-34) 
 
Figure 6.1 and Figure 6.2, show the spread of workload for arthroscopic and open surgery 
respectively.  
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Figure 6.1: Surgeon workload for arthroscopic surgery 
 
Figure 6.2: Surgeon workload for open surgery 
 
Each surgeon returning data was assigned a postcode for their NHS practice and this was 
used to create a choropleth map of the workload data based upon regions within the UK. A 
choropleth map is a thematic map with areas shaded in proportion to the measurement of the 
variable being displayed on the map.  Figure 6.3 and Figure 6.4 are UK choropleth maps for 
arthroscopic and open surgery respectively based on regions. 
 
 
 
 
 
 
0
50
100
150
1 11 21 31 41 51 61 71 81 91
W
o
rk
lo
ad
 in
 1
2
 m
o
n
th
s 
Surgeons 
Individual Surgeon workload for  
FAI treated arthroscopically  
0
20
40
60
80
100
1 11 21 31 41 51 61 71 81 91
W
o
rk
lo
ad
 in
 1
2
 m
o
n
th
s 
Surgeons 
Individual Surgeon workload for  
FAI treated with open surgery 
 110 | P a g e  
 
 
 
 
 
 
 
 
Figure 6.3: Choropleth map of arthroscopic surgery 
Figure 6.4: Choropleth map of open surgery 
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Prevalence rates were calculated for each region per 100,000 population using mid 2010 
population estimates from the Office for National Statistics (ONS), the results are shown in 
Table 6.3: Prevalence of surgical workload based on regional populations.  
Table 6.3: Prevalence of surgical workload based on regional populations 
Region 
Mid 2010 
Population 
estimate
194
 
Arthroscopic 
FAI surgery 
cases 
Arthroscopic 
FAI surgery 
per 100,000 
population 
Open 
FAI 
surgery 
cases 
Open FAI 
surgery 
per 
100,000 
population 
Total FAI 
workload 
per 
100,000 
population 
London 7,825,000 392 5.0 73 0.9 5.9 
South East 8,523,000 326 3.8 3 0.0 3.9 
West 
Midlands 
5,455,000 250 4.6 64 1.2 5.8 
South West 5,274,000 249 4.7 198 3.8 8.5 
North West 6,936,000 198 2.9 6 0.1 2.9 
East of 
England 
5,832,000 178 3.1 51 0.9 3.9 
Yorkshire & 
Humber 
5,301,000 103 1.9 4 0.1 2.0 
North East 2,607,000 95 3.6 25 1.0 4.6 
Scotland 5,222,000 62 1.2 38 0.7 1.9 
Wales 3,006,000 55 1.8 9 0.3 2.1 
East 
Midlands 
4,481,000 0 0.0 20 0.4 0.4 
N. Ireland 1,799,000 0 0.0 0 0.0 0.0 
Total 62,261,000 1908 3.1 491 0.8 3.9 
 
The data was also sorted into individual hospital trusts undertaking FAI surgery. There were 
a total of 75 individual hospital trusts employing FAI surgeons.  A summary of this data is 
shown in Table 6.4. 
Table 6.4: Summary of workload for hospital trusts 
Summary 
statistic 
FAI surgeons 
per hospital trust  
Arthroscopy per 
hospital trust in 
2011/12 
Arthroscopy for 
FAI per hospital 
trust in 2011/12 
Open surgery for 
FAI per hospital 
trust in 2011/12 
Mean 1.3 37.3 25.4 6.5 
SD 0.6 52.7 34.0 17.2 
Median 1 22 12 0 
Interquartile 
range 
1 45 41 5 
Minimum and 
maximum 
1-4 0-352 0-149 0-132 
 
 
There were a total of 44 hospital trusts that undertook ≥10 hip arthroscopies for FAI in 
2011/12 and 12 hospital trusts that undertook ≥10 open surgeries for FAI.  
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Table 6.5 provides details of the hospital trusts performing ≥10 hip arthroscopies for FAI in 
2011/12.  
Table 6.5: Hospital trusts performing ≥10 hip arthroscopies for FAI in 2011/12 
Individual Hospital 
Trust 
No. of 
surgeons 
Hip arthroscopies 
in 2011/12 
Hip arthroscopies 
for FAI in 2011/12 
Open surgery for 
FAI in 2011/12 
Frimley Park Hospital NHS 
Foundation Trust 
2 159 149 1 
Guy’s and St Thomas’ NHS 
Foundation Trust 
2 333 144 9 
Barts Health NHS Trust 3 50 140 30 
Epsom and St Hellier University 
Hospitals NHS Trust 
4 135 129 1 
Royal Cornwall Hospital 
(Treliske) 
3 157 100 132 
Addenbrookes Hospital 2 143 91 0 
The Royal Orthopaedic Hospital 
NHS Foundation Trust 
2 135 90 15 
Robert Jones and Agnes Hunt 
Hospital 
2 90 80 1 
South Tees Hospitals NHS 
Foundation Trust 
2 73 73 0 
Wrightington, Wigan and Leigh 
NHS Foundation Trust 
2 76 71 2 
Bangor Hospital 3 59 55 9 
Buckinghamshire Healthcare 
NHS Trust 
1 53 53 1 
University College London 
Hospitals NHS Foundation Trust 
2 50 50 0 
Bolton NHS Foundation Trust 1 51 50 0 
Harrogate and District NHS 
Foundation Trust 
1 50 50 0 
Royal National Orthopaedic 
Hospital NHS Trust 
1 50 50 30 
South London Healthcare NHS 
Trust 
1 50 50 0 
Oxford Radcliffe Hospitals NHS 
Trust 
2 50 45 0 
Great Western Hospitals NHS 
Foundation Trust 
3 47 43 7 
Sheffield Children's NHS 
Foundation Trust 
1 102 43 0 
Royal Infirmary of Edinburgh 1 48 42 0 
King's College Hospital NHS 
Foundation Trust 
2 40 39 6 
Plymouth Hospitals NHS Trust 1 35 35 0 
Yeovil District Hospital NHS 
Foundation Trust 
2 40 33 7 
Central Manchester University 
Hospitals  
1 40 30 0 
Northumbria Healthcare NHS 
Foundation Trust 
1 30 25 0 
The Princess Alexandra Hospital 
NHS Trust 
1 25 25 5 
Royal Devon & Exeter NHS 
Foundation Trust 
1 28 23 0 
Weston Area Health NHS Trust 1 352 23 4 
Gateshead Health NHS 
Foundation Trust 
2 22 22 5 
Western Sussex Hospitals NHS 
Trust 
1 22 22 0 
Southern General Hospital – 1 38 20 38 
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Glasgow 
University Hospital of South 
Manchester Hospital 
1 17 17 0 
East Kent Hospitals University 
NHS Foundation Trust 
1 15 15 0 
Maidstone and Tunbridge Wells 
NHS Trust 
1 40 15 1 
University Hospital Coventry 
and Warwickshire NHS Trust 
1 60 15 0 
Wirral University Teaching 
Hospital  
1 30 15 0 
Blackpool, Fylde and Wyre 
Hospitals  
1 31 12 0 
Luton and Dunstable Hospitals 
NHS Trust 
1 15 12 0 
North Bristol NHS Trust 1 52 12 20 
Royal Surrey County NHS 
Foundation Trust 
1 12 12 0 
South Warwickshire Hospital 1 18 12 0 
Hull and East Yorkshire 
Hospitals  
1 29 10 4 
Poole Hospital 1 20 10 0 
 
The workload data obtained from the surgeons relies heavily on the accuracy of their own 
recall. Only two surgeons volunteered that the data provided was from their own independent 
records. 
 
From the initial survey there were 69 hospital trusts in England with at least one FAI surgeon. 
Of these 69 trusts, 53 trusts had evidence of coded procedural activity from the HES data 
search. However, the data for both arthroscopic and open surgery was different by > 5 
procedures in 68 trusts when the two sources of data were compared. Local database results 
at UHCW showed that 12 arthroscopic and 0 open surgeries were undertaken for FAI. The 
corresponding HES data reported 15 arthroscopic and >1 but <5 open surgeries for FAI. 
6.6 Discussion 
There are a minimum of 120 practising NHS consultant FAI surgeons who collectively 
undertook a reported 2399 FAI surgical procedures in 2011/12 within the NHS. There is a 
considerable difference in the number of arthroscopic (mean 25.4 cases per hospital trust in 
2011/12) and open FAI surgery (mean 6.5 cases per hospital trust in 2011/12) being 
undertaken.  
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Based upon a proposed sample size of 372 participants for a RCT (see Chapter 10) the 
workload data indicates that there is likely to be a large pool of eligible patients from which to 
undertake a RCT within the NHS. The data also suggests that a RCT could be conducted to 
measure the clinical effectiveness of arthroscopic FAI surgery alone. However, a RCT for 
open surgery alone would be much more challenging. A RCT measuring the clinical 
effectiveness of arthroscopic FAI surgery may be preferable to one combined with open 
surgery, given that the survey showed that the majority of FAI surgery was undertaken 
arthroscopically. The results of open and arthroscopic surgery are generally regarded as 
comparable but the risk of complications is greater for those undergoing open surgery (see 
Chapter 1). It is therefore likely that arthroscopic surgery will continue to be the preferred 
surgical option for patients with FAI.      
 
The survey data relies heavily on surgeons’ recall and memory which is likely to have some 
inaccuracies. However, the alternative using the coded procedural data suffers from two 
major problems: 
i. Coding for surgical procedures is known to be inaccurate. The coding of one study has 
reported accuracy of 47%.195 Coding is frequently undertaken retrospectively by staff with 
no medical training and there are multiple ways of coding the same procedure.195 
ii. FAI surgery has no specific procedural codes and is therefore coded using alternative 
combinations of the OPCS–4 coding system across NHS trusts. 
For this reason the HES data was used to triangulate/confirm locations of FAI surgery rather 
than provide any robust measure of the quantity of surgery. 
 
Based on the ONS population data, the prevalence of surgery for FAI within the UK is 3.9 per 
100,000 head of population. This figure represents a conservative estimate for prevalence of 
surgery for FAI within the UK because:  
i. Twenty surgeons did not provide data.   
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ii. The survey does not include surgery without NHS funding. The extent of privately 
funded FAI surgery (of both types) is unclear. And no statistics appear to be readily 
available. Any future RCTs would clearly be better informed if privately funded FAI 
were included.    
The prevalence data presented in this study has not previously been available because of 
the absence of any formal operative coding for FAI and because FAI surgical registries have 
only recently been introduced. Although all Health Boards and Trusts and their Clinical 
Directors responded to our enquiries it is possible that Clinical Directors are not always 
aware of the range of expertise within their department.  
 
The results suggest the workload of FAI surgery is not spread evenly by surgeon or by 
region. For both arthroscopic and open surgery there was a positive skew with a small 
number of surgeons doing the majority of the surgery. Similarly, there is a suggestion that 
more surgery is taking place in the South West, London and the West Midlands per head of 
population, with marked variations in surgical workload across neighbouring regions e.g. 
West Midland and East Midlands (5.8 and 0.4 per 100,000 respectively).  It seems unlikely 
that these differences are due to regional variations in the prevalence of FAI and are more 
likely to represent regional variation in both surgical expertise and funding for FAI surgery. 
Surgical treatment for FAI is a relatively new and technically demanding procedure196,197 The 
availability of surgeons with sufficient experience and expertise is likely to be limited. This is 
corroborated by the high workload amongst a small number of surgeons nationally. 
 
The survey results provide a conservative estimate for both the number of FAI surgeons 
currently practising with the NHS and the prevalence of FAI surgery being undertaken. The 
results also highlight marked regional variation in surgical workload and it is possible that 
some patients, for geographical reasons may not have easy access to appropriate care. The 
results are sufficient to enable planning for a multi-centre RCT based on the FAI surgical 
workload at each Hospital Trust.   
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Chapter 7 Femoroacetabular impingement: exploring 
equipoise amongst arthroscopic surgeons 
7.1 Declarations 
This work has been presented at an international conference: 
May 2012: Femoroacetabular Research Symposium, Chicago, USA. FASHIoN Study: 
equipoise amongst arthroscopic FAI surgeons. 
 
This work was part of a larger project (UK FASHIoN study) funded by the NIHR HTA 
programme (project number 10/41/02) and the draft final report for the whole project has 
been submitted to HTA September 2013: 
Griffin DR, Wall PDH, Realpe A, Adams A, Parsons N, Hobson R, Achten J, Fry J, Costa M, 
Petrou S, Foster NE, Donovan J. UK FASHIoN: Feasibility study of a randomised controlled 
trial of arthroscopic surgery for hip impingement compared with best conservative care. 
7.2 Introduction 
Equipoise is a state of genuine uncertainty about the comparative therapeutic merits of each 
treatment arm in a trial.198 In order to engage fully with and participate in RCTs, surgeons 
need to have a degree of uncertainty or equipoise between the relative merits of different 
treatments. Although the published literature suggests a degree of research equipoise about 
the optimal treatment for FAI, it does not necessarily follow that all those undertaking FAI 
surgery share this position. In fact, it is conceivable that many surgeons performing FAI 
surgery are not subjectively in a state of equipoise.   
 
Quantitative research methodology has been used previously to help understand both 
community equipoise and manage equipoise amongst surgeons within a RCT.199,200 
However, qualitative research methodology can also be used to understand recruitment 
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difficulties and inform the development of strategies to improve recruitment in difficult RCTs 
such as those in surgery.201-203 In a RCT, clinicians not only have to make diagnostic 
decisions but also consider recruiting their patients. By deconstructing the cognitive 
processes involved when a clinician considers recruiting a patient to a RCT, it is possible to 
elucidate the state of individual equipoise that may be influencing a recruitment decision.  
7.3 Objectives 
To identify through qualitative methods those arthroscopic FAI surgeons who are in 
equipoise about the optimal treatment for FAI and would therefore be most suitable to act as 
local investigators/recruiters for a pilot multi centre RCT (see Chapter 8 and 9). 
7.4 Methods 
Ethical approval was granted for this study by Research Ethics Committee - West Midlands 
(11/WM/0389). Following the FAI surgical workload survey (Chapter 6) a number of surgeons 
(n=14) expressed a provisional interest in taking part in a proposed multi centre pilot RCT 
(Chapter 8 and 9). These 14 hip arthroscopy surgeons were from 12 different hospital trusts 
within England. All of the surgeons performed more than 10 cases of arthroscopic FAI 
surgery in 2011/12 and on the basis of workload would be suitable candidates to act as local 
investigators / recruiters to a multicentre pilot RCT. A qualitative research study was 
undertaken amongst these surgeons using semi-structured interviews. The surgeons were 
interviewed and asked to articulate their thoughts out loud as they engaged in tasks involving 
diagnosis and recruitment to a theoretical RCT to determine the clinical effectiveness of 
arthroscopic FAI surgery.  
In order to stimulate a process of decision making for the surgeons, three real life patient 
vignettes were prepared by PW. The written patient vignettes (which included a photograph) 
provided detail of: 
i. Patient demographics (age, gender and occupation) 
ii. Clinical history typical of FAI including details about the patient’s previous treatments 
iii. Examination findings typical of FAI 
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iv. Imaging findings (Plain radiographs, CT and MRA) suggestive of FAI 
v. Patient preference for treatment of FAI 
In two of the vignettes, the patient had received extensive physical therapy prior to being 
eligible for the trial. The purpose of this was to test whether surgeons would still agree to 
randomise patients for potentially a further course of physical therapy as part of the RCT. In 
the third vignette the patient had not had prior physiotherapy. Surgeons were asked to pick 
two of the vignettes which were held faced down on a table. Therefore all surgeons received 
a vignette in which at least one patient had received extensive previous physical therapy. 
Only two vignettes where chosen because of time constraints with each surgeon. Typically 
each vignette took 20 minutes to fully review and discuss. Each vignette was presented to 
the surgeon along with an explanation of a theoretical model for a RCT comparing hip 
arthroscopy and nonoperative care for FAI. The vignettes were aided by a modified 
CONSORT flow chart for the RCT study design (see Figure 7.1). 
 
 
 
Figure 7.1: Modified CONSORT flow chart for a RCT  
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All surgeons agreed to the interview being audio-recorded. The surgeons were then given 
the following instruction:  
“These are the notes of a patient who may have FAI. I would like you to think aloud and tell 
me what is going through your mind as you read this case. I am particularly interested in 
thoughts you may have when considering an intervention, including referring the patient to 
the RCT.” Once the surgeons finished their description, further questions were asked to 
clarify their views: 
i. Which patients would you try to recruit to a RCT such as this? 
ii. Do you think the RCT is necessary? 
iii. Are you in equipoise about the treatment for FAI? 
The audio-recordings were transcribed and analysed thematically by PW and AR. For each 
surgeon interview a principle of theoretical saturation was applied when analysing the 
recordings (i.e. a point is reached when new data does not add materially to the current 
findings). Themes were analysed for frequency and tabulated. 
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7.5 Results 
Surgeons did not dispute the diagnosis and relevance of the cases of FAI presented to them, 
with 12 surgeons explicitly revealing they felt the cases and scenarios were appropriate. 
When asked directly, 12 of the surgeons interviewed declared that they were in equipoise 
about the most effective treatment for FAI in the short and long term. The interviews revealed 
the factors that surgeons consider to be important when making a diagnosis of FAI and when 
considering treatment and possible trial randomisation. These are: activity level, age, gender, 
duration of symptoms, previous therapy and imaging findings - see Table 7.1. 
Table 7.1: Patient factors surgeons consider when making diagnostic, treatment and eligibility 
decisions for a theoretical RCT 
Patient factors considered No. of surgeons citing factors (%) 
Activity level 11 (79) 
Age 9 (64) 
Gender 7 (50) 
Duration of symptoms 7 (50) 
Previous therapy for FAI 7 (50) 
Imaging findings 5 (36) 
Expectations of patient 2 (14) 
Patient preference 2 (14) 
Severity of symptoms 1 (7) 
Evidence of degenerative change in the hip 1 (7) 
 
The surgeons were asked to consider inviting the presented ‘patients’ to take part in the 
theoretical RCT. During their deliberations they made inferences about FAI, its management 
and the RCT. The themes for the inferences made are presented in Table 7.2 and Table 7.3. 
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Surgeons’ inferences were subdivided into themes expressing either certainty or uncertainty 
about FAI treatment and the proposed RCT. 
 
Table 7.2: Certainty themes amongst surgeons about FAI treatment and RCT participation 
Inferences expressing 
certainty 
No. of surgeons 
expressing 
theme (%) 
Example quotes given when no. 
expressing theme ≥3 
About surgery 
Surgery is more effective 
than conservative care in 
the short term 
5 (36) 
“ I am reasonably convinced FAI surgery is 
superior in the short term in carefully 
selected patients” 
Some patients do not 
benefit from surgery 
4  (29) 
“There are some patients who would be 
worse after this operation” 
Patients improve without 
surgery in the short term  
2 (14)  
Surgery is effective in the 
long term  
2 (14)  
No equipoise in the 
surgical community 
2 (14)  
Surgeons have a vested 
interest in the success of 
surgery  
1 (7)  
FAI with large cams 
benefit from surgery 
1 (7)  
Surgery for cam type FAI 
has the best surgical 
outcome 
1 (7) 
 
Surgery for pincer type 
FAI is not effective 
1 (7) 
 
About alternative treatments 
Conservative care does 
not work 
 
3 (21) 
 “There is no evidence anywhere that 
conservative treatment will work” 
Conservative care works 
for some patients 
2 (14)  
Treatments for FAI are 
comparable 
2 (14) 
 
Conservative care works 
for patients with mixed 
type FAI 
1 (7)   
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Table 7.3: Uncertainty theme amongst surgeons about FAI treatment and RCT participation 
Inferences and 
questions expressing 
uncertainty 
No. of surgeons 
expressing theme 
(%) 
Example quotes given when no. 
expressing theme ≥3 
About surgery 
Uncertain long term 
outcome from surgery 
 
8 (57) 
When referring to the long term results of 
surgery “It is my personal opinion, I don't 
know” 
About the RCT 
Is the trial duration 
adequate? 
 
5 (36) 
“You're going to follow up for only 12 
months, I wonder if that gives enough time 
for recovery from surgery” 
Mild cases of FAI may 
influence results 
 
4 (29) 
“The study may be weakened by a 
tendency for individuals with mild 
symptoms to accept randomisation” 
Is the research question 
relevant? 
 
3 (21) 
“The question we really want to know is 
'are we influencing the natural history of 
the condition.” 
Do adequate outcome 
tools exist for the trial? 
2 (14)  
 
7.6 Discussion 
Twelve (86%) of the fourteen surgeons interviewed gave explicit indications that they were in 
equipoise about the efficacy of treatments for FAI in both the long and short term and 
suggested that a RCT to measure the clinical effectiveness of surgical treatment for FAI was 
desirable. These views are supported by current published literature which calls for such a 
trial.48,204 However, the explicit statements of equipoise amongst the majority of surgeons 
were challenged by the interview data obtained when the surgeons discussed the patient 
vignettes. Five (36%) surgeons believe surgery is more effective in the short term than 
nonoperative care, which is not in keeping with a position of equipoise about the true efficacy 
of treatment for FAI. In addition, 3 (21%) surgeons suggested nonoperative care does not 
work which questions whether the majority of these surgeons are in total equipoise.  
 
Of concern for future RCT research, is the fact that despite the majority believing they were 
in equipoise, only 3 (21%) surgeons believed that a RCT was the optimum solution to 
improve the evidence base. The current published literature describes FAI as a chronic 
painful hip condition in adults with evidence of hip shape abnormality on specialist imaging, 
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which can vary by gender.37,42 This was reflected in the findings that the factors most 
frequently cited by the surgeons interviewed as influencing their diagnostic and treatment 
decisions were: patients’ age, gender, activity level, duration of symptoms, imaging findings 
and previous therapy.  All of these factors were mentioned by at least 5 of the surgeons 
interviewed emphasising not only their importance for validating a diagnosis of FAI, but also 
for making decisions about patients’ treatment and suitability for a RCT.  
 
The results suggest that explicit statements of equipoise used in isolation may be too 
simplistic in order to determine complete equipoise and while many surgeons may think they 
are in equipoise it is in theory only. Their actions and management decisions do not always 
support a position of “active equipoise”. Such discrepancies may be fundamental to the 
success or failure of a RCT. Addressing these issues is important, but may not be 
straightforward. However, education, with reference to current literature, is likely to be helpful 
in establishing a more uniform state of equipoise amongst surgeons.  
Current literature suggests that symptomatic FAI is a cause for subsequent OA.23 In order to 
capture any effect surgery may have on progression to OA, it would be necessary to 
measure clinical outcome many years after a patient is randomised to treatment. Such a 
RCT may prove technically very challenging when surgeons, (also likely to be recruiters), are 
not whole-heartedly in equipoise, and are concerned that delaying surgery for any lengthy 
period may be detrimental. Although 8 (57%) of the surgeons interviewed in our sample 
highlighted that they were uncertain about the long term results of their surgery.  
 
The survey reported in Chapter 6 suggests that there are approximately 75 active 
arthroscopic FAI surgeons practising within the NHS. The sample of 14 surgeons represents 
a small non-random sample (19%) of the population and therefore the conclusions drawn 
from this study may not be representative all the views of arthroscopic FAI surgeons. 
 
 124 | P a g e  
Seven surgeons displayed both “theoretical” and “active” equipoise when assessing the case 
vignettes and these surgeons were invited to act as local investigators/recruiters in a multi-
centre pilot RCT (see Chapter 8 and 9). Of these 7 there were 3 who clearly believed that a 
RCT was the optimum solution to improving evidence the evidence base. The qualitative 
approach described helped to identify areas of uncertainty amongst the surgical community, 
such as trial duration (5 surgeons), that would need to be addressed for a future full RCT.  
 
The qualitative approach used does require an interview to be undertaken; in larger scale 
RCTs involving many more investigators/recruiters this approach may not be feasible. 
However, the qualitative principal of theoretical saturation (i.e. a point is reached when new 
data does not add materially to the current findings) may allow to be used in small samples in 
order to build up a picture of potential problems across the larger study group. Other 
techniques have been used to measure equipoise and uncertainty amongst clinical 
communities.199 The qualitative method described provides a novel approach to determining 
a more complete assessment of clinical uncertainty and equipoise in a specialist area of 
orthopaedics (arthroscopic FAI surgery). As far as can be established this is the first 
examination using qualitative research methodology designed to better understand the 
presence or otherwise of equipoise amongst practising surgeons. Such an understanding is 
essential when planning a RCT, including selecting appropriate local investigators/recruiters 
and where subsequent recruitment of participants for a RCT will be equally challenging. 
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Chapter 8 Pilot RCT: recruitment 
8.1 Declarations 
The sample size calculation and randomisation sequence were completed by 
Dr N. Parsons at the University of Warwick. 
This work was part of a larger project (UK FASHIoN study) funded by the NIHR HTA 
programme (project number 10/41/02) and the draft final report for the whole project has 
been submitted to HTA September 2013: 
Griffin DR, Wall PDH, Realpe A, Adams A, Parsons N, Hobson R, Achten J, Fry J, Costa M, 
Petrou S, Foster NE, Donovan J. UK FASHIoN: Feasibility study of a randomised controlled 
trial of arthroscopic surgery for hip impingement compared with best conservative care. 
8.2 Introduction 
Several barriers to undertaking a RCT to measure the clinical effectiveness of surgery for FAI 
have already been explored in this thesis so far, such as: 
i. Determining a nonoperative treatment comparator. 
ii. Equipoise within the surgical community. 
iii. The quantity of FAI surgery being undertaken within the NHS.   
Of equal, if not more importance however is whether patients can be recruited to a RCT. An 
understanding of likely recruitment rates will help establish the viability and scale of a full 
trial. RCTs comparing orthopaedic surgical treatments with nonoperative treatment 
comparators historically show widely varying recruitment rates. For example: 
i. Jarvik et al who undertook a RCT of surgery versus nonoperative treatment for 
carpal tunnel found that 408 patients refused to enter the RCT. A total of 116 patients 
were randomised and recruitment rate was 22%.169 The loss to follow up at 1 year 
was 13%. 
ii. Klazen et al who undertook a RCT of vertebroplasty versus conservative treatment in 
acute osteoporotic vertebral compression fractures recruited 202 of 479 eligible 
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patients; therefore the recruitment rate was 42%.205 The loss to follow up at 1 year 
was 19%. 
iii. Kirkley et al who undertook a RCT of arthroscopic surgery versus physiotherapy for 
osteoarthritis of the knee recruited 188 patients out of 219; therefore recruitment rate 
was 86%.170 The loss to follow up at 1 year was 11%. 
In order to help estimate the recruitment for a full RCT comparing FAI surgery versus 
nonoperative care a pilot RCT was undertaken comparing hip arthroscopy (surgery) versus 
personalised hip therapy (nonoperative care). 
8.3 Objectives 
i. Estimate recruitment for a full RCT comparing hip arthroscopy versus PHT care for 
FAI. 
ii. Road test the PHT protocol for deliverability, compliance and safety - see Chapter 9. 
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8.4 Methods 
Ethical approval was granted for this study by Research Ethics Committee - West Midlands 
(11/WM/0389). 
8.4.1 Sample size 
The pilot RCT was not powered to measure any treatment effect. Instead the study was 
designed and the sample size calculated to estimate the recruitment rate. Table 8.1 shows 
the precision (95% CI) of 10, 20, 30, 40 and 50 recruitment percentage for sample sizes of; 
15, 30, 60, 90 and 120 eligible patients. The pilot RCT was modelled around approaching 60 
eligible patients to determine a recruitment rate with a reasonable degree of precision. 
Table 8.1: 95% confidence intervals for recruitment based on sample sizes of 15, 30, 60, 90 and 
120 
 Number of eligible patients approached 
 
n=15 n=30 n=60 n=90 n=120 
R
e
c
ru
it
m
e
n
t 
ra
te
 %
 
  
10  (0.0, 25.2) 
 
(0.0, 20.7) 
 
(2.4, 17.6) (3.8, 16.2) (4.6, 15.4) 
20 (0.0,40.2) 
 
(5.7, 34.3) 
 
(9.9, 30.1) (11.7, 28.3) (12.8, 27.2) 
30 (6.8, 53.2) 
 
(13.6, 46.4) 
 
(18.4, 41.6) (20.5, 39.5) (21.8, 38.2) 
40 (15.2, 64.8) 
 
(22.5, 57.5) 
 
(27.6, 52.4) (29.9, 50.1) (31.2, 48.8) 
50 (24.7, 75.3) 
 
(32.1, 67.9) (37.3, 62.7) (39.7, 60.3) (41.1, 58.9) 
 
Eligibility criteria were initially drafted by PW and supervisor DG and then agreed in 
collaboration with the Multicenter Arthroscopy of the Hip Outcomes Research Network 
(MAHORN - number of FAI surgeons=12) and FAI surgeons who attended the American 
Academy of Orthopedic Surgeons (AAOS) Femoroacetabular Research Symposium in 
Chicago n=4 (see appendix F). Patients were eligible to participate in the study if: 
i. Aged ≥16; 
ii. They had symptoms of hip pain; 
iii. They showed radiographic evidence of pincer- or cam-type FAI on plain radiographs 
confirmed with MR and/or CT;  
iv. The treating surgeon believed that they would benefit from arthroscopic FAI surgery. 
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Patients were excluded from participation in the study if: 
v. They had previous significant hip pathology such as Perthes’ disease, slipped upper 
femoral epiphysis or avascular necrosis; 
vi. They had a previous hip injury such as acetabular fracture, hip dislocation or femoral 
neck fracture; 
vii. They already had osteoarthritis, defined as Tonnis grade >1
17, or more than 2mm loss 
of superior joint space width on AP pelvic radiograph;75 
viii. There is evidence that the patient was be unable to adhere to trial procedures or to 
complete questionnaires, such as cognitive impairment or intravenous drug abuse. 
A total of 10 hospital trusts agreed to take part in the multi-centre pilot RCT (see Table 8.2). 
Of these 10 hospital trusts, 5 (6 surgeons) had taken part in the preceding equipoise study 
having expressed both “theoretical” and “active” equipoise and a willingness to take part in 
the pilot RCT (see Chapter 7). One surgeon who had been identified as in “theoretical” and 
“active” equipoise did not want to take part in the pilot because of plans to begin their own 
similar trial which might clash with the pilot RCT outlined. A further 5 hospital trusts agreed to 
take part in the pilot RCT. These 5 trusts were identified during the FAI workload survey (see 
Chapter 6) having shown enthusiasm during correspondence. These surgeons were not 
formally interviewed in order to determine their level of equipoise but a level of implied 
equipoise was assumed amongst these pilot RCT enthusiasts.       
Table 8.2: Recruitment sites 
Site Number Site Name 
1 University Hospital Coventry and 
Warwickshire NHS Trust 
2 Yeovil District Hospital NHS Foundation 
Trust 
3 Royal Devon & Exeter NHS Foundation Trust 
4 The Royal Orthopaedic Hospital NHS 
Foundation Trust 
5 Frimley Park Hospital NHS Foundation Trust 
6 Royal Cornwall Hospital (Treliske) 
7 Epsom and St Hellier University Hospitals 
NHS Trust 
8 Guy’s and St Thomas’ NHS Foundation Trust 
9 Barts Health NHS Trust 
10 University College London Hospitals NHS 
Foundation Trust 
 129 | P a g e  
 
Patients attending dedicated hip clinics run by the local investigators were screened for 
eligibility. Those patients who were eligible were provided with a patient information sheet 
(see appendix G) and invited to take part in the pilot RCT. If patients agreed they provided 
written informed consent (see appendix H). Recruitment and consent was undertaken by 
either PW or a trained recruiter (TR). The TRs were research associates working in the local 
hospital sites who had been trained to recruit by PW. Randomisation was done by telephone. 
Randomisation sequences (1:1 allocation) were generated for each site.  Patients were 
allocated to one of the two treatments: 
i. Personalised Hip Therapy 
ii. Arthroscopic FAI surgery 
Although not the primary aim of this study, patients were followed up after the start of 
intervention. The purpose of the follow-up was to enable use of data from the pilot RCT in 
any future full RCT analysis (an internal pilot). The data collected as part of this follow up is 
shown in Table 8.3. Patients, surgeons, physical therapists and research associates were 
not blinded to treatment allocation.  
Table 8.3: Follow up data collected 
Time Data to be collected 
Baseline  NAHS, IHOT-33, SF-12, EQ5D 
6 weeks Complications questionnaire 
3 months NAHS, IHOT-33, SF-12, EQ5D; complications questionnaire 
6 months NAHS, IHOT-33, SF-12, EQ5D; complications questionnaire 
12 months NAHS, IHOT-33, SF-12, EQ5D; complications questionnaire 
NAHS=Non Arthritic Hip Score; IHOT-33=International Hip Outcome Tool-33; SF-12=Short 
Form 12; EQ5D=EuroQol 5D 
8.4.2 Statistics 
Summary statistics and analysis were prepared using IBM SPSS version 21 for Windows.86 
Differences in mean recruitment activity between types of recruiter were analysed using an 
independent samples t-test. 
 130 | P a g e  
8.5 Results 
A total of 60 eligible patients were approached for recruitment to the pilot RCT across 9 
centres. One centre (Site 10) was considerably delayed in being setup and did not attempt 
recruitment before 60 approaches had already been made. It took 9.3 months to approach 
60 eligible patients for recruitment. Of these 42 patients consented to take part in the pilot 
RCT; therefore recruitment was 70% (95% CI 58-81). During this period a total of 134 
patients were screened for eligibility. Due to time restrictions and other commitments of the 
TRs less than half of all suitable clinics at peripheral sites were screened and attended by a 
trained TR. Where possible potentially eligible patients were put into clinics that a TR would 
be able to attend and potentially recruit. Overall recruitment activity is shown in Figure 8.1. 
Figure 8.1: Scatter plot of recruitment activity against time 
 
 
Not all centres commenced the study at the same time due to delays in local Research and 
Development (R&D) departmental approval. Table 8.4 shows the duration each centre was 
open to recruitment. 
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Table 8.4: Site recruitment data 
Site Recruitment 
duration 
(months) 
Eligible 
patients 
Recruited 
patients 
Eligible 
patients 
/ month 
Recruited 
patients / 
month 
Recruitment 
% 
1 9.3 24 19 2.6 2.1 79.2 
2 7.1 7 3 1.0 0.4 42.9 
3 4.4 3 2 0.7 0.5 66.7 
4 5.0 6 3 1.2 0.6 50.0 
5 4.1 4 4 1.0 1.0 100.0 
6 3.1 4 4 1.3 1.3 100.0 
7 3.0 1 1 0.3 0.3 100.0 
8 2.8 10 5 3.6 1.8 50.0 
9 2.2 1 1 0.5 0.5 100.0 
10 n/a n/a n/a n/a n/a n/a 
Mean (all 
sites)  
4.6 6.7 4.7 1.5 1.0 70.0 (95% 
CI 58-81) 
Mean 
(excl.site1) 
3.5 4.0 2.6 1.2 0.8 63.9 (95% 
CI  
 
The data was broken down by recruiter in order to determine any difference in recruitment 
between PW and TRs (see Table 8.5). An independent samples t-test to determine if there 
was a significant difference in recruitment between PW and the TRs (see Table 8.6). 
Table 8.5: Recruitment figures for PW and trained recruiters 
 
Site 
1 2 3 4 5 6 7 8 9 All sites 
Recruiter PW TR PW TR TR PW TR TR PW TR PW PW PW TR PW TR 
No. eligible 8 16 1 5 3 1 6 4 2 2 1 10 1 0 24 36 
No. recruited 5 14 1 2 2 1 2 4 2 2 1 5 1 0 16 26 
Recruitment % 63 88 100 40 67 100 33 100 100 100 100 50 100 0 67 72 
 
Table 8.6: Independent samples test of recruitment % between recruiters 
Mean recruitment % between PW 
and all TRs collectively 
Sig (2-
tailed) 
Mean difference 
95% CI 
Lower  Upper 
Recruitment % 0.65 -0.06 -0.3 0.19 
8.6 Discussion 
The pilot RCT suggests that recruitment of patients is possible across multiple sites. The 
recruitment rate of 70% was encouraging when compared to similar challenging RCTs (i.e. 
comparisons of surgical and nonsurgical intervention: see 8.2). As expected site 1 which was 
the lead site was recruiting for the longest period (9.3 months) and recruited the greatest 
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number of participants both in total and per month, which is in keeping with published 
research suggesting that lead sites/single centre RCTs achieve the highest recruitment in 
RCTs.175 There was a marked difference in both the number of eligible patients and recruited 
patients per month between site 1 and sites 2-10 combined.  Higher absolute recruitment at 
the lead site is probably a reflection of: 
i. Local enthusiasm for the RCT amongst investigators. 
ii. Delay at all peripheral sites in gaining R&D approval.   
iii. Logistically it is much easier for the study team to identify and resolve problems with 
the lead site compared to peripheral sites. 
To plan a full RCT it may be reasonable to exclude the lead site or make appropriate 
adjustments for its effect on the data in order to more accurately predict the effect of adding 
further study sites. Also when planning a full RCT a lengthy setup period for peripheral sites 
would need to be considered in order to negotiate the local R&D approval process prior to 
recruitment. In the pilot RCT only 2 out of 10 sites managed to recruit for greater than 5 
months. 
 
PW (a medically qualified doctor with a specialist interest in FAI) began recruitment at the 
lead site and then as additional sites became active he trained local recruiters (TRs) who 
were either research nurses or physiotherapists with no prior knowledge of FAI. At some 
sites this involved PW attempting recruitment of the first patient and the TR observing. As a 
result initially PW undertook a substantial amount of recruitment. The recruitment percentage 
by recruiter type, however, suggests that this model of training was effective and that 
recruitment by TRs was feasible. The collective mean recruitment percentage amongst the 
TRs was 72% compared to 67% for PW. There was no significant difference in recruitment 
percentage between TRs and PW. Although the pilot was not powered to undertake a 
statistical test of significance between recruiter types the results are nevertheless were 
promising and could be used to help inform and plan a full RCT. The results are in keeping 
with a study by Donovan et al that found similar recruitment rates between trained nurses 
 133 | P a g e  
and surgeons in a trial of treatments for prostate cancer.206 In this context TRs would be a 
more cost effective mechanism for recruiting patients within the NHS. Although unproven, the 
additional potential benefits of TRs recruiting patients are that they may be less likely to: 
i. Systematically bias patients with their own views. 
ii. Deviate from a position of pure equipoise. 
iii. Have any vested interest in the research being proposed and therefore unlikely to 
demonstrate any conflict of interest to patients. 
 
The number of patients screened (134) was over twice the number of eligible patients (60) in 
the pilot.  This created a considerable amount of additional work for the TRs in order to 
recruit patients. As a result not all potential patients were screened i.e. not all available 
clinics were screened for patients, due to constraints on the availability of TRs (as already 
mentioned less than half of all available clinics at peripheral sites were screened). This 
information has implications for a full RCT when substantially more recruitment of patients 
will be required and therefore screening of patients will need to increase proportionately 
along with corresponding increases in funds for and availability of TRs.  In the pilot RCT, a 
conscious effort was made across all sites to ensure patients likely to be eligible were in 
clinics that were scheduled to be screened by recruiters.  
 
The pilot study suggests that patients can be recruited to a full RCT comparing hip 
arthroscopy versus PHT and that the recruitment percentage may be favourable (70%). The 
pilot data also suggests that recruitment by trained non specialist recruiters is feasible. 
Although the lead site shows better recruitment activity, it is also clear that peripheral sites 
can also achieve good recruitment activity. Whether the recruitment achieved could sustain a 
full RCT when scaled up will be explored further in Chapters 10 and 11. 
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Chapter 9 Pilot RCT: testing the nonoperative 
comparator 
9.1 Declarations 
This work was part of a larger project (UK FASHIoN study) funded by the NIHR HTA 
programme (project number 10/41/02) and the draft final report for the whole project has 
been submitted to HTA September 2013: 
 
Griffin DR, Wall PDH, Realpe A, Adams A, Parsons N, Hobson R, Achten J, Fry J, Costa M, 
Petrou S, Foster NE, Donovan J. UK FASHIoN: Feasibility study of a randomised controlled 
trial of arthroscopic surgery for hip impingement compared with best conservative care. 
9.2 Introduction 
The protocol of PHT was designed with support and input from physical therapists and was 
subsequently delivered by physical therapists at all the recruiting centres. However, PHT is a 
new protocol and a period of testing to determine safety, deliverability and acceptability 
amongst both patients and physical therapists is needed.   
9.3 Objectives 
i. To determine the lead time to commencing intervention. 
ii. To determine the number and frequency of any adverse events up to 3 months. 
iii. To determine the frequency of per protocol PHT delivery. 
iv. To determine patient and physical therapist compliance with PHT including frequency 
of withdrawal and/or crossovers. 
9.4 Methods 
Physical therapists completed a case report form (CRF) for all patients recruited to the pilot 
RCT (chapter 8) and allocated to PHT (see appendix I). Patients were assessed to determine 
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the number and type of any reported adverse events (AE) using a questionnaire completed 
at 6 weeks and 3 months (see appendix J and K). All serious adverse events (SAE) were 
reported to the lead site within 24 hours of the local site investigator becoming aware of 
them. AEs were defined as any untoward medical occurrence in the pilot RCT which do not 
necessarily have a causal relationship with the treatment.  
 
SAEs were defined as any untoward and unexpected medical occurrence that: 
i. Results in death 
ii. Is life-threatening 
iii. Requires hospitalisation or prolongation of an existing inpatient’s hospitalisation 
iv. Results in persistent or significant disability or incapacity 
v. Is a congenital anomaly or birth defect 
vi. Any other important medical condition which, although not included in the above, may 
require medical or surgical intervention to prevent one of the outcomes listed 
 
At 3 months all patients were checked to see if they had withdrawn from the study or had 
received the intervention to which they were not allocated (crossover). 
All the completed PHT CRFs were reviewed by the core study group (see Chapter 4) in order 
to determine by consensus whether each patient had received per protocol care. When 
reviewing the CRFs the core study group looked for evidence of an individualised supervised 
exercise programme which was progressed over at least 12 weeks and had involved a 
minimum of 6 patient contacts.    
9.5 Results 
Forty-two (42) patients were recruited to the pilot RCT. Of these 21 patients were allocated to 
PHT. Twenty patients provided follow up data at 6 weeks and 3 months. shows the outcome 
for all 21 patients. 
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Table 9.1: Outcome of those allocated to PHT 
Patient ID Site ID Time to 
commence 
PHT (days) 
Reported 
AE / SAE 
at 6 weeks 
Reported 
AE / SAE 
at 3 
months 
Per 
Protocol 
Care 
Y / N. If N 
reason 
given 
Outcome 
at 3 
months 
E / W  
1 1 32 Muscle 
soreness 
X Y E 
3 1 32 Muscle 
soreness 
X N E 
6 1 43 Muscle 
soreness 
X N E 
8 1 70 Muscle 
soreness 
X Y E 
11 2 25 Muscle 
soreness 
X Y E 
14 3 61 X X Y E 
15 1 33 Muscle 
soreness  
X Y E 
16 5 22 Muscle 
soreness 
X Y E 
19 1 40 Muscle 
soreness 
X Y E 
21 1 46 Muscle 
soreness 
X Y E 
22 5 12 Muscle 
soreness 
X Y E 
26 1 39 Muscle 
soreness 
X Y E 
28 8 61 L L N L 
30 8 27 X X Y E 
31 6 76 Muscle 
soreness 
X Y E 
32 6 DNSI* X X N - CO E 
35 1 25 X X Y E 
36 7 56 Muscle 
soreness 
X Y E 
38 2 19 Muscle 
soreness 
X Y E 
39 1 32 X X Y E 
43 4 53 X X Y E 
Total 21 patients Mean = 40 
SD = 17 
Median = 36 
Mode = 32 
14 cases of 
muscle 
soreness 
X 17 (81%) 
per 
protocol  
20 (95%) 
still 
engaged 
with study 
 DNSI = Did Not Start Intervention 
*Patient decided that they were unable to travel for treatment and therefore did 
not receive any intervention. 
Y = Yes, N = No, X = nil reported, CO = Cross Over, E = Engaged with the 
study, L = Lost to follow up W = Withdrawn from the study 
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A breakdown of all the physical therapists providing PHT at each study site is shown in Table 9.2. 
Table 9.2: Expertise and Experience of Physical Therapists Delivering PHT 
 
9.6 Discussion 
The results from the 21 patients allocated to PHT suggest that 81% received treatment as 
per protocol. This is in keeping with similar exercise based intervention regimes used in 
RCTs for musculoskeletal disease such as:  
i. Van de Baar et al 2001.207 Effectiveness of exercise in patients with OA of the hip or 
knee: 9 months’ follow up. In this RCT, one group received exercise treatment (12 
week duration) from a primary care physical therapist of these 92% received per 
protocol treatment.   
ii. Foley et al 2003.208 Does hydrotherapy improve strength and physical function in 
patients with osteoarthritis—a RCT comparing a gym based (6 week programme) and 
a hydrotherapy based strengthening programme. Although no definition / description 
of per protocol treatment is given, in this RCT there was a compliance rate of 75% for 
the prescribed gym sessions. 
iii. Fransen et al 2007.209  Physical Activity for Osteoarthritis Management: A RCT 
evaluating Hydrotherapy or Tai Chi Classes (12 week programme). Although no 
definition / description of per protocol treatment is given, in this RCT there was 61% 
attendance at half the Tai Chi classes.  
Post Surgery 
Physiotherapy
Primary 
Physiotherapy
1 1 Yes Yes 5 5 Senior Physiotherapist Band 6
2 1 Yes Yes 30 20 Extended Scope Physiotherapist Band 8a
3 2 Yes Yes 6 1 Clinical Specialist Physiotherapist Band 7
4 2 Yes Yes 6 6 NIHR Research Physiotherapist Band 7
5 3 Yes Yes 10 75 Extended Scope Physiotherapist Band 8a
6 4 Yes Yes 8 15 Specialist Research Physiotherapist Band 7
7 5 Yes Yes 10 2 Physiotherapy Gym Team Leader Band 7
8 6 Yes Yes 18 35 Clinical Lead Physiotherapist Band 7
9 6 Yes Yes 30 60 Specialist Physiotherapist Band 6
10 7 Yes Yes 0 3 Clinical Specialist Physiotherapy Band 8a
11 8 Yes Yes 2 3 Highly Specialist Physiotherapist Band 7
12 8 Yes Yes 0 4 Clinical Specialist Physiotherapist Band 8a
Physio. ID Job Tite NHS Banding
Previously managed patients with 
FAI
Manage 
Patients with 
Musculoskeletal 
Diease
Site ID
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There had been some concern at the start of the pilot RCT (raised in the surgeon interviews 
(Chapter 7) that a substantial number of patients might wish to cross over from PHT to 
surgery after randomisation. This might be because they saw no perceived benefit from PHT 
or because many of them would have tried some sort of physical therapy previously without 
benefit. It was encouraging that only one patient crossed over from PHT to surgery in the 
pilot RCT. This was at the 3 months stage and was because the patient was unable to attend 
the PHT sessions and therefore surgery was more convenient. Any evidence of a large 
number of “crossovers” in the pilot RCT would have raised concerns about the viability of a 
full RCT. A large number of patient crossovers would make an intention to treat analysis 
difficult to interpret as any observed differences in treatment effect could not necessarily be 
attributed to one defined intervention. A per protocol analysis would also be likely to have an 
inadequate sample size to draw any meaningful conclusions.  
 
There were no reported SAEs in by the 20 patients who provided follow up data. The only 
AEs reported were muscle soreness in 14 patients’ up to 6 weeks, but none were reported at 
3 months. Early muscle soreness was expected as part of an exercise based physical 
therapy regime as the muscles adapt to the increased demand. Reassuringly this had 
resolved in all cases at 3 month. The results suggest that PHT is safe which is in keeping 
with other RCTs measuring exercise based physical therapy regimes.207,208 Although AEs are 
possible after the intervention has completed, these are less likely to be a result of the 
intervention itself. However, a longer period of follow up and a larger sample size in a full 
RCT would be required in order to capture both late and rarer AEs / SAEs.  
 
Evidence gathered from pilot testing of PHT revealed that patients typically start treatment 
within 2 months (mean 40 days SD 17 days) of randomisation. When planning a full RCT a 
long lead time before intervention commences would make comparisons of treatment effect 
more difficult particularly if the time to primary outcome measurement is short.  
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The starting band for a physical therapist in the NHS is Band 5. All patients in the pilot RCT 
received their PHT treatment from a physical therapist at Band 6 level or above, confirming 
that delivery of PHT by non-trainee physical therapists was achievable and that a reasonable 
level of seniority could be expected. 
 
The evidence gathered from the pilot testing suggests that PHT is deliverable within the 
context of NHS services, and patient compliance with the treatment is good. While there is 
evidence of some early AEs these are typical of similar exercise based regimes and are to 
be reasonably expected. There is no evidence of them unduly affecting the delivery of care 
or patient compliance. There no SAEs although a larger sample size and longer period of 
sampling / surveillance is needed to provide a more robust safety profile of PHT. 
 140 | P a g e  
Chapter 10 Design of a full RCT 
10.1  Declarations 
The sample size calculation for a full RCT was performed by Dr N Parsons at the University 
of Warwick. 
 
A full grant proposal has been submitted to the HTA for a full randomised controlled trial of 
athroscopic surgery for hip impingement versus personalised hip therapy. The proposal 
draws on many of the findings from this thesis. The following people are study collaborators 
for this grant proposal: 
Damian Griffin (Chief Investigator), Peter Wall, Nadine Foster, Juul Achten, Nicholas 
Parsons, Stavros Petrou, Ann Adams, Jeremy Fry (lay representative), David Ralph (lay 
representative), Simon Gates, Jenny Donovan and Matt Costa.   
10.2  Introduction 
The pilot RCT (Chapter 8) used a pragmatic type design; in order to keep the environment in 
which the RCT is conducted as close to standard NHS practice as possible. Historically 
RCTs have been criticised, for not generating results/answers that are generalizable enough 
for application in day to day practice.210 For example a purely experimental RCT might seek 
to establish which of the two treatments is superior under ideal conditions, such as hip 
arthroscopy being conducted on a good surgical candidate, performed by the most 
experienced surgical team with a very structured post-surgical rehabilitation programme. 
Such a scenario is unrealistic in clinical practice. Establishing the effectiveness of hip 
arthroscopy under ideal conditions is useful information at an experimental level but is not as 
helpful for most patients or clinicians. A more pragmatic approach involves knowing the 
effectiveness of hip arthroscopy for a typical patient, done by a typical surgeon with routine 
post-surgical rehabilitation. A pragmatic design is made to be much more representative of 
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usual practice within the NHS and the subsequent results are much more helpful in guiding 
actual NHS practice.  
However, a pragmatic RCT design may dilute any potential treatment effects of the 
interventions under scrutiny because of the many variables introduced. Larger sample sizes 
are therefore typically required in order to better test the null hypothesis and maintain power.     
10.3  Outcome measures for a full RCT 
There are many potential ways of measuring the outcome after treatment for FAI. For 
example: 
i. Symptomatology such as pain, function and quality of life. 
Although the purpose of the pilot RCT was not to determine clinical effectiveness, patient 
reported outcome measures (PROMs) were collected. These are standardised 
questionnaires completed by the patient before and after the intervention. PROMs focus on 
symptomatology, and allow a patient to report their own view on matters as such as: pain, 
functional ability and quality of life.211 PROMs can be disease specific or generic; the pilot 
RCT used both types. Disease specific PROMs have greater face validity and credibility, but 
generic PROMS facilitate comparisons across conditions.211 PROMs are now widely used in 
hip surgery in an attempt to objectively quantify levels of hip disease and measure the results 
of an intervention. Using a PROM in a RCT avoids observer bias and reflects the importance 
of a patient being the most appropriate person to report their own levels of pain, disability 
and quality of life.  
A variety of PROMs have been used for FAI. Some, such as the Western Ontario and 
McMaster Universities Osteoarthritis Index (WOMAC) and the Modified Harris Hip Score 
(MHH) were originally designed for patients with more severe hip symptoms typically 
undergoing THA. As a result these PROMs tend to exhibit ceiling effects when applied to 
pre-arthritic conditions such as FAI where patient function is at a higher level. Newer 
instruments such as IHOT-33 and the NAHS have been designed in an attempt to capture a 
clinically relevant outcome, but have only recently been validated and not had the same 
scrutiny as the older outcome measures. For an outcome measure to be formally recognised 
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and accepted a process of validation is required.212 Content validity, criterion validity and 
construct validity are all aspects that are typically considered.212 The outcome measure must 
also be reliable, sensitive and have internal consistency and reproducibility.212 The NAHS 
and IHOT-33 were used in the pilot RCT and could be used as the primary outcome for a full 
RCT. NAHS is valid compared to other measures of hip performance, internally consistent 
and reproducible.213 However, the IHOT-33 has the advantage that it was developed with 
patients undergoing hip arthroscopy. There was no evidence of a ceiling / edge effect when 
used in this setting. In addtionathe minimum clinically important difference (MCID) has been 
determined (6.1 points) for IHOT-33.85  
ii. Examination findings such as hip ROM and presence of a positive anterior 
impingement test. 
iii. Imaging findings such as evidence of a change in hip shape and a normalisation of 
radiographic hip parameters (alpha and CE angle). 
Examination and imaging findings could be used to determine the outcome from the 
interventions. However, the relationship between these outcomes and patient benefit is less 
clear. In particular there remains controversy about what constitutes an abnormality of hip 
shape or hip ROM (see Chapter 1) and so interpreting the clinical significance of any 
measured differences in hip shape or hip ROM between interventions would be difficult. 
10.4  Timing of outcome measures for a full RCT 
A primary outcome measurement at one year was proposed for the pilot RCT. Observational 
evidence suggests that patients have fully recovered from either surgery or nonoperative 
care by 12 months.75,82,214 This is in keeping with other hip surgery such as hip arthroplasty 
whereby optimal/plateaued patient reported outcome scores are reported at 12 months.215 
Other outcome time points were undertaken in the pilot RCT at 3 and 6 months. Similar 
patterns of outcome scores at 3, 6 and 12 months in a full RCT would help to support any 
observed treatment effect at 12 months. In the pilot trial, participants allocated to hip 
arthroscopy usually had surgery within 10 weeks, and those allocated to PHT usually 
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commenced treatment within 4 weeks, therefore outcome assessments earlier than 3 months 
would not have been helpful. 
 
Longer term assessments are important such as an effect of surgery on progression of FAI to 
OA .23,37 However, such a trial would require a much long term follow-up to answer this 
question. It was therefore agreed the first and most important question to answer was 
whether surgery in the short to medium term was effective (improves hip related quality of life 
and is safe, therefore a 12 month primary outcome assessment remains appropriate 
10.5  Sample size for a full RCT 
Although the published evidence suggests that arthroscopic hip surgery can have a 
standardized effect of up to 2, there is also likely to be an effect with PHT.216 Cochrane 
reviews have shown that good exercise based regimes treating musculoskeletal conditions 
typically have a standardised effect in the order of 0.3.217,218 Pragmatic RCTs tend to yield 
small to moderate differences in standardised effect size between treatments when 
measuring clinical effectiveness, for the reasons discussed earlier in section 10.2.  The 
published development work for IHOT-33 which shows that the MCID and SD is 6.1 and 19.3 
respectively is helpful. In this context IHOT-33 would be capable of detecting a standardised 
effect size between treatments of 0.32. The published data (MCID = 6.1 and SD = 19.3) 
provide an upper bound for the required sample size for a full RCT, as outcome data for a full 
RCT is likely to be less variable (more homogeneous). Assuming an approximate normal 
distribution for the IHOT-33 score, the expected total sample size (sum of both groups) is 
shown for scenarios with 80% and 90% power to detect an effect, if it exists, at the 5% 
significance level in Table 10.1. The scenarios tabulated span a range of standardized effect 
sizes from small to moderate (0.32) to moderate (0.47).  
Table 10.1: Total sample size for MCID = 6.1 
Standard Deviation Power Standardized Effect Size 
80% 90% 
13 144 192 0.47 
16 218 292 0.38 
19.3 316 422 0.32 
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A conservative strategy for a full RCT would be to base the sample size calculation on an SD 
of 19.3, which requires 316 (158 in each group) patients to be recruited for a final 12 month 
primary outcome analysis.  
 
Loss to follow up in similar multicentre orthopaedic RCTs using a PROM at 12 months varies 
between 10 and 20% (see Chapter 8). Assuming an average loss to follow-up of 15%, 372 
(186 in each group) patients would be needed in total for a full RCT. This would provide 80% 
power to detect a difference of 6.1 IHOT-33 units, if any. It is possible that the population SD 
for IHOT-33 scores might be lower in a full RCT. A recent publication and the original IHOT-
33 paper suggest a baseline SD of 20.1 and 19.3 respectively.85,219 However, both papers 
used patient cohorts undergoing hip arthroscopy in contrast to a full RCT which would 
potentially reflect a more homogenous population with a single diagnosis of FAI. The 
potential for a lower SD in a full trial is however, merely an observation that may allow 
improved power in a full RCT and is far from certain.  
 
The preferred method for analysing pragmatic RCTs is on an intention to treat (ITT) basis.217 
An ITT analysis includes every participant who is randomised according to the treatment to 
which they were allocated. ITT ignores noncompliance, protocol deviations, withdrawal, and 
any other patient related changes after randomisation. As a result the ITT analysis tends to 
lead to more conservative results.217  ITT provides an estimate of the effect of a change in 
treatment policy rather than of any potential effect in patients who receive treatment exactly 
as planned.217 The ITT analysis therefore follows a more pragmatic approach and takes 
account of events that would tend to happen in day to day practice. By virtue of the ITT 
approach loss to follow-up is the only additional factor that needs to be considered when 
planning the sample size for a full RCT, as all the patients who deviate from the study 
protocol (crossover etc.), will all be counted in the final analysis.    
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If the key features of the pilot RCT (see Chapter 8) are retained (e.g. blinding, outcomes and 
follow-up) then the data from the pilot could be pooled with a full RCT making the pilot a so 
called “internal pilot study”.220 As 42 eligible patients have already been recruited in the pilot 
RCT, an additional 330 patients would be required for a full RCT. Using the figures 
discussed, and a conservative recruitment rate (half the pilot RCT recruitment rate) and an 
assumed loss to follow up of 15% it is possible to build a CONSORT diagram for a full RCT 
(see Figure 10.1). 
Figure 10.1: CONSORT for a full RCT 
 
10.6  Duration and size 
The duration and size of a full RCT has been informed by results from the pilot RCT (Chapter 
8) and workload survey (Chapter 6). The pilot RCT achieved a recruitment of 70% with 1 
patient recruited per centre per month. The recruitment achieved in the pilot RCT may drop 
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during a full RCT as the initial enthusiasm to recruit tapers off. For RCTs in orthopaedics 
comparing operative and nonoperative treatments, on-going recruitment of 70% is 
rare.169,170,205 Therefore, it may be reasonable to plan a full RCT based on a more 
conservative halving of the pilot recruitment rate. 
Table 10.2 shows the potential variation in recruitment duration for 10, 15, 20, 25 and 30 
recruiting centres and a recruitment rate of 1 patient per centre per month (rate achieved in 
pilot - 70% recruitment) or 0.5 patients per centre per month (half the rate achieved in the 
pilot – 35% recruitment).  
Table 10.2: Recruitment duration in months for a full RCT based on 10, 15, 20, 25 and 30 
centres and a recruitment rate of 0.5 or 1 patient per centre per month  
Number of centres Recruitment per centre per month 
0.5 (35% recruitment) 1 (70% recruitment) 
10 66 months 33 months 
15 44 months 22 months 
20 33 months 17 months 
25 27 months 14 months 
30 22 months 11 months 
 
Each centre in a full RCT would require at least 18 eligible patients per year in order to be 
able achieve the recruitment figures achieved in the pilot RCT and quoted in Table 10.2. The 
workload survey (Chapter 6) suggests that there are a further 22 hospital trusts within the UK 
that might have ≥18 eligible patients per year 
 
It may be appropriate to consider a larger sample size based around 90% power and reduce 
the chance of type II statistical error. However the implications of having to recruit a further 
106 patients (a longer recruitment period of between 6 and 22 months-see Table 10.3) would 
have to be weighed against the improved power. One of the major risks with lengthy 
recruitment periods is that the interventions under assessment change so markedly between 
the start and finish of a trial that any subsequent results are difficult to meaningfully interpret; 
a particular risk with hip arthroscopy were new more sophisticated instruments are released 
regularly. 
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Table 10.3: Additional months recruitment required to achieve 90% power based on 10, 15, 25 
and 30 centres and a recruitment rate of 0.5 or 1 patient per centre per month. 
Number of centres Recruitment per centre per month 
0.5 (35% recruitment) 1 (70% recruitment) 
10 22 16 
15 15 11 
20 11  8 
25 9 7 
30 8 6 
 
A full RCT would potentially continue to recruit from the original 10 centres included in the 
pilot RCT therefore requiring up to an additional 20 centres depending upon the chosen 
recruitment duration. 
 
The pilot RCT showed that the actual identification rate of eligible patients per centre per 
month was low (mean 1.5). As a result any drop in recruitment rates of patients could make a 
full RCT difficult. Therefore, efforts to increase the pool of eligible patients at each centre are 
likely to help expedite a full RCT. Measures that could be used include: 
i. Providing education to primary care about FAI and its diagnosis, in order to optimise 
referral of patients for specialist opinion. 
ii. Ensuring all outpatient clinics with potentially eligible patients are covered with a 
trained recruiter. 
iii. Lobbying policy makers to facilitate patients with FAI being treated in centres that 
have been identified as undertaking high volumes of arthroscopic FAI surgery and 
have surgeons with adequate levels of equipoise. 
10.7  Recruitment strategies 
Recruitment in surgical RCTs is often very challenging and as already discussed previous 
RCTs in surgery have shown quite varied recruitment rates (Jarvik et al169 22%, Klazen et 
al205 19% and Kirkley et al170 86%). Kirkley et al was a single centre RCT as opposed to 
Klazen et al and Jarvik et al which were both multi-centre RCTs. Therefore the large 
discrepancy in recruitment rates between these RCTS is likely to be largely structural. A full 
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RCT outlined for FAI would need to be multicentre and therefore measures to optimise 
recruitment may need to be utilised in order to successfully complete it. As already discussed 
one such strategy would be to use trained researchers to recruit patients and thus minimise 
biasing patients to one particular treatment. Other methods not reported in this thesis but 
tested within the pilot RCT are qualitative measures. Qualitative research methodology can 
be used to understand recruitment difficulties and inform the development of strategies to 
improve recruitment in difficult RCTs such as those in surgery.201-203 Particular aspects of this 
may include: 
i. Develop with public and patient involvement patient information material that is user 
friendly and with no treatment biases. 
ii. Interviewing all investigators and TRs to ensure that the RCT is being described, and 
recruitment procedures followed, according to the study protocol, and to identify 
where they are not.  
iii. Develop training packages to correct common problems.  
iv. Identify structural features associated with successful recruitment, such as running 
targeted clinics and ensuring referred patients arrive with expectations of receiving 
treatment for FAI rather than being told they had been referred for surgery. 
 
It is possible that recruitment to a full RCT will be less easy over time. The overwhelming 
focus in the published orthopaedic literature is the favourable outcome from surgical 
intervention. As evidence, albeit weak, grows in favour of surgery the number of high volume 
arthroscopic surgeons that are in equipoise and prepared to randomise their patients will fall. 
At present the pool of surgeons and centres keen to engage and recruit patients to a RCT is 
sufficient to achieve the required sample size, but a shift in the levels of surgeon equipoise 
would quickly change this, lending considerable urgency to the initiation of a full RCT. 
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Chapter 11 Conclusions 
11.1 Summary of new findings 
Since early descriptions of subtle hip shape abnormalities and their relationship to hip pain 
and OA in the 1960s and 1970s, the concept of bony hip impingement has developed under 
scrutiny. Over the last 15 years the term FAI as a condition which can cause hip pain and 
subsequent OA in adults has become established in the medical literature. 
 
The cause of FAI hip shape abnormalities and the impact they have remains less clear. New 
information presented in Chapter 2 of this thesis reports on SCFE and its relationship with 
longer term hip symptoms. SCFE including subtle cases is one mechanism thought to cause 
cam type FAI. However, this thesis found no evidence of a strong or even moderate 
correlation between changes in hip shape secondary to SCFE (including FAI like 
morphology) and long term hip specific quality of life. This finding is in keeping with 
epidemiological  research on FAI (Chapter 1) which has found that although the prevalence 
of hip shape abnormalities in the general population is high the reported symptomatology is 
much less. These findings along with established epidemiological research discussed in 
Chapter 1 suggest that the relationship between abnormalities of hip shape and hip pain is 
weak and that other factors in addition to hip shape morphology have a role in the 
development of symptoms associated with FAI. 
 
The thesis has demonstrated that a large amount of surgery is being undertaken for FAI 
within the NHS and that the majority of this is done arthroscopically despite limited evidence 
to suggest it is clinically effective. Much of the workload is undertaken in centres in London, 
the South West of England and the West Midlands. In addition this thesis has demonstrated 
that FAI can be treated nonoperatively but there is even less evidence to guide care. 
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So why in a modern world, is a syndrome such as FAI not fully understood, yet treated in 
such an enthusiastic but unproven way, with surgery taking place across multiple centres, 
and by an even greater number of surgeons? Similarly why is nonoperative care for FAI so 
haphazard and without any robust research? It is likely the answer in part is because FAI as 
a concept was developed amongst surgeons. Therefore the solutions are predominantly 
surgical, and the livelihood of many surgeons relies on a FAI workload. As a result the 
majority of information and research publications concern surgery for FAI. Without access to 
a systematic analytical review of the literature the typical patient and or clinician could be 
forgiven for being misguided into thinking that the only and best solution is surgery. There is 
a marked “publication bias” in favour of surgery which now permeates through into the so 
called “grey literature and popular press”.  In addition scepticism amongst the research 
community about the true effects of surgery are not formally voiced and publicised in the 
literature. It is likely that these factors have slowed a more evidence based understanding 
and treatment of FAI and made constructing a RCT more difficult. This thesis sought to 
untangle the problem and begin the process of constructing a RCT.   
 
The lack of a clear non-operative comparator to FAI surgery was one major obstacle to 
undertaking a RCT. Other areas of musculoskeletal research determining the feasibility of 
surgical RCTs have found so called “sham” procedures or simple observation to be 
unworkable because of both low recruitment and lack of surgical equipoise. The findings in 
Chapter 4 and developed in Chapter 5 which reports for the first time a consensus amongst 
physical therapists about how best to manage patients with FAI nonoperatively. The regime 
developed (PHT) has shown that it can be delivered successfully and within the budgetary 
constraints of a state run health care system (Chapter 8 and 9). This thesis has highlighted 
that factors other than hip shape may play a role in the development of symptoms of FAI. 
There is existing research which demonstrates a degree of muscle dysfunction associated 
with FAI.81 It is therefore possible that muscle dysfunction is one important additional primary 
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factor (rather than a secondary consequence) in the development of FAI symptoms. This 
could be effectively addressed with the exercise based treatment approach (PHT) described.  
 
A pilot RCT comparing arthroscopic surgery and nonoperative care was undertaken and 
reported in Chapter 8. The purpose was to test recruitment to such a trial. The results 
showed that 42 out of 60 (70%) patients agreed to participate. These results are encouraging 
and suggest that there is sufficient enthusiasm and equipoise amongst patients and 
healthcare professionals for a full RCT to be viable. However, the pilot did not measure long 
term follow up rates, withdrawals or protocol violations all of which could have a marked 
effect on such a study. 
 
Although the qualitative research presented in Chapter 7 suggested that there is support for 
a RCT and many surgeons believe they are in equipoise, it would be important to monitor 
additional recruitment centres in a full RCT to ensure that they too were in “active” equipoise. 
A lack of suitable additional centres with clinicians in equipoise could potentially be 
addressed by channelling patients to centres where recruitment is not impeded by a lack of 
equipoise; however it is likely that such a strategy would encounter numerous bureaucratic 
obstacles. 
 
The protocol for nonoperative care (so called “personalised hip therapy”) is likely to have 
been an important part of the success of the pilot RCT. Many patients with FAI have 
experienced some form of physical therapy for their symptoms prior to being considered for 
surgery. In some regions a trial of physical therapy is a pre-requisite before surgery can be 
considered. It follows that at the time of recruitment to a RCT a patient’s previous experience 
of physical therapy may not be positive. The regime of physical therapy on offer in the pilot 
RCT was likely to be different to previous therapy because it was customised to the patient, 
specifically designed for FAI and delivered by a senior physical therapist.        
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The sample size for a full RCT with 80% power was estimated to be 372 patients (Chapter 
10). Based upon the workload survey results (Chapter 7) and pilot RCT recruitment (Chapter 
9) this number of patients could be recruited across 20 centres (the original 10 pilot centres 
and a further 10 new centres) over 17 months. Even if recruitment was half that achieved in 
the pilot RCT then 20 centres could recruit sufficient numbers over 33 months. A trial with 
90% power would require an additional 106 participants. Across 20 centres this would 
lengthen recruitment by a further 16 months at 70% recruitment and 22 months at 35% 
recruitment. 
 
We have evidence of only 22 additional new centres that may have ≥18 eligible patients per 
year and may be suitable to act as a new recruitment centres. Therefore the feasibility of a 
full trial may in part depend upon surgeons with adequate levels of equipoise in at least 10 of 
these 22 new centres.  
 
The research presented in this thesis has outlined the design of a RCT capable of measuring 
the clinical effectiveness of surgery. However, the feasibility may be very finely balanced. 
Critical areas are likely to be: 
i. The flow of patients.  
Both the number of eligible and recruitment rate of patients will need to be closely 
monitored. Strategies to optimise both of these aspects have been outlined in 
Chapter 9 but implementing many of them will considerably increase the cost of 
running a trial.  
ii. The chosen design strategy.  
Both 80% power and a primary outcome assessment at 12 months have been 
chosen in the potential design outline in order to allow a workable trial that recruits 
patients and answers an important research question in a timely manner. A change to 
90% power although more robust would lengthen recruitment (and cost) considerably. 
Similarly striving to determine the long term effects of FAI treatment such as its 
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effects on OA although desirable may divert attention from the first step which is to 
establish if treatments have any effect in the short to medium term. 
iii. Setup times 
The pilot trial was only able to recruit in two out of the ten sites for greater than five 
months. Each site encountered delays in obtaining local R&D approval with one site 
failing to obtain approval within nine months. Similar delays in a full RCT could 
lengthen the recruitment period considerably and would need to be avoided in a RCT 
to prevent: 
i. Apathy and loss of interest amongst other recruiting centres as the trial 
duration lengthens. 
ii. Changes in the intervention technology that mean the research question is no 
longer pertinent. 
11.2  Implications and future directions 
The aetiology and epidemiology of FAI is not fully understood. Although the prevalence of 
FAI hip shape abnormalities within the general population has been explored by researchers 
the reasons why only a small proportion of patients report pain is not known. There are likely 
to be several other variables which contribute to this and these need to be clarified. One 
solution would be to undertake a cohort study of asymptomatic patients with hip shape 
abnormalities and record which patients develop symptoms and when. Such a cohort study 
would ideally be continued to monitor patients who develop symptomatic FAI without any 
subsequent intervention to document the true natural history of FAI. This thesis has 
highlighted that such a study would be technically challenging because patients with 
symptoms typically undergo some form of treatment which in many cases may involve shape 
corrective surgery.    
 
At present, patients with symptomatic FAI are in the unenviable position of either undergoing 
surgery for their symptoms without good evidence of effectiveness, or considering 
nonoperative treatment for which there is less risk of complications but also very limited 
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evidence to support effectiveness. This thesis outlines some of the challenges and solutions 
for achieving higher quality evidence to guide best practice in treating FAI. The solutions 
presented have been tested within a pilot RCT and developed into the design for a full RCT 
which could commence as soon as appropriate funding and support is secured.    
 
A further important natural development to this research could deal with the question whether 
surgery or other interventions for FAI influences a patient’s risk of developing future OA. The 
first step to answering such a research question would first be to establish the effectiveness 
of FAI treatments in the short to medium term using a RCT. Thereafter long term monitoring 
of these patients for symptoms and signs of OA would provide valuable evidence of any link.   
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Appendices 
Appendix A – Example search strategy (Chapter 3) 
Example search strategy   
Database: Ovid MEDLINE(R) In-Process & Other Non-Indexed Citations and Ovid 
MEDLINE(R) <1946 to Present> 
1     exp Femoracetabular Impingement/ 
2     femoroacetabular.tw. 
3     fai.tw. 
4     femoro-acetabular.tw. 
5     pincer.mp. 
6     (cam adj3 impingement).tw. 
7     or/1-6 
8     exp Surgical Procedures, Operative/ 
9     su.fs. 
10     (surger$ or surgical$ or operat$).tw. 
11     exp osteotomy/ 
12     exp osteoplasty/ 
13     osteochondroplasty.tw. 
14     mini-open.tw. 
15     (arthroscopic adj2 assisted).tw. 
16     ganz.tw. 
17     Arthroscopy/ 
18     arthroscop$.tw. 
19     hueter.tw. 
20     (trochanteric adj3 flip).tw. 
21     cheilectomy.tw. 
22     or/8-21 
23     randomised controlled trial.pt. 
24     controlled clinical trial.pt. 
25     randomized.ab. 
26     placebo.ab. 
27     drug therapy.fs. 
28     randomly.ab. 
29     trial.ab. 
30     groups.ab. 
31     or/23-30 
32     (animals not (humans and animals)).sh. 
33     31 not 32 
34     7 and 22 
35     33 and 34 
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Appendix B - initial survey used 
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Appendix C– Independent protocol prepared and presented by NF 
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Appendix D– Independent protocol prepared and presented by PW 
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Appendix E – Examples of exercises for Personalised Hip Therapy 
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Appendix F - Designing the Eligibility Criteria and Operative Protocol for a Pilot RCT 
 
Introduction 
To date no RCTs have been undertaken for FAI surgery.  As a result no previous eligibility criteria exist 
as guide for the pilot RCT. In addition as a relatively new procedure, there are a variety of surgical 
techniques for arthroscopic FAI surgery and therefore it is necessary to develop and define a protocol 
of operative care in order to ensure that patients received the same standard intervention and that a 
process of quality control could be systematically implemented.  
 
Methods 
Researchers PW and DG discussed and produced two provisional documents: 
 
Document 1 - Initial Eligibility Criteria Survey 
Please read through the following text and bullet points. You will be asked to indicate your response 
after each point / section. Please delete the words so that your response remains. The space below 
each response is an opportunity to add further reasoning, comments and suggestions for change.  
Patients will be eligible to participate in this study if:  
9. Aged 18-50; 
Please indicate circle your response here:  YES No UNSURE  
Please add additional comments below if you have answered no or unsure.   
 
10. They have symptoms of hip pain - they may also have symptoms of clicking, catching or giving way; 
Please indicate circle your response here:  YES No UNSURE  
Please add additional comments below if you have answered no or unsure.   
11. They show radiographic evidence of pincer- or cam-type FAI on plain radiographs and cross-sectional 
imaging;
66
 
Please indicate circle your response here:  YES No UNSURE  
Please add additional comments below if you have answered no or unsure.   
12. The treating surgeon believes that they would benefit from arthroscopic FAI surgery. 
Please indicate circle your response here:  YES No UNSURE  
Please add additional comments below if you have answered no or unsure.   
13. Able to give written informed consent 
Please indicate circle your response here:  YES No UNSURE  
Please add additional comments below if you have answered no or unsure.   
14. Able to participate fully in the interventions 
Please indicate circle your response here:  YES No UNSURE  
Please add additional comments below if you have answered no or unsure.   
 
Patients will be excluded from participation in this study if: 
15. They have previous significant hip pathology such as Perthes’ disease, slipped upper femoral epiphysis or 
avascular necrosis; 
Please indicate circle your response here:  YES No UNSURE  
Please add additional comments below if you have answered no or unsure.   
16. They have had a previous hip injury such as acetabular fracture, hip dislocation or femoral neck fracture; 
Please indicate circle your response here:  YES No UNSURE  
Please add additional comments below if you have answered no or unsure.   
17. They already have osteoarthritis, defined as Tonnis grade >1
17
, or more than 2mm loss of superior joint 
space width on AP pelvic radiograph;
75
 
Please indicate circle your response here:  YES No UNSURE  
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Please add additional comments below if you have answered no or unsure.   
18. There is evidence that the patient would be unable to participate fully in the interventions, adhere to trial 
procedures or to complete questionnaires, such as cognitive impairment or intravenous drug abuse. 
Please indicate circle your response here:  YES No UNSURE  
Please add additional comments below if you have answered no or unsure.   
 
Documents 2 - Initial Operative Protocol Survey 
Please read through the following text and bullet points. You will be asked to indicate your response 
after each point / section. Please delete the words so that your response remains. The space below 
each response is an opportunity to add further reasoning, comments and suggestions for change.  
7. General anaesthetic with muscle relaxation. 
Please indicate circle your response here:  YES No UNSURE  
Please add additional comments below if you have answered no or unsure.   
 
8. Supine or lateral patient positioning. 
Please indicate circle your response here:  YES No UNSURE  
Please add additional comments below if you have answered no or unsure.   
 
9. Operating table with facility for traction and allows range of movement testing. 
Please indicate circle your response here:  YES No UNSURE  
Please add additional comments below if you have answered no or unsure.   
 
10. Arthroscopy of central compartment. 
Please indicate circle your response here:  YES No UNSURE  
Please add additional comments below if you have answered no or unsure.   
 
11. Arthroscopy of peripheral compartment working with one of the following; intact capsule, 
capsulotomy or capsulectomy. 
Please indicate circle your response here:  YES No UNSURE  
Please add additional comments below if you have answered no or unsure.   
 
12. Ability to undertake bony surgery to correct abnormalities on both the femoral head neck 
junction and acetabular side of the hip joint. 
Please indicate circle your response here:  YES No UNSURE  
Please add additional comments below if you have answered no or unsure.   
 
13. Ability to undertake soft tissue repair and or debridement to the labrum and or articular 
cartilage. 
Please indicate circle your response here:  YES No UNSURE  
Please add additional comments below if you have answered no or unsure.   
 
14. Ability to record with either video or photos the intraoperative findings and solutions. 
Please indicate circle your response here:  YES No UNSURE  
Please add additional comments below if you have answered no or unsure.   
 
These documents were based on their own experience as surgeons and the available published 
literature. Hip arthroscopy surgeons, recognised as international experts in the field were then 
invited to comment upon these provisional documents. These expert surgeons were from the 
Multicenter Arthroscopy of the Hip Outcomes Research Network (MAHORN) n=12 and surgeons who 
attended the American Academy of Orthopedic Surgeons Research Symposium on Femoroacetabular 
Impingement in Chicago n=4. All surgeons approached agreed to participate (16 out of 16). Each 
surgeon was asked to provide feedback on the two provisional documents. The feedback they 
provided was then used by PW and DG to modify the two documents. A final version of both 
 162 | P a g e  
documents was agreed and is being used in the pilot RCT. The two documents continue to be 
evaluated in light of feedback from the recruiting sites.  
 
Results 
The feedback received from the initial consultation about the eligibility criteria and operative 
protocol with expert hip arthroscopy surgeons is summarised in Table 0.1, Table 0.2 and Table 0.3. 
 
 
 
Table 0.2: Feedback on the eligibility criteria – second part 
 
Table 0.1: Feedback on the eligibility criteria – first part 
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Table 0.3: Feedback on surgical the protocol 
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In light of the relatively high level of agreement 69% and 81% for both documents only a small 
number of minor changes were made as described below. 
 
Modifications made to eligibility criteria in light of feedback 
v. Age range should be changed to accommodate feedback. Considered appropriate to include 
all patients’ ≥16 years.  
vii. Radiographic evidence of FAI should be further defined to include: 
iv. Femur – an alpha angle of >55 degrees or 
v. Acetabulum  - a lateral centre edge angle Wiberg of >40 degrees 
 
Modifications made to operative protocol in light of feedback 
It would be appropriate to stipulate that: 
vii. The entire acetabular labrum should be examined 
viii. The entire articular surface should be examined 
ix. Confirm that FAI has been relieved using either range of movement testing or an image 
intensifier. 
x. No need to record with video of photos as the results will be difficult to interpret / validate. 
Not a reliable measure of surgical quality. Exclude from final protocol 
xi. Need to document intra-operative complication and their solutions 
 
The final agreed eligibility criteria and operative protocol are outlined below: 
 
Final Eligibility Criteria 
Patients will be eligible to participate in this study if:  
ii. Aged ≥16; 
iii. They have symptoms of hip pain - they may also have symptoms of clicking, catching or 
giving way; 
iv. They show radiographic evidence of pincer- or cam-type FAI on plain radiographs and cross-
sectional imaging;66 
a. Femur – an alpha angle of >55 degrees or 
b. Acetabulum  - a lateral centre edge angle Wiberg of >40 degrees  
v. The treating surgeon believes that they would benefit from arthroscopic FAI surgery. 
vi. Able to give written informed consent 
vii. Able to participate fully in the interventions 
 
Patients will be excluded from participation in this study if: 
viii. They have previous significant hip pathology such as Perthes’ disease, slipped upper femoral 
epiphysis or avascular necrosis; 
ix. They have had a previous hip injury such as acetabular fracture, hip dislocation or femoral 
neck fracture; 
x. They already have osteoarthritis, defined as Tonnis grade >1
17, or more than 2mm loss of 
superior joint space width on AP pelvic radiograph;75 
xi. There is evidence that the patient would be unable to participate fully in the interventions, 
adhere to trial procedures or to complete questionnaires, such as cognitive impairment or 
intravenous drug abuse. 
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Final Operative Protocol 
3. General anaesthetic with muscle relaxation. 
4. Supine or lateral patient positioning. 
5. Operating table with facility for traction and allows range of movement testing. 
6. Arthroscopy of central compartment. 
7. Examine entire acetabular labrum 
8. Examine entire articular surface 
9. Arthroscopy of peripheral compartment working with one of the following; intact capsule, 
capsulotomy or capsulectomy. 
10. Ability to undertake bony surgery to correct abnormalities on both the femoral head neck 
junction and acetabular side of the hip joint. 
11. Ability to undertake soft tissue repair and or debridement to the labrum and or articular 
cartilage. 
12. Confirm impingement has been relieved using either range of movement testing or an image 
intensifier. 
13. Document intra-operative complications and their solutions e.g. fracture, iatrogenic cartilage 
damage, anaesthetic problems etc. 
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Appendix G – pilot RCT patient information sheet 
Version 3 PIS 6
th
 June 2012 
Patient Information Sheet 
UK FASHIoN Study 
Chief Investigator:    Professor Damian Griffin 
You are invited to take part in our research study.  Before you decide whether to take part we 
would like you to understand why the research is being done and what it would involve for 
you.  Once you have had a chance to read and absorb this information sheet a member of 
our team will personally go through the information with you and answer any questions you 
may have. 
 
Background Information 
Your hip joint has two bones that fit together like a ball in a socket, see diagram. 
Normal Hip Joint 
In some people like you these bones have abnormal shapes. Therefore as your hip moves 
these abnormally shaped bones press against each other and damage the local soft tissues 
such as the labrum (a soft cushioning around the hip joint- see figure 1) which can cause 
pain.  
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This is called Hip Impingement and the medical term for this is femoroacetabular 
impingement (FAI for short). Hip impingement has only been discovered in the last 10 years 
and we do not understand everything about the condition. Most importantly it is not clear 
what the best treatment for hip impingement is. Good results have been shown for both 
physiotherapy and hip arthroscopy (explained below) as treatments for hip impingement, but 
we do not yet know if one is better than the other. There is thought to be a long-term risk of 
osteoarthritis in patients with hip impingement. It is not known either of these two treatments 
(physiotherapy or hip arthroscopy) has any effect on this risk. In order to decide which 
treatment is best for you and future patients we need a study to compare these two 
treatments. 
 
What is the purpose of this study?  
This study aims to compare two different treatments for your condition - hip impingement: 
iv. Personalised Hip Therapy – this is a new individualised and structured programme 
of exercise therapy designed for you by a physiotherapist. A more detailed 
description is provided later.    
v. Hip Arthroscopy – this is keyhole surgery and is designed to reshape the bone 
around your hip joint. A more detailed description is provided later 
  
Why have I been chosen to take part in the study? 
We need 60 volunteer patients like you with hip impingement to take part in the study. 
 
Do I have to do to take part? 
It is up to you to decide whether or not to take part. If you do take part you can withdraw at 
any time and this will not affect the care you receive. 
 
What will happen to me if I take part? 
If you decide to take part you will be asked to sign a consent form. You will then be invited to 
one of the two treatments. In order to make our study work it is crucial that we have equal 
numbers of volunteers in each treatment group and that the one you (are invited to) join is 
determined by a sophisticated machine designed for this purpose, and not influenced by us. 
More information about the two possible treatments is given below. Whichever treatment you 
have, please be assured that your care will be based on meeting your individual needs, and 
you will continue with the same team of physiotherapists and surgeons throughout. Both 
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these teams work closely together and they will be able to monitor your progress and share 
information with one another about your individual case continually. During the study we will 
ask you to complete 4 short questionnaires by post /email (whichever is easier for you). You 
will do one questionnaire before you begin treatment and then one at 3, 6 and 12 months 
after your treatment. If you need help completing a questionnaire, a researcher can contact 
you by phone soon after you receive it to help you complete it.  
 
Which treatments are you comparing? 
The two treatments that are being compared are:  
iii. Personalised Hip Therapy - this is a personalised programme of hip therapy that 
is supervised by a senior physiotherapist and designed to meet your individual needs. 
You may already have had a course of physiotherapy for your hip, however this 
programme of care is different and has been designed specifically to relieve pain in your 
hip and improve how it works. You will meet a senior physiotherapist with a specialist 
interest in hip impingement who will undertake a thorough assessment of your condition 
including the effect it has on your life. They will then customise a specific programme of 
hip exercises designed to help your hip. They will teach you these exercises in clinic and 
you will then be able to practise these exercises at home. This programme of exercises 
will gradually increase in intensity and difficulty so that by the end of the programme (12 
weeks) we hope you will have developed improved control and strength around your hip 
with less pain. In addition to the hip exercise programme, a range of additional treatments 
will be offered to you. These include: 
a. Techniques to improve the control and strength of your posture and walking 
b. Personalised advice on techniques to modify the way you undertake daily 
activities 
o Specific advice about pain medications to help control your pain in the initial 
stages of the therapy. 
The programme lasts 12 weeks and you will need to be able to attend the physiotherapy 
clinic at least 3 times to be assessed, and to have your treatment progressed by your 
physiotherapist. In addition to this, your physiotherapist will keep a close eye on your 
progress over the telephone and will contact you at least 3 times in order to ensure you 
progress well with the programme. The exercises you will be taught will focus on muscle 
control and balance in the first few weeks. You will then progress to resistance and 
stretching exercises, and activity/sport-specific exercises in later stages of the 
programme. You and your physiotherapist will be able to arrange an additional 2 
“booster” sessions of assessment / treatment if either of you feel that more time is 
required to undergo the therapy after the 12 week plan is over. 
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 Hip arthroscopy – The procedure is done under a general anaesthetic (you will be 
put to sleep). The surgeon opens up a small passage through to your hip joint using 
special instruments introduced through incisions on the surface of your skin. A telescope 
is passed through these small passages, to look inside the hip, and further instruments 
are inserted that allow the surgeon to reshape the hip joint and repair locally damaged 
tissues, such as the labrum. You will normally need to stay in hospital for between 1-3 
days after the procedure. Depending on the extent of surgery, some patients have to use 
crutches to walk for between 6-8 weeks after the procedure. There is a period of 
rehabilitation after the procedure, which will be supervised by a physiotherapist in clinic, 
and practised at home. It will take between 2-3 months to complete the rehabilitation 
programme. 
 
What are the possible risks of taking part? 
The treatments are designed to help you, however, this cannot be guaranteed. The individual 
risks of each treatment are outlined below: 
 
 Personalised Hip Therapy - There are some small risks with pain medications 
and joint injections. However, the main risk is muscle soreness and short-term increases 
in pain from the exercises that you will undertake. Generally the risks of this treatment 
are much lower than hip arthroscopy (surgery) 
 
 Hip Arthroscopy – about 1 in 50 people have specific complications from hip 
arthroscopy. One very rare but serious risk is a break (fracture) of the hip during the 
surgery. If this happened you would need an additional operation to fix the break. Other 
risks of hip arthroscopy include: 
 
- Infection within the joint or around the wounds. This can sometimes be treated with 
antibiotics alone. In more serious cases it requires a further procedure to washout the 
hip.  
- Bleeding from the wounds, but this is usually a very small amount and quickly settles.  
- Numbness in groin, leg or foot. To undertake hip arthroscopy we need to apply a 
pulling force on your leg in order to access the hip joint. This can cause some 
numbness in your groin, leg or foot as a result. This usually resolves within a few 
hours or days after the procedure. 
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How do these treatments work? 
Personalised Hip Therapy – this therapy works by allowing soft tissues which are damaged 
and painful as a result of hip impingement, such as the labrum, a period of relative rest, so 
that they can heal naturally. This can take up to several weeks or months. During this period 
you will have learnt and practised many exercises that improve the movement and control of 
the hip and local joints (such as your lower back and pelvis), which should ensure that your 
hip impingement can no longer occur, and that damaged soft tissues, such as the labrum, 
can continue to heal. 
 
Hip Arthroscopy – this procedure relies on surgically removing bits of bone from around the 
hip so that they no longer rub together and damage the soft tissues such as the labrum. 
Once the bits of bone have been removed, a period of rehabilitation is required so that the 
soft tissues can continue to heal.  
 
One of the long-term concerns with hip impingement is that you have an increased risk of 
developing arthritis of the hip. It is really important that you know that at the moment we have 
no evidence that any treatment (including personalised hip therapy or hip arthroscopy) will 
have any effect on whether you subsequently develop arthritis of your hip. However by taking 
part in this study it will help us in the long term to determine if either of these two treatments 
can help prevent arthritis.  
 
What if new information becomes available? 
Sometimes during the course of a study, new information becomes available about the 
treatments that are being studied.  If this happens, someone from our research team will tell 
you about it and discuss with you whether you want to continue in the study. If you decide to 
withdraw, you can discuss your continued care with your doctor. If you decide to continue in 
the study you might be asked to sign an updated consent form. Also, on receiving new 
information, we might consider it to be in your best interests to withdraw you from the study.  
If this happens we will explain the reasons to you and arrange for your care to continue. 
  
What happens when the research study stops? 
You will be in the study for one year.  If you are still having problems after this time, we will 
arrange for you to see your hip specialist to continue your care. 
 
What if something goes wrong? 
In the event that something goes wrong and you are harmed during the research due to 
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someone’s negligence, then you may have grounds for legal action for compensation against 
the University of Warwick (contact Miss Nicola Owen, Deputy Registrar, 02476 522713) and 
/or UHCW NHS Trust (contact Mrs Ceri Jones, Research & Development Services Manager, 
02476966196), but you may have to pay your legal costs. The normal National Health 
Service complaints mechanisms will still be available to you.  
 
Will my taking part in this study be kept confidential? 
All information which is collected about you during the course of the research will be kept 
strictly confidential.  Research data including your name and address will be sent to the 
University of Warwick so that research staff can stay in touch with you over the course of the 
year, and send you follow-up questionnaires at 3, 6 and 12 months by post or email.  These 
details will be sent from the hospital by secure means, and kept in locked filing cabinets or in 
password-protected computer databases accessible only to essential research personnel at 
the University of Warwick.  All other information about you which leaves the hospital will have 
your name and address removed so that you cannot be recognised from it. If you agree, your 
GP and other doctors who may treat you, but are not part of this study, will be notified that 
you are taking part in this study. 
 
What will happen to the results of the research study? 
At the end of the study we will publish the findings in medical journals and at medical 
conferences.  You will not be identified in any reports or publications resulting from the study.  
If you would like to obtain a copy of the published results, please contact the study 
coordinator Rachel Hobson on 02476-968629 or email: fashion@warwick.ac.uk 
 
Who has reviewed this project? 
This study has been reviewed and approved by West Midlands Edgbaston Research Ethics 
Committee. Approval was granted on 15th February 2012.  
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Appendix H: pilot RCT consent form 
Version 2: 8th February 2012 
<<<TO BE PRINTED ON LOCAL HEADED PAPER>>> 
 
CONSENT FORM – Randomisation 
UK FASHIoN  
Chief Investigator: Professor Damian Griffin 
 
 
1. I confirm that I have read and understand the information sheet dated  
8th February, 2012 – version 2 for the above study.  I have had the 
opportunity to consider the information, ask questions and have had these 
answered satisfactorily. 
 
 
2. I understand that my participation is voluntary and that I am free to withdraw 
at any time, without giving any reason, without my medical care or legal rights 
being affected. 
 
 
3. I understand that relevant sections of any of my medical notes and data 
collected during the study may be looked at by responsible individuals from 
the University of Warwick, from regulatory authorities, or from the NHS trust, 
where it is relevant to my taking part in this research.  I give permission for 
these individuals to have access to my records. 
 
 
4. I agree to my GP being informed of my participation 
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5. I agree to take part in the above study. 
 
 
                
                                                                                                                          
________________________ ____________ _____________ 
Name of Patient Date Signature 
 
 
_________________________ _____________ _____________ 
Name of Person taking consent Date Signature 
 
_________________________ 
Role of person taking consent 
 
Copies 
1 for Patient, 1 for Hospital Notes 
Original document retained in site file  
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Appendix I: Personalised Hip Therapy Case Report Form 
 
 
Appendix J: Six week telephone complications questions 
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In the past 6 weeks has the patient experienced or been treated for any of the following events? 
i) Please complete for patients who have undergone hip arthroscopy ONLY. 
1. Numbness in the groin leg or foot?   Yes  No 
If yes, please give details:          
 
            
 
2. Wound infection?         Yes   No 
 
 Was the wound  i) Deep  ii) Superficial 
 
 Was a course of antibiotics prescribed?     Yes   No 
  
 Was further surgery required?      Yes   No 
  
3. Hip fracture (break)         Yes   No  
If yes, please give details:          
 
            
4. Further surgery because of your hip impingement?     Yes  No  
If yes, please give details:          
 
ii) Please complete for ALL patients 
1. Problems with pain medications for your hip impingement?      Yes    No  
If yes, please give details:          
 
            
 
2. Problems with hip joint injections       Yes    No 
If yes, please give details:          
 
            
 
3. Muscle soreness from exercises that you have been undertaking? Yes   No 
If yes, please give details:          
 
            
 
4. 
 
A regional pain syndrome?        Yes   No 
If yes, please give details:          
           
  
5. Deep Vein Thrombosis (DVT)?     Yes  No 
  
  
  
 If yes, were you prescribed medication?   Yes  No 
 
6. 
 
Any other complications?     Yes  No 
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If yes, please give details:          
 
            
 
7. Have you had any other unscheduled appointment at hospital 
because of your hip impingement?    Yes  No  
If yes, please give details:          
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Appendix K: Three month complications questions 
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